<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5102</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26903812</article-id>
<article-id pub-id-type="pmc">4751280</article-id>
<article-id pub-id-type="doi">10.3389/fncel.2016.00027</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Marinelli</surname>
<given-names>Carla</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bertalot</surname>
<given-names>Thomas</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zusso</surname>
<given-names>Morena</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
<uri xlink:href="http://loop.frontiersin.org/people/298494/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Skaper</surname>
<given-names>Stephen D.</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
<uri xlink:href="http://loop.frontiersin.org/people/296816/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Giusti</surname>
<given-names>Pietro</given-names>
</name>
<xref ref-type="aff" rid="aff1"></xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/296811/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Department of Pharmaceutical and Pharmacological Sciences, University of Padua</institution>
<country>Padua, Italy</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Tycho M. Hoogland, Erasmus MC, Netherlands</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Gonzalo Alvarez-Bolado, University of Heidelberg, Germany; Tobias David Merson, Florey Institute of Neuroscience and Mental Health, Australia</p>
</fn>
<corresp id="fn001">*Correspondence: Pietro Giusti <email xlink:type="simple">pietro.giusti@unipd.it</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>12</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>10</volume>
<elocation-id>27</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>11</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>1</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 Marinelli, Bertalot, Zusso, Skaper and Giusti.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Marinelli, Bertalot, Zusso, Skaper and Giusti</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Oligodendrogenesis and oligodendrocyte precursor maturation are essential processes during the course of central nervous system development, and lead to the myelination of axons. Cells of the oligodendrocyte lineage are generated in the germinal zone from migratory bipolar oligodendrocyte precursor cells (OPCs), and acquire cell surface markers as they mature and respond specifically to factors which regulate proliferation, migration, differentiation, and survival. Loss of myelin underlies a wide range of neurological disorders, some of an autoimmune nature—multiple sclerosis probably being the most prominent. Current therapies are based on the use of immunomodulatory agents which are likely to promote myelin repair (remyelination) indirectly by subverting the inflammatory response, aspects of which impair the differentiation of OPCs. Cells of the oligodendrocyte lineage express and are capable of responding to a diverse array of ligand-receptor pairs, including neurotransmitters and nuclear receptors such as γ-aminobutyric acid, glutamate, adenosine triphosphate, serotonin, acetylcholine, nitric oxide, opioids, prostaglandins, prolactin, and cannabinoids. The intent of this review is to provide the reader with a synopsis of our present state of knowledge concerning the pharmacological properties of the oligodendrocyte lineage, with particular attention to these receptor-ligand (i.e., neurotransmitters and nuclear receptor) interactions that can influence oligodendrocyte migration, proliferation, differentiation, and myelination, and an appraisal of their therapeutic potential. For example, many promising mediators work through Ca<sup>2+</sup> signaling, and the balance between Ca<sup>2+</sup> influx and efflux can determine the temporal and spatial properties of oligodendrocytes (OLs). Moreover, Ca<sup>2+</sup> signaling in OPCs can influence not only differentiation and myelination, but also process extension and migration, as well as cell death in mature mouse OLs. There is also evidence that oligodendroglia exhibit Ca<sup>2+</sup> transients in response to electrical activity of axons for activity-dependent myelination. Cholinergic antagonists, as well as endocannabinoid-related lipid-signaling molecules target OLs. An understanding of such pharmacological pathways may thus lay the foundation to allow its leverage for therapeutic benefit in diseases of demyelination.</p>
</abstract>
<kwd-group>
<kwd>oligodendrocyte</kwd>
<kwd>GABA</kwd>
<kwd>glutamatergic</kwd>
<kwd>cholinergic</kwd>
<kwd>muscarinergic</kwd>
<kwd>opioids</kwd>
<kwd>nuclear receptor</kwd>
<kwd>regeneration</kwd>
</kwd-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="282"></ref-count>
<page-count count="19"></page-count>
<word-count count="17055"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="introduction">
<title>Introduction</title>
<p>The central nervous system (CNS) relies on a network of neuronal cells to transmit electrical impulses known as action potentials along the axon. A lipid-rich membrane, myelin (Virchow, <xref ref-type="bibr" rid="B259">1854</xref>), insulates the axon and allows for rapid conduction of such impulses and proper delivery to the target cell (Hartline and Colman, <xref ref-type="bibr" rid="B119">2007</xref>). Schwann cells supply myelin for the peripheral nervous system (PNS), whereas in the CNS, oligodendrocytes (OLs; Iglesias-Rozas and Garrosa, <xref ref-type="bibr" rid="B129">2012</xref>) are responsible for myelin production, and are generated in the germinal zone from migratory bipolar oligodendrocyte precursor cells (OPCs; Grinspan, <xref ref-type="bibr" rid="B110">2002</xref>; Brazel et al., <xref ref-type="bibr" rid="B35">2003</xref>). Myelinating OLs not only provide trophic support for axons, but also release lactate through the monocarboxylate transporter 1 which is then utilized by axons for mitochondrial adenosine triphosphate (ATP) generation (Saab et al., <xref ref-type="bibr" rid="B213">2013</xref>). The migration of OPCs is influenced by receptor-ligand adhesions with the extracellular matrix, such as integrins, and signaling molecules (Soliven, <xref ref-type="bibr" rid="B231">2001</xref>) which may provide a critical link between neuronal cell activity and OPCs. Cells of the OL lineage acquire cell surface markers with maturation and respond specifically to factors which regulate proliferation, migration, differentiation, and survival (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p><bold>Stages of oligodendrocyte maturation toward the oligodendroglial lineage: oligodendrocyte precursor cells (OPCs), preoligodendrocytes (pre-OLs), immature oligodendrocytes (OLs) and myelinating mature OLs.</bold> These stages are identified by their increasingly complex morphology and expression pattern of well-defined markers. Two basic helix-loop-helix transcription factors, Olig1 and Olig2, play essential roles in determining the oligodendroglial lineage and in the generation and maturation of OLs (Zhou et al., <xref ref-type="bibr" rid="B279">2000</xref>; Lu et al., <xref ref-type="bibr" rid="B156">2001</xref>). The localization of Olig1/2 is observed in the nucleus of OPCs during development; however, although Olig2 remains in the nucleus of OPCs in the adult mouse (Arnett et al., <xref ref-type="bibr" rid="B9">2004</xref>), Olig1 translocation into the cytosol highly correlates with the differentiation of OLs, the termination of the cell cycle and Olig1 phosphorylation (Niu et al., <xref ref-type="bibr" rid="B186">2012</xref>). CNPase, 2′,3′-cyclic nucleotide 3′-phosphodiesterase; GalC, galactocerebroside C; MAG, myelin associated glycoprotein; MBP, myelin basic protein; MOG, myelin oligodendrocyte glycoprotein; PDGF-Rα, platelet-derived growth factor receptor; PLP, proteolipid protein.</p>
</caption>
<graphic xlink:href="fncel-10-00027-g0001"></graphic>
</fig>
<p>Impairment of one or more of these processes can lead to myelin degeneration, dysfunction or loss in nerve signal conduction and ultimately, nerve deterioration (Felts et al., <xref ref-type="bibr" rid="B87">1997</xref>; Mensch et al., <xref ref-type="bibr" rid="B170">2015</xref>). Loss of myelin results in a wide range of neurological disorders, including reduced motor function, impaired cognitive abilities, and vision problems. Demyelinating diseases of the CNS include multiple sclerosis (MS), acute disseminated encephalomyelitis, neuromyelitis optica, transverse myelitis, central pontine myelinolysis and leukodystrophy, while those of the PNS include chronic inflammatory demyelinating polyneuropathy, Guillain-Barré syndrome and Charcot-Marie-Tooth disease (<ext-link ext-link-type="uri" xlink:href="http://www.neurodegenerationresearch.eu/about/what">http://www.neurodegenerationresearch.eu/about/what</ext-link>). Perinatal white matter (WM) injury, or periventricular leukomalacia, is the most common cause of brain injury in premature infants and is the leading cause of cerebral palsy. Late OPCs exhibit selective vulnerability in this last pathology (Back et al., <xref ref-type="bibr" rid="B15">2007</xref>). Contrary to what was once believed, we now know that the mammalian CNS can undergo neurogenesis and gliogenesis, re-establishing axon-glial interactions needed for remyelination (Compston, <xref ref-type="bibr" rid="B58">2002</xref>). Importantly, cells of the OL lineage express and respond to a broad range of receptor-ligand pairs, in particular neurotransmitters and nuclear receptors (NRs) like glutamate (Glu), γ-aminobutyric acid (GABA), ATP, serotonin, acetylcholine (ACh), nitric oxide (NO), opioids, prostaglandins, prolactin (PRL), cannabinoids and the superfamilty of NRs (steroid hormones, sex hormones, oxysterols, vitamin D3, thyroid hormone (TH), retinoic acid, fatty acid amides). Clearly, knowledge about the OL lineage has increased greatly over the past few years, with attention shifting towards manipulation of that lineage for therapeutic purposes. This review is intended to provide an overview of current knowledge on the pharmacological properties of the OL lineage, with particular attention to these receptor-ligand interactions and how they may influence OL migration, proliferation, differentiation, and myelination, together with an appraisal of their therapeutic potential. In this context, a number of mediators work through Ca<sup>2+</sup> signaling, with the balance between Ca<sup>2+</sup> influx and efflux determining the temporal and spatial properties of OLs. Moreover, Ca<sup>2+</sup> signaling in OPCs can influence not only differentiation and myelination, but also process extension and migration, as well as cell death in mature mouse OLs. Research until now has identified cholinergic antagonists, as well as endocannabinoid-related lipid-signaling molecules with the ability to target OLs. Understanding the above-mentioned relationships may help to delineate additional new therapeutic avenues for remyelination/repair. The main systems examined are briefly summarized on Figure <xref ref-type="fig" rid="F2">2</xref>.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p><bold>Expression of neurotransmitter and other signaling receptors during oligodendrocyte maturation</bold>. ADP, adenosine diphosphate; ATP, adenosine triphosphate; β-ARs, β-adrenoreceptors; DA, dopamine; GABA, γ-aminobutyric acid; GLU, glutamate; NE, norepinephrine; 5-HT, 5-hydroxytryptamine; NO, nitric oxide.</p>
</caption>
<graphic xlink:href="fncel-10-00027-g0002"></graphic>
</fig>
</sec>
<sec id="s2" sec-type="materials and methods">
<title>Materials and Methods</title>
<p>The literature search for this review was carried out according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines as they apply to systematic reviews (Moher et al., <xref ref-type="bibr" rid="B176">2010</xref>). The search strategy is given after Conclusion and Perspectives. A total of 387 manuscripts were retrieved. Exclusion criteria are given in Figure <xref ref-type="fig" rid="F3">3</xref>. In all, 279 articles remained for this review.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p><bold>Study inclusion flowchart</bold>. This depicts the methodology for search and collection of relevant articles for this review, following PRISMA guidelines.</p>
</caption>
<graphic xlink:href="fncel-10-00027-g0003"></graphic>
</fig>
<sec id="s2-1">
<title>GABAergic Signals</title>
<p>GABA is the main inhibitory neurotransmitter in adult brain (Koós and Tepper, <xref ref-type="bibr" rid="B143">1999</xref>; Markram et al., <xref ref-type="bibr" rid="B160">2004</xref>; Takesian and Hensch, <xref ref-type="bibr" rid="B239">2013</xref>), where it binds two main receptor types: fast hyperpolarizing ionotropic GABA<sub>A</sub> receptors and metabotropic GABA<sub>B</sub> receptors.</p>
<p>GABA participation in inhibitory neurotransmission is limited in adulthood, as in many brain regions during early development activation of GABA<sub>A</sub> receptors excites neurons through activation of Na-K-Cl cotransporter1 (NKCC1) symporter which increases extracellular K<sup>+</sup> and a depolarizing efflux of Cl<sup>−</sup>, in turn triggering Ca<sup>2+</sup> influx (Dzhala et al., <xref ref-type="bibr" rid="B80">2005</xref>). Similarly OPCs, but not OLs, express NKCC1. Muscimol, a GABA<sub>A</sub> agonist, increases intracellular Ca<sup>2+</sup> [Ca<sup>2+</sup>]<sub>i</sub> protecting cultured OLs following withdrawal of culture medium supplements (N1, biotin, platelet-derived growth factor, PDGF; Wang et al., <xref ref-type="bibr" rid="B263">2003</xref>). Using the GABA<sub>A</sub> receptor antagonist pentylentetrazole, Mensch et al. (<xref ref-type="bibr" rid="B170">2015</xref>) showed a subtle increase in the number of OLs and a 40% increase in the number of myelin sheaths in the zebrafish ventral spinal cord. OLs may express also GABA<sub>B</sub> receptors, whose activation increases proliferation and migration of OPCs via a negatively coupled adenlyl cyclase signaling pathway. The GABA<sub>B</sub> receptor agonist baclofen significantly reduced cyclic adenosine monophosphate and adenlyl cyclase and led to an increase in OPC migration (Luyt et al., <xref ref-type="bibr" rid="B158">2007</xref>).</p>
</sec>
<sec id="s2-2">
<title>Glutamatergic Signals</title>
<p>Glu, the principal excitatory neurotransmitter, acts on postsynaptic ionotropic and G-protein-coupled metabotropic (mGluR) receptors. The former comprise the ligand-gated ion channel N-methyl-D-aspartate (NMDA), alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) and kainate receptor subtypes (Dingledine et al., <xref ref-type="bibr" rid="B73">1999</xref>; Swanson et al., <xref ref-type="bibr" rid="B235">2005</xref>). These receptors are expressed by glial cells in both gray matter (Jabs et al., <xref ref-type="bibr" rid="B132">2005</xref>; Matute, <xref ref-type="bibr" rid="B164">2006</xref>; Bakiri et al., <xref ref-type="bibr" rid="B17">2009</xref>) and WM (Matute, <xref ref-type="bibr" rid="B165">2010</xref>). Virtually all neurons expressing ionotropic Glu receptors are sensitive to excitotoxic injury (Choi, <xref ref-type="bibr" rid="B51">1988</xref>; Lipton and Rosenberg, <xref ref-type="bibr" rid="B152">1994</xref>). Glu is toxic also for astrocytes (Haas and Erdö, <xref ref-type="bibr" rid="B114">1991</xref>) and OLs (Matute et al., <xref ref-type="bibr" rid="B166">1997</xref>; McDonald et al., <xref ref-type="bibr" rid="B168">1998</xref>).</p>
<p>Cells of the OL lineage express functional AMPA and kainate-type Glu receptors throughout their development and across species, including man. NMDA receptors on both immature and mature OLs can be activated during injury (Káradóttir et al., <xref ref-type="bibr" rid="B135">2005</xref>; Salter and Fern, <xref ref-type="bibr" rid="B215">2005</xref>; Micu et al., <xref ref-type="bibr" rid="B172">2006</xref>). OLs express as well all three groups of metabotropic Glu receptors in a developmentally-regulated fashion (Deng et al., <xref ref-type="bibr" rid="B70">2004</xref>; Spampinato et al., <xref ref-type="bibr" rid="B233">2015</xref>). In addition to astrocytes, OLs also express glutamate transporters, mainly the Glu aspartate transporter (GLAST; EAAT1 in the modern nomenclature). The neuronal transporter, termed excitatory amino acid carrier 1 (EAAC1; EAAT3 in the modern nomenclature), is present in a subpopulation of adult OPCs (Domercq et al., <xref ref-type="bibr" rid="B75">1999</xref>).</p>
<p>Primary cells of the OL lineage are highly vulnerable to a form of excitotoxic injury mediated by a transporter-related mechanism involving inhibition of cystine uptake, glutathione depletion and oxidative stress (Oka et al., <xref ref-type="bibr" rid="B192">1993</xref>). Alterations in Glu homeostasis in WM may thus determine injury to OLs and myelin. Prolonged activation of GluRs is toxic to primary OLs <italic>in vitro</italic> and <italic>in vivo</italic> (Matute et al., <xref ref-type="bibr" rid="B166">1997</xref>; McDonald et al., <xref ref-type="bibr" rid="B168">1998</xref>; Li and Stys, <xref ref-type="bibr" rid="B151">2000</xref>).</p>
<p>Activation of AMPA and kainate receptors on microglia leads to the release of tumour necrosis factor-α (TNF-α), which can potentiate Glu neurotoxicity and kill OLs, destroy myelin and damage axons (Merrill and Benveniste, <xref ref-type="bibr" rid="B171">1996</xref>). Inflammatory cytokines like TNF-α and interleukin-1β released by reactive microglia can impair Glu uptake and trigger excitotoxic OL death (Takahashi et al., <xref ref-type="bibr" rid="B238">2003</xref>). Indeed, inhibiting the expression and function of Glu transporters in axonal tracts is sufficient to induce OL loss and demyelination (Domercq et al., <xref ref-type="bibr" rid="B74">2005</xref>). AMPA receptors on OLs lack GluR2 subunits, suggesting a higher Ca<sup>2+</sup> permeability than for these cells in gray matter (Matute, <xref ref-type="bibr" rid="B164">2006</xref>).</p>
<p>Myelin regeneration can occur spontaneously, even in pathological conditions such as MS. Using an <italic>in vivo</italic> remyelination model, Gautier et al. (<xref ref-type="bibr" rid="B101">2015</xref>) demonstrated that demyelinated axons are electrically active and generate <italic>de novo</italic> synapses with recruited OPCs which, early after lesion induction, sense neuronal activity by expressing AMPA/kainate receptors. Furthermore, blocking neuronal activity, axonal vesicular release or AMPA receptors in demyelinated lesions results in reduced remyelination. In the absence of neuronal activity there is a ~6-fold increase in OPC number within the lesions and a reduced proportion of differentiated OLs. These findings reveal that neuronal activity and release of glutamate instruct OPCs to differentiate into new myelinating OLs that recover lost function (Gautier et al., <xref ref-type="bibr" rid="B101">2015</xref>).</p>
<p>Another mechanism of Glu action on OPC differentiation involves activation of specific NMDA receptor subunits, as NMDAR1 and NMDAR2A protein levels increase during differentiation whereas NMDAR2B and NMDAR3 levels decrease (Sawada et al., <xref ref-type="bibr" rid="B219">1996</xref>; Cavaliere et al., <xref ref-type="bibr" rid="B44">2012</xref>). These authors showed that activation of NMDA receptors during OLs differentiation elevated cytosolic Ca<sup>2+</sup> levels and promoted myelination when co-cultured with neurons. NMDA receptors on multipotent stem cells promote maturation of OLs and favor myelination through production of reactive oxygen species; levels of the latter correlate with degree of differentiation, an effect negatively modulated by the NADPH inhibitor apocynin (Cavaliere et al., <xref ref-type="bibr" rid="B44">2012</xref>). Interestingly, NMDA receptors are expressed in clusters on OL processes, whereas AMPA and kainate receptors are diffusely located on the cell somata (Káradóttir et al., <xref ref-type="bibr" rid="B135">2005</xref>; Salter and Fern, <xref ref-type="bibr" rid="B215">2005</xref>; Micu et al., <xref ref-type="bibr" rid="B172">2006</xref>).</p>
<p>Activation of mGlu4 on astrocytes appears to be involved in sparing OLs from excitotoxic challenge (Spampinato et al., <xref ref-type="bibr" rid="B233">2015</xref>), hinting that they may be a novel target to protect from demyelination. Other pharmacological approaches, such as ionotropic Glu receptor antagonists, increase OL survival but have no effect on neuroinflammation (Pitt et al., <xref ref-type="bibr" rid="B199">2000</xref>). A close interplay between astrocytes and OLs is supported by the observation that kainate-induced toxicity is attenuated by stimulation of mGlu4 receptors only in a mixed culture of OLs and astrocytes; the mGlu4 receptor agonist L-AP4 does not act directly on OLs. Activation of mGluRs, including mGlu4 on astrocytes, is reported to be neuroprotective (Yao et al., <xref ref-type="bibr" rid="B274">2005</xref>; Corti et al., <xref ref-type="bibr" rid="B61">2007</xref>).</p>
<p>Soluble factors released by astrocytes might mediate L-AP4-increased OL viability. Transforming growth factor beta 1, which increases upon L-AP4 treatment, protects OLs from kainate-induced toxicity (Spampinato et al., <xref ref-type="bibr" rid="B233">2015</xref>), an effect attenuated by a neutralizing anti-transforming growth factor beta 1 antibody. Factors that contribute to Glu homeostasis include glutaminase, which is present in OLs and microglia (Domercq et al., <xref ref-type="bibr" rid="B75">1999</xref>; Werner et al., <xref ref-type="bibr" rid="B265">2001</xref>). Non-toxic concentrations of Glu acting at kainate receptors can induce OL death also by sensitizing these cells to complement attack (Alberdi et al., <xref ref-type="bibr" rid="B3">2006</xref>), an action mediated by proteolysis of complement protein C5 to generate the potent chemoattractant C5a which interacts with its G-protein-coupled receptor C5aR (CD88; Ward and Newman, <xref ref-type="bibr" rid="B2630">1969</xref>) on OLs and other CNS cells (Nataf et al., <xref ref-type="bibr" rid="B184">2001</xref>).</p>
<p>In conclusion, factors that evoke an increase in [Ca<sup>2+</sup>]<sub>i</sub> can regulate cell proliferation, survival, growth and differentiation or induce a pathological condition, as a function of OL developmental stage.</p>
</sec>
<sec id="s2-3">
<title>Purinergic Signals</title>
<p>ATP is a co-transmitter released with other “classical” transmitters and activates ionotropic (P2X) and metabotropic (P2Y) receptors (Ralevic and Burnstock, <xref ref-type="bibr" rid="B203">1998</xref>; North, <xref ref-type="bibr" rid="B189">2002</xref>). In the CNS, ATP can be released by neurons and glia via membrane transporters, vesicles, and ATP-permeable channels (Fields and Stevens, <xref ref-type="bibr" rid="B89">2000</xref>; Ballerini et al., <xref ref-type="bibr" rid="B18">2002</xref>; Coco et al., <xref ref-type="bibr" rid="B54">2003</xref>). OPCs express several ionotropic (P2X<sub>1,2,3,4,7</sub>) and metabotropic (P2Y<sub>1,2,4</sub>) receptors, with P2X<sub>7</sub> and P2Y<sub>1</sub> receptors being the main ionotropic and metabotropic P2 receptors, respectively (Agresti et al., <xref ref-type="bibr" rid="B2">2005</xref>). ATP and adenosine diphosphate (ADP) may regulate OPC functions through P2Y<sub>1</sub> receptors. For example, ATP and ADP (the P2Y<sub>1</sub>-specific agonist ADPbS) induced OPC migration. Moreover, ATP and ADP inhibited OPC proliferation induced by PDGF in purified cell cultures and in cerebellar tissue slices (Agresti et al., <xref ref-type="bibr" rid="B2">2005</xref>). These effects of ATP and ADP on cell migration and proliferation were being blocked by a P2Y<sub>1</sub> antagonist (MRS2179). P2Y1 receptors localize to NG2-labeled OPCs in the developing rat brain (Agresti et al., <xref ref-type="bibr" rid="B2">2005</xref>).</p>
<p>OPC migration involves the interactive effects of growth factors, chemokines, integrins, neurotransmitters, and extracellular matrix molecules (Decker et al., <xref ref-type="bibr" rid="B68">2000</xref>; Tsai and Miller, <xref ref-type="bibr" rid="B252">2002</xref>). PDGF and basic fibroblast growth factor induce OPC migration <italic>in vitro</italic>, acting mainly as chemotactic stimuli (Armstrong et al., <xref ref-type="bibr" rid="B8">1990</xref>; Milner et al., <xref ref-type="bibr" rid="B173">1997</xref>), while ATP enhances the migration of OPCs by stimulating predominantly random motility and to a lesser extent, chemotaxis (Agresti et al., <xref ref-type="bibr" rid="B2">2005</xref>). These authors propose that ATP, acting mainly at P2Y<sub>1</sub> receptors, may be important in stimulating OPC migration along a chemotactic gradient towards specific sites. However, under pathological conditions the P2X<sub>7</sub> receptor is involved in OPC migration (Feng et al., <xref ref-type="bibr" rid="B88">2015</xref>). High concentrations of ATP or the P2X<sub>7</sub> receptor agonist BzATP increased the number of migrating OPCs <italic>in vitro</italic>, while pre-treatment with the P2X<sub>7</sub> receptor antagonist oxidized ATP decreased the promotive effect. This effect appeared to depend on Fyn, a member of the Src family of kinases (Feng et al., <xref ref-type="bibr" rid="B88">2015</xref>).</p>
<p>Differentiated OLs <italic>in vitro</italic> express functional P2X and P2Y receptors, which can act as mediators of axono-oligodendroglial communication during myelination (Alberdi et al., <xref ref-type="bibr" rid="B4">2005</xref>). P2X<sub>1</sub> and P2X<sub>3</sub> receptors produce rapidly desensitizing currents whereas P2X<sub>7</sub> receptors, as well as P2X<sub>2</sub> and P2X<sub>4</sub> receptors, may undergo a conformational change which results in formation of a large pore upon prolonged exposure to ATP (Khakh et al., <xref ref-type="bibr" rid="B140">1999</xref>). ATP signaling can directly trigger OL excitotoxicity via activation of Ca<sup>2+</sup>-permeable P2X<sub>7</sub> receptors, leading to WM lesions reminiscent of MS plaques (Walz et al., <xref ref-type="bibr" rid="B262">1993</xref>; Butt, <xref ref-type="bibr" rid="B36">2006</xref>).</p>
</sec>
<sec id="s2-4">
<title>Serotoninergic Signals</title>
<p>Serotonin (5-hydroxytryptamine, 5-HT) plays critical roles in early neural development, being involved in neuronal cell differentiation and migration, axonal growth and pathfinding, dendritic arborization, synaptogenesis, circuit formation, and neuronal plasticity (Daubert and Condron, <xref ref-type="bibr" rid="B63">2010</xref>). Mice with either 5-HT transporter (Esaki et al., <xref ref-type="bibr" rid="B82">2005</xref>) or monoamine oxidase A gene deficiencies (Cases et al., <xref ref-type="bibr" rid="B43">1996</xref>) show disrupted primary somatosensory cortical organization.</p>
<p>Depression is reported to be accompanied by myelin and OL abnormalities (Yamazaki et al., <xref ref-type="bibr" rid="B271">2007</xref>), including a significant reduction in myelin basic protein (MBP) expression in multiple brain areas of post-mortem samples from depressed patients (Honer et al., <xref ref-type="bibr" rid="B123">1999</xref>; Taylor et al., <xref ref-type="bibr" rid="B243">2004</xref>; Regenold et al., <xref ref-type="bibr" rid="B205">2007</xref>). Further, Aston et al. (<xref ref-type="bibr" rid="B11">2005</xref>) found in temporal cortex a down-regulation of both OL development-related and myelin formation-related genes.</p>
<p>Manipulation of 5-HT levels in postnatal day 6–8 rats with selective 5-HT reuptake inhibitors (SSRIs; Xu et al., <xref ref-type="bibr" rid="B270">2004</xref>) or <italic>p</italic>-chlorophenylalanine-induced 5-HT depletion (Persico et al., <xref ref-type="bibr" rid="B197">2000</xref>) leads to disorganized cortical barrel fields, abnormal social behavior, callosal myelin malformation, and OL pathology. 5-HT receptor subtypes 1A and 2A have been found in OL lineages and to co-localize with developmental lineage-selective markers (Fan et al., <xref ref-type="bibr" rid="B85">2015</xref>). Exposure to 5-HT not only disturbed development of OLs with aberrant process outgrowth and reduced MBP and proteolipid protein (PLP) expression, but even caused a developmentally-dependent cell death at the highest doses via 5-HT<sub>2A</sub>. By means of a neuron-OL myelination co-culture model, Fan et al. (<xref ref-type="bibr" rid="B85">2015</xref>) demonstrated that 5-HT exposure alters the localization and regular space patterns of the paranodal contactin-associated protein (Caspr), but did not cause OL death or reduce OL density. These authors suggested that 5-HT exposure induces a diffuse and enlarged pattern affecting other axon-derived factors for myelination.</p>
<p>It is tempting to speculate that manipulation of 5-HT levels affects OL development and myelination, thereby contributing to the altered neural connectivity seen in SSRI-treated animals (Simpson et al., <xref ref-type="bibr" rid="B226">2011</xref>). SSRIs (Loughhead et al., <xref ref-type="bibr" rid="B155">2006</xref>) and serotonin/norepinephrine reuptake inhibitors (Wang et al., <xref ref-type="bibr" rid="B264">2014</xref>), which are widely prescribed for major depression in pregnant women, are able to cross the placenta and reach fetal compartments. Animal data suggest that extracellular 5-HT levels in CNS could rise up to 20-fold upon SSRI exposure (Tao et al., <xref ref-type="bibr" rid="B240">2000</xref>). Such high levels of extracellular 5-HT may adversely affect OL development and/or myelination, perhaps contributing to altered neural connectivity seen in depression and in autism spectrum disorders. Further, the late maturation of human myelin, especially in prefrontal cortex has potential implications in the treatment of humans with SSRIs in early adolescence or young adulthood.</p>
<p>Spinal cord injury (SCI) causes secondary damage involving OL cell death and axon demyelination. SSRIs like fluoxetine improve neurological outcome in animal models of SCI by inhibiting microglia activation which can cause the death of OLs. The underlying mechanism involves inhibition of p38 mitogen-activated protein kinase (p38-MAPK) and pro-nerve growth factor expression. In addition, fluoxetine can attenuate Ras homolog gene family member A activation, decrease the level of phosphorylated c-Jun and alleviate activation of caspase-3. Fluoxetine may thus be a novel therapeutic agent for acute SCI in humans (Lee et al., <xref ref-type="bibr" rid="B149">2015</xref>).</p>
</sec>
<sec id="s2-5">
<title>Catecholaminergic Signals</title>
<p>The brain’s principal catecholamine neurotransmitters include 3,4-dihydroxyphenethylamine (dopamine, DA) and 4,5-β-trihydroxyphenethylamine (norepinephrine, NE). DA controls locomotor activity, cognition, emotion, positive reinforcement, food intake, and endocrine regulation (Missale et al., <xref ref-type="bibr" rid="B174">1998</xref>). Neuropsychiatric and motor function disorders like schizophrenia and Parkinson’s disease (PD) are often linked to abnormal DA signaling (Civelli et al., <xref ref-type="bibr" rid="B53">1993</xref>). DA receptors can be divided into two main groups: D<sub>1</sub>-like (D<sub>1</sub> and D<sub>5</sub>; Sunahara et al., <xref ref-type="bibr" rid="B234">1991</xref>; Tiberi et al., <xref ref-type="bibr" rid="B247">1991</xref>) and D<sub>2</sub>-like (D<sub>2</sub>, D<sub>3</sub>, D<sub>4</sub>; Sokoloff et al., <xref ref-type="bibr" rid="B230">1990</xref>; Van Tol et al., <xref ref-type="bibr" rid="B255">1991</xref>; Sawada et al., <xref ref-type="bibr" rid="B218">1998</xref>).</p>
<p>D<sub>2</sub> and D<sub>3</sub> receptors are expressed by differentiated rat cortical OLs (Rosin et al., <xref ref-type="bibr" rid="B211">2005</xref>), although little is known about their role(s) in OL biology. Cortical OLs <italic>in vitro</italic> are vulnerable to receptor-independent Glu-induced cell death (Oka et al., <xref ref-type="bibr" rid="B192">1993</xref>; Rosin et al., <xref ref-type="bibr" rid="B210">2004</xref>) which involves oxidative stress, inhibition of cystine uptake and depletion of intracellular stores of reduced glutathione (Murphy et al., <xref ref-type="bibr" rid="B182">1990</xref>). Glu-induced death of cortical OLs was protected by co-treatment with either D<sub>2</sub> or D<sub>3</sub> agonists (Avenell et al., <xref ref-type="bibr" rid="B14">1999</xref>) and appeared to involve quinpirole-sensitive activation of MAPK/extracellular signal-regulated kinase and oxidative stress (Rosin et al., <xref ref-type="bibr" rid="B211">2005</xref>). The protective effect of quinpirole was fully attenuated by the D<sub>2</sub> receptor antagonist L-741,626 (Avenell et al., <xref ref-type="bibr" rid="B13">1998</xref>). Intriguingly, oxygen/glucose deprivation up-regulated expression of D<sub>2</sub> and D<sub>3</sub> receptors over a much shorter time scale (2 h) compared to the time needed to induce injury (18 h; Rosin et al., <xref ref-type="bibr" rid="B211">2005</xref>). Cellular responsiveness to oxygen/glucose deprivation injury may depend on the state of OL maturation (Deng et al., <xref ref-type="bibr" rid="B69">2003</xref>). As D<sub>3</sub> receptors are expressed in differentiating OLs before terminal maturation, it is possible that DA plays a role in OL lineage differentiation and/or the formation of myelin by mature OLs (Bongarzone et al., <xref ref-type="bibr" rid="B34">1998</xref>).</p>
<p>NE is a hormone and neurotransmitter that affects brain areas involved in vigilant concentration. NE underlies the fight-or-flight response, directly increasing heart rate, triggering the release of glucose from energy stores, and increasing blood flow to skeletal muscle. OPCs express functional α- and β-adrenoreceptors (ARs). Response to NE is enhanced following OPC maturation into differentiated OLs: α<sub>1A</sub>-ARs induce phosphoinositide hydrolysis without effecting OPC proliferation, while β-ARs increase intracellular cyclic AMP and inhibit their proliferation (Cohen and Almazan, <xref ref-type="bibr" rid="B55">1993</xref>; Ghiani et al., <xref ref-type="bibr" rid="B105">1999</xref>). The effects of NE can be mirrored by molecules like phorbol esters, which mimic the action of second messengers, leading to inhibition of terminal differentiation of OLs and block of myelin-specific protein expression (Baron et al., <xref ref-type="bibr" rid="B20">1998</xref>). Protein kinase C activators work at a later stage of differentiation to facilitate myelination (Vartanian et al., <xref ref-type="bibr" rid="B256">1986</xref>; Asotra and Macklin, <xref ref-type="bibr" rid="B10">1993</xref>; Yong et al., <xref ref-type="bibr" rid="B276">1994</xref>).</p>
</sec>
<sec id="s2-6">
<title>Cholinergic Signals</title>
<p>ACh was the first identified neurotransmitter, and has important roles in neuron-glia signaling (Wessler et al., <xref ref-type="bibr" rid="B267">2001</xref>). ACh can act on different tissues and cell types (Proskocil et al., <xref ref-type="bibr" rid="B201">2004</xref>; Kawashima and Fuji, <xref ref-type="bibr" rid="B137">2008</xref>) to modulate growth, survival, differentiation, and apoptosis (Eglen, <xref ref-type="bibr" rid="B81">2005</xref>). While muscarinic cholinergic receptors can promote neuronal cell differentiation during neurogenesis (Lauder, <xref ref-type="bibr" rid="B147">1993</xref>; Tata et al., <xref ref-type="bibr" rid="B242">2003</xref>; Salani et al., <xref ref-type="bibr" rid="B214">2009</xref>), nicotinic cholinergic receptors affect inflammation centrally by modulating microglial release of cytokines, and peripherally through immune system cells (Tracey, <xref ref-type="bibr" rid="B249">2002</xref>; De Simone et al., <xref ref-type="bibr" rid="B67">2005</xref>; Kawashima and Fuji, <xref ref-type="bibr" rid="B137">2008</xref>). Several glial cell populations, including OLs express ACh receptors (Murphy et al., <xref ref-type="bibr" rid="B181">1986</xref>; Van Der Zee et al., <xref ref-type="bibr" rid="B254">1993</xref>; Rogers et al., <xref ref-type="bibr" rid="B209">2001</xref>; Loreti et al., <xref ref-type="bibr" rid="B154">2007</xref>).</p>
<p>Stimulation of muscarinic receptors on OLs (Larocca and Almazan, <xref ref-type="bibr" rid="B145">1997</xref>; Molina-Holgado et al., <xref ref-type="bibr" rid="B177">2003</xref>) activates MAPK and increases inositol trisphosphate levels and Ca<sup>2+</sup> waves (Ritchie et al., <xref ref-type="bibr" rid="B207">1987</xref>; Kastritsis and McCarthy, <xref ref-type="bibr" rid="B136">1993</xref>; Cohen and Almazan, <xref ref-type="bibr" rid="B56">1994</xref>; Larocca and Almazan, <xref ref-type="bibr" rid="B145">1997</xref>). Rat OPCs express all muscarinic receptors with particular abundance of M<sub>3</sub>, while mature OLs have barely detectable levels of all subtypes except for M<sub>2</sub>, suggesting a dynamic regulation during OL maturation (De Angelis et al., <xref ref-type="bibr" rid="B64">2011</xref>). Furthermore, specific physiological role(s) may be inferred from their diverse cellular distribution: M<sub>1</sub> and M<sub>3</sub> are localized in cell bodies and processes while M<sub>4</sub> is found only in the cell body (De Angelis et al., <xref ref-type="bibr" rid="B64">2011</xref>).</p>
<p>Muscarinic receptors can affect OPCs proliferation. For example, carbachol induces proliferation via both muscarinic and nicotinic cholinergic receptors (Peralta et al., <xref ref-type="bibr" rid="B196">1987</xref>; Cohen et al., <xref ref-type="bibr" rid="B57">1996</xref>). De Angelis et al. (<xref ref-type="bibr" rid="B64">2011</xref>) used selective muscarinic antagonists to discriminate receptor subtype involved in OPC proliferation. These authors showed that only M<sub>1</sub>, M<sub>3</sub> and M<sub>4</sub> antagonists were able to reduce proliferation. Indeed, gallamine did not affect proliferation via M<sub>2</sub> antagonism. In contrast, M<sub>2</sub> activation by arecaidine influenced OPC survival in a dose-dependent manner, showing toxic effects, indicating the involvement of M<sub>2</sub> in OPC survival (De Angelis et al., <xref ref-type="bibr" rid="B64">2011</xref>).</p>
<p>ACh receptors have been extensively studied in terms of expression levels of myelin proteins (i.e., MBP, PLP, and the myelin and lymphocyte protein). Muscarine treatment of cultured OPCs and mature OLs decreased expression of MBP (De Angelis et al., <xref ref-type="bibr" rid="B64">2011</xref>), although the drug’s effect on expression of other myelin proteins was equivocal, suggesting a specific role of muscarinic activation in MBP production and terminal differentiation of OLs (De Angelis et al., <xref ref-type="bibr" rid="B64">2011</xref>). However, it should be kept in mind that MBP is a marker for mature myelinating and non-myelinating OLs but not OPCs. Given their ability to control glial cell proliferation, M<sub>1</sub>, M<sub>3</sub> and M<sub>4</sub> muscarinic receptor antagonists (Felder et al., <xref ref-type="bibr" rid="B86">2000</xref>; Wess, <xref ref-type="bibr" rid="B266">2004</xref>; Langmead et al., <xref ref-type="bibr" rid="B144">2008</xref>; McArthur et al., <xref ref-type="bibr" rid="B167">2010</xref>) might be useful in the treatment of brain tumors such as gliomas and oligodendrogliomas (Guizzetti et al., <xref ref-type="bibr" rid="B112">1996</xref>; Loreti et al., <xref ref-type="bibr" rid="B154">2007</xref>; Tata and Calogero, <xref ref-type="bibr" rid="B241">2010</xref>).</p>
<p>Muscarinic drugs could also find utility in stem cell therapy, based on their capability to regulate myelin repair in demyelinating diseases such as MS (Goldman et al., <xref ref-type="bibr" rid="B107">2012</xref>). Abiraman et al. (<xref ref-type="bibr" rid="B1">2015</xref>), using OPCs isolated from human fetal forebrain showed that the potent, non-selective muscarinic receptor agonist oxotremorine-M reduces OL differentiation. In contrast, the selective M<sub>3</sub> antagonist darifenacin (Moriya et al., <xref ref-type="bibr" rid="B179">1999</xref>) failed to influence OL differentiation, suggesting that M<sub>3</sub> receptors are not expressed by human OPCs and/or that darifenacin does not act as an inverse agonist. However, when human OPCs were cultured with fetal human neuronal re-aggregates, ACh release from ACh<sup>+</sup> neurons delayed OPC differentiation in a darifenacin-sensitive manner, suggesting that M<sub>3</sub> antagonism could promote human OL differentiation (Abiraman et al., <xref ref-type="bibr" rid="B1">2015</xref>). Further, solifenacin, a blood-brain barrier-permeable analog of darifenacin, promoted differentiation and myelination in neonatal mice transplanted with human OPCs (Maruyama et al., <xref ref-type="bibr" rid="B161">2008</xref>). Collectively, these findings encourage the view that such pharmacological treatments could one day serve to induce resident OPC differentiation and improve outcome in demyelinating diseases such as MS, where OL differentiation is impaired (Franklin and Kotter, <xref ref-type="bibr" rid="B92">2008</xref>; Franklin and ffrench-Constant, <xref ref-type="bibr" rid="B93">2008</xref>).</p>
</sec>
<sec id="s2-7">
<title>Nitric Oxide</title>
<p>NO is a gaseous, cell-penetrant neurotransmitter. Under physiological conditions NO is present in the picomolar-nanomolar range in the CNS (Hall and Garthwaite, <xref ref-type="bibr" rid="B115">2009</xref>), where it is generated by neuronal NO synthase (nNOS) in response to NMDA receptor-triggered rises in [Ca<sup>2+</sup>]<sub>i</sub> (Hall and Garthwaite, <xref ref-type="bibr" rid="B115">2009</xref>). NO stimulates specialized guanylyl cyclase-coupled receptors to generate cyclic GMP (Garthwaite, <xref ref-type="bibr" rid="B100">2008</xref>; Hardingham et al., <xref ref-type="bibr" rid="B117">2013</xref>). Neurons and astrocytes are the principal targets of NO, although neuronally-derived NO may also act on the microvasculature to regulate blood flow (Yang et al., <xref ref-type="bibr" rid="B272">2003</xref>). NO, superoxide, and hydrogen peroxide regulate MBP phosphorylation which contributes to neuron–oligodendrocyte signaling by promoting stability of the myelin sheath (Atkins and Sweatt, <xref ref-type="bibr" rid="B12">1999</xref>).</p>
<p>The cerebellum is an important area for motor control and one in which NO-cyclic GMP signaling contributes to synaptic plasticity and other phenomena (Garthwaite, <xref ref-type="bibr" rid="B100">2008</xref>; Contestabile, <xref ref-type="bibr" rid="B60">2012</xref>). Myelination in the rat cerebellum begins in the central WM at around postnatal day 6 (P6) and proceeds along the axial core of the lobules to appear in the internal granule cell layer 4–6 days later (Gianola et al., <xref ref-type="bibr" rid="B106">2003</xref>). The development of OL NO-reactivity between P3 and P8 would be consistent with its role in this process. In cortical cell cultures, NO and cyclic GMP enhance arborization of OLs. Compounds that increase NO activity promote OL growth and maturation (Garthwaite et al., <xref ref-type="bibr" rid="B99">2015</xref>). Moreover, NO can coordinate axon myelination with neuronal activity during development and contribute to adaptive changes in adult myelination (Garthwaite et al., <xref ref-type="bibr" rid="B99">2015</xref>). However, in OLs high NO concentrations can inhibit mitochondrial respiration and contribute to oxidative/nitrosative stress through peroxynitrite formation that induces uncontrolled MBP phosphorylation (Atkins and Sweatt, <xref ref-type="bibr" rid="B12">1999</xref>), which may render the myelin sheet less stable. Therefore, anti-oxidant and mitochondria protective therapeutic strategies may be beneficial in MS, in particular in early stages of the disease (Lassmann, <xref ref-type="bibr" rid="B146">2011</xref>).</p>
</sec>
<sec id="s2-8">
<title>Opioids</title>
<p>Neural stem cells (NSCs) and cells at different stages along the oligodendrolial lineage express opioid receptors, whose modulation can induce both mitogenesis and differentiation (Knapp et al., <xref ref-type="bibr" rid="B142">1998</xref>; Persson et al., <xref ref-type="bibr" rid="B198">2006</xref>; Eschenroeder et al., <xref ref-type="bibr" rid="B83">2012</xref>). These cells are also capable of synthesizing opioids in a developmentally regulated manner (Knapp et al., <xref ref-type="bibr" rid="B141">2001</xref>). Cultured bipolar progenitors produce dynorphin, whose expression is lost upon differentiation into mature OLs. In contrast, proenkephalin-derived peptides are found in OPCs and differentiated OLs (Knapp et al., <xref ref-type="bibr" rid="B141">2001</xref>). Activation of mu opioid receptor (MOR) in cultured OPC stimulates DNA synthesis, whereas kappa opioid receptor inhibition increases membrane extensions (Knapp et al., <xref ref-type="bibr" rid="B142">1998</xref>). Although these observations suggest that interference with the endogenous opioid system affects OL maturation and myelination in the developing CNS, further studies will be needed to fully resolve this question.</p>
<p>The growing use/abuse of opioids among younger persons (Compton and Volkow, <xref ref-type="bibr" rid="B59">2006</xref>; Calcaterra et al., <xref ref-type="bibr" rid="B37">2013</xref>) poses an especially high risk to pregnant addicts (in whom drug effects could target early myelination in the fetus and newborn) and adolescents and young adults (in whom late myelination of cortical regions takes place). Prolonged administration of morphine to neonatal rats is associated with increased neuronal cell apoptosis in selective CNS areas (Bajic et al., <xref ref-type="bibr" rid="B16">2013</xref>) and leads to increased Toll-like receptor-4 and microglial activation in adolescent rats (Schwarz and Bilbo, <xref ref-type="bibr" rid="B222">2013</xref>). Heroin and morphine abusers can suffer from leukoencephalopathy and myelin loss (Chen et al., <xref ref-type="bibr" rid="B48">2000</xref>; Nanan et al., <xref ref-type="bibr" rid="B183">2000</xref>). Perinatal exposure to therapeutic doses of methadone and buprenorphine (used to treat opioid addiction) altered early myelination in the developing rat brain (Eschenroeder et al., <xref ref-type="bibr" rid="B83">2012</xref>; Vestal-Laborde et al., <xref ref-type="bibr" rid="B257">2014</xref>), with elevated brain levels of MBP, PLP, and myelin-oligodendrocyte glycoprotein. Not surprisingly, these animals showed an increased number of axons with a highly compacted myelin membrane. There was no parallel reduction in the number of axons with a still uncompacted myelin membrane, pointing to the existence of complex drug effects. Methadone exerts direct effects at specific stages of the OL lineage <italic>in vitro</italic>, stimulating the proliferation of OPCs while accelerating maturation of more differentiated but still immature preOLs (Vestal-Laborde et al., <xref ref-type="bibr" rid="B257">2014</xref>). While the long-term effects of these observations remain unknown, accelerated or increased OL maturation and myelination could disrupt the complex sequence of synchronized events leading to normal connectivity in the developing brain. These findings further point to a crucial function of the endogenous opioid system in controlling OL development and the timing of myelination, as well as the potential for disrupting brain maturation at critical stages of myelin formation.</p>
<p>The partial MOR agonist and kappa opioid receptor antagonist buprenorphine merits special comment. While treatment of mothers with therapeutic doses of methadone results in accelerated and increased brain expression of mature markers of OLs in pups, supra-therapeutic doses delayed MBP expression and decreased the number of myelinated axons (Eschenroeder et al., <xref ref-type="bibr" rid="B83">2012</xref>). Buprenorphine anti-nociceptive action also showed a biphasic bell-shaped curve, with low doses being analgesic and higher doses loosing efficacy (Dum and Herz, <xref ref-type="bibr" rid="B78">1981</xref>; Lizasoain et al., <xref ref-type="bibr" rid="B153">1991</xref>). Buprenorphine anti-nociceptive effects are mediated by MOR and counteracted by nociceptin (NOP) receptors (Lutfy et al., <xref ref-type="bibr" rid="B157">2003</xref>). In the latter study J-113397, a specific NOP receptor inhibitor, not only enhanced the anti-nociceptive effect of buprenorphine but also eliminated its bell-shaped response. This biphasic response was not seen in NOP receptor knockout mice (Lutfy et al., <xref ref-type="bibr" rid="B157">2003</xref>). In OL cultures J-113397 abolished the biphasic dose-dependent effect of buprenorphine on MBP expression (Eschenroeder et al., <xref ref-type="bibr" rid="B83">2012</xref>). The latter findings point to a crucial role for interactive MOR and NOP receptor-mediated signaling in the timing of OL maturation. Perinatal exposure to buprenorphine increases the caliber of myelinated axons and with disproportionally thinner myelin sheaths, possibly indicative of alterations in axon-oligodendroglia/myelin interaction (Sanchez et al., <xref ref-type="bibr" rid="B216">2008</xref>). Exposure of rat pups to the MOR agonist methadone did not cause these effects (Vestal-Laborde et al., <xref ref-type="bibr" rid="B257">2014</xref>).</p>
</sec>
<sec id="s2-9">
<title>Prostaglandins</title>
<p>Cyclooxygenase (COX) catalyzes the rate-limiting step in the synthesis of prostanoids from arachidonic acid (Smith et al., <xref ref-type="bibr" rid="B229">1996</xref>), and occurs as both constitutive (COX-1) and inducible (COX-2) forms (Hewett et al., <xref ref-type="bibr" rid="B122">2000</xref>). COX-2 expression increases in CNS neurons in response to GluR activation (Nogawa et al., <xref ref-type="bibr" rid="B187">1997</xref>; Carlson, <xref ref-type="bibr" rid="B39">2003</xref>), and its inhibition by non-steroidal anti-inflammatory drugs and non-selective COX-1/COX-2 inhibitors protects neurons from GluR-mediated excitotoxic death <italic>in vitro</italic> (Hewett et al., <xref ref-type="bibr" rid="B122">2000</xref>; Carlson, <xref ref-type="bibr" rid="B39">2003</xref>) and <italic>in vivo</italic> (Nogawa et al., <xref ref-type="bibr" rid="B187">1997</xref>). Transgenic mice over-expressing neuronal COX-2 are more susceptible to excitotoxicity (Kelley et al., <xref ref-type="bibr" rid="B138">1999</xref>) and age-associated neuronal cell loss (Andreasson et al., <xref ref-type="bibr" rid="B7">2001</xref>). In contrast, COX-2-deficient mice are more resistant to neuronal cell death caused by ischemia or NMDA receptor activation (Iadecola et al., <xref ref-type="bibr" rid="B128">2001</xref>).</p>
<p>OLs and OPCs are more susceptible to excitotoxic death following GluR-dependent COX-2 induction (Carlson et al., <xref ref-type="bibr" rid="B42">2010</xref>). COX-2 is expressed in dying OLs at the onset of demyelination in Theiler’s murine encephalomyelitis virus model of MS (Carlson et al., <xref ref-type="bibr" rid="B41">2006</xref>) and in dying OLs in MS lesions (Carlson et al., <xref ref-type="bibr" rid="B42">2010</xref>). In the former case COX-2 inhibitors reduced demyelination (Carlson et al., <xref ref-type="bibr" rid="B42">2010</xref>). COX-2 contributes to OL vulnerability also in the cuprizone model of demyelination (Palumbo et al., <xref ref-type="bibr" rid="B194">2012</xref>). COX-2 may thus have an important role in demyelinating diseases like MS.</p>
<p>Prostanoids can contribute to excitotoxic death in OPCs either via direct production by OPCs or activation of prostanoid receptors on OPCs. Prostaglandin E<sub>2</sub> (PGE<sub>2</sub>) synthesized by OPCs in a GluR-dependent fashion engages EP3 subtype receptors and contributes to excitotoxic death of OPCs (Carlson, <xref ref-type="bibr" rid="B39">2003</xref>). In contrast, the EP2 receptor is protective (Carlson, <xref ref-type="bibr" rid="B39">2003</xref>). Although EP1 receptor activation does not affect an OPC excitotoxic challenge (Carlson et al., <xref ref-type="bibr" rid="B40">2015</xref>), PGI<sub>2</sub> can promote OPC migration and remyelination in damaged areas (Takahashi et al., <xref ref-type="bibr" rid="B237">2013</xref>). During myelination in developing rat brain, EP3 and thromboxane A2 receptor are localized to the plasma membrane and perinuclear membrane of OPCs, and their expression levels—as well as thromboxane A2 synthesis—increase during OLs maturation in concert with enhanced MBP expression (Carlson et al., <xref ref-type="bibr" rid="B42">2010</xref>).</p>
<p>Given the role of EP3 receptors in OPC excitotoxic death, this receptor may be a potential therapeutic target for promoting remyelination in demyelinating diseases such as MS.</p>
</sec>
<sec id="s2-10">
<title>Prolactin</title>
<p>PRL, originally described in the anterior pituitary gland plays a role not only in reproduction, but also controls a variety of behaviors and may participate in cell homeostasis, as well (Kelly et al., <xref ref-type="bibr" rid="B139">1991</xref>; Freeman et al., <xref ref-type="bibr" rid="B94">2000</xref>). Initially described in the brain in hypothalamic axon terminals (Fuxe et al., <xref ref-type="bibr" rid="B96">1977</xref>), PRL immunoreactivity was later detected in telencephalon, cerebral cortex, hippocampus, amygdala, septum (Devito, <xref ref-type="bibr" rid="B72">1988</xref>), caudate putamen (Harlan et al., <xref ref-type="bibr" rid="B118">1989</xref>), brain stem (Devito, <xref ref-type="bibr" rid="B72">1988</xref>; Harlan et al., <xref ref-type="bibr" rid="B118">1989</xref>), cerebellum (Seroogy et al., <xref ref-type="bibr" rid="B223">1988</xref>), spinal cord (Harlan et al., <xref ref-type="bibr" rid="B118">1989</xref>; Siaud et al., <xref ref-type="bibr" rid="B225">1989</xref>), choroid plexi, and circumventricular organs (Thompson, <xref ref-type="bibr" rid="B246">1982</xref>). The PRL receptor belongs to class 1 of the cytokine receptor superfamily (Bazan, <xref ref-type="bibr" rid="B26">1990a</xref>,<xref ref-type="bibr" rid="B27">b</xref>) whose gene shows widespread CNS expression.</p>
<p>PRL increases neurogenesis in the maternal mouse forebrain during the first week of pregnancy, along with an increase in OPC proliferation, OL generation, MBP expression and ultimately, increased numbers of myelinated axons (Gregg et al., <xref ref-type="bibr" rid="B109">2007</xref>). PRL infused subcutaneously can mimic these effects (Gregg et al., <xref ref-type="bibr" rid="B109">2007</xref>). These observations suggest a novel form of WM plasticity in the adult CNS and propose that PRL may have therapeutic potential in treating WM damage. At the same time, several reports suggest that PRL can exert also an inflammatory role. In an animal model of MS, the D2 agonists bromocriptine and dihydroergocryptine reduced the PRL level and disease severity (Riskind et al., <xref ref-type="bibr" rid="B206">1991</xref>; Canonico et al., <xref ref-type="bibr" rid="B38">1993</xref>; Zhornitsky et al., <xref ref-type="bibr" rid="B278">2015</xref>). Although PRL or PRL receptor knockout mice develop a delayed onset experimental autoimmune encephalomyelitis but with full clinical severity (Costanza et al., <xref ref-type="bibr" rid="B62">2013</xref>) a small clinical trial failed to demonstrate benefit of bromocriptine administration in MS patients (Bissay et al., <xref ref-type="bibr" rid="B33">1994</xref>). Thus, the therapeutic utility of PRL in MS remains an open question; it would be interesting to perform a trial combining PRL with an immunomodulator (i.e., interferon-β commonly used in clinical practice; Zhornitsky et al., <xref ref-type="bibr" rid="B278">2015</xref>).</p>
</sec>
<sec id="s2-11">
<title>Cannabinoids</title>
<p>Cannabidiol (CBD), the most abundant cannabinoid in <italic>Cannabis sativa</italic>, is devoid of psychoactive properties and exerts anti-inflammatory, antioxidant and neuroprotective effects (Izzo et al., <xref ref-type="bibr" rid="B131">2009</xref>). CBD is used for the treatment of inflammation, pain and spasticity associated with MS (Sastre-Garriga et al., <xref ref-type="bibr" rid="B217">2011</xref>). Its biological effects are mediated through cannabinoid receptors CB<sub>1</sub> and CB<sub>2</sub> (Howlett et al., <xref ref-type="bibr" rid="B125">2002</xref>). The former is widely expressed in CNS neurons, where it modulates neurotransmitter release and synaptic plasticity regulated by Ca<sup>2+</sup> and K<sup>+</sup> channels (Chevaleyre et al., <xref ref-type="bibr" rid="B49">2006</xref>; Basavarajappa, <xref ref-type="bibr" rid="B24">2007</xref>). CB<sub>2</sub> receptor expression is mainly, but not exclusively limited to immune cells (Walter and Stella, <xref ref-type="bibr" rid="B261">2004</xref>). OPCs and mature OLs both expess CB<sub>1</sub>and CB<sub>2</sub> receptors (Molina-Holgado et al., <xref ref-type="bibr" rid="B177">2003</xref>; Benito et al., <xref ref-type="bibr" rid="B28">2007</xref>).</p>
<p>In rat optic nerve OLs, the CB<sub>1</sub> receptor agonist arachidonoyl-chloro-ethanolamide inhibited depolarization-induced Ca<sup>2+</sup> influx (Mato et al., <xref ref-type="bibr" rid="B162">2009</xref>). Similar effects were obtained with the endocannabinoids anandamide and 2-arachidonoylglycerol and the CB<sub>1</sub> receptor agonist CP 55,940, but not the CB<sub>2</sub> receptor agonist JWH133. In line with these findings CBD, which acts also as a low-affinity CB<sub>1</sub>/CB<sub>2</sub> receptor antagonist raised [Ca<sup>2+</sup>]<sub>i</sub> concentration in OL primary cultures (Mato et al., <xref ref-type="bibr" rid="B162">2009</xref>, <xref ref-type="bibr" rid="B163">2010</xref>) and was cytotoxic (Mato et al., <xref ref-type="bibr" rid="B163">2010</xref>). However, these [Ca<sup>2+</sup>]<sub>i</sub> changes appeared to be CB receptor-independent (Mato et al., <xref ref-type="bibr" rid="B163">2010</xref>). Given its lipophilic properties, it is possible that CBD can directly affect [Ca<sup>2+</sup>]<sub>i</sub> stores. Not only are mitochondria the main source of Ca<sup>2+</sup> released from CBD-stimulated OLs (Mato et al., <xref ref-type="bibr" rid="B163">2010</xref>), but CB<sub>1</sub> receptors have been identified on brain mitochondrial membranes (Hebert-Chatelain et al., <xref ref-type="bibr" rid="B121">2014</xref>). In contrast, in neurons CBD reduced [Ca<sup>2+</sup>]<sub>i</sub> influx and prevented apoptosis (Ryan et al., <xref ref-type="bibr" rid="B212">2009</xref>). The patho-physiological consequences of CBD action may thus depend on the cellular context in which it is expressed.</p>
</sec>
<sec id="s2-12">
<title>Nuclear Receptors</title>
<p>NRs are members of a large superfamily of evolutionarily related transcription factors that regulate a broad spectrum of physiological phenomena (Gronemeyer et al., <xref ref-type="bibr" rid="B111">2004</xref>; Chambon, <xref ref-type="bibr" rid="B46">2005</xref>; Evans, <xref ref-type="bibr" rid="B84">2005</xref>). Each of the 48 NRs identified to date has crucial and non-redundant roles, notably in biologically important processes like growth, development, and homeostasis. NRs modulate transcription through mechanisms which include both activation and repression (Germain et al., <xref ref-type="bibr" rid="B103">2006b</xref>). The NR superfamily includes receptors for hydrophobic molecules such as steroid hormones (e.g., estrogens, glucocorticoids (GCs), progesterone, mineralocorticoids, androgens, vitamin D3, ecdysone, oxysterols and bile acids), retinoic acids, TH, fatty acids, leukotrienes and prostaglandins (Laudet and Gronemeyer, <xref ref-type="bibr" rid="B148">2002</xref>).</p>
<sec id="s2-12-1">
<title>Steroid Hormone Receptors</title>
<p>GCs are steroid hormones with recognized anti-inflammatory properties. In the brain, two types of high-affinity receptors bind GCs: the type I mineralocorticoid receptor (MR) and the type II glucocorticoid receptor (GR; Vielkind et al., <xref ref-type="bibr" rid="B258">1990</xref>). Each receptor dimerizes with a GC-responsive element leading to suppression of pro-inflammatory gene expression via block of nuclear factor-kB or activator protein-1 (Trousson et al., <xref ref-type="bibr" rid="B251">2009</xref>). Both receptor types are widely expressed across neuronal cell populations and glia, although the latter finding awaits confirmation. Purified OLs and astrocytes from rat cerebrum and cerebellum were shown to express differential levels of GR by immunocytochemistry (Vielkind et al., <xref ref-type="bibr" rid="B258">1990</xref>). At least <italic>in vitro</italic>, all classes of glial cells express GRs that can translocate to the nucleus in the presence of the cognate hormone ligand (Vielkind et al., <xref ref-type="bibr" rid="B258">1990</xref>).</p>
<p>Dexamethasone (DEX) alters OLs differentiation and myelination in a developmental stage-specific manner. In rat forebrain cell cultures DEX stimulated the early stages of myelination but caused a markedly inhibition at later stages (Almazan et al., <xref ref-type="bibr" rid="B5">1986</xref>). When given systemically to 3-day-old rats for 7 consecutive days DEX significantly decreased the relative abundance of MBP and PLP mRNAs at P20 and P30 in cerebrum, although in cerebellum MBP, PLP and glial fibrillary acidic protein mRNAs decreased at P10 (Tsuneishi et al., <xref ref-type="bibr" rid="B253">1991</xref>). DEX thus appears to suppress expression of genes related to glial functions, especially myelination, when administered in the early postnatal period (Tsuneishi et al., <xref ref-type="bibr" rid="B253">1991</xref>), notwithstanding differences in susceptibility across brain areas.</p>
</sec>
<sec id="s2-12-2">
<title>Sex Hormones</title>
<p>Sexual dimorphism in the brain vocal control area of the songbird was first demonstrated four decades ago (Nottebohm and Arnold, <xref ref-type="bibr" rid="B190">1976</xref>). Magnetic resonance imaging shows morphological differences in human cortical gray matter volume (Gur et al., <xref ref-type="bibr" rid="B113">1999</xref>) with females having larger volumes in areas associated with language functions (Schlaepfer et al., <xref ref-type="bibr" rid="B220">1995</xref>; Harasty et al., <xref ref-type="bibr" rid="B116">1997</xref>). In terms of WM differences between sexes, men have larger overall WM relative to cerebral size (Goldstein et al., <xref ref-type="bibr" rid="B108">2001</xref>), while women appear to have larger WM volumes involved in interhemisphere connectivity (Nopoulos et al., <xref ref-type="bibr" rid="B188">2000</xref>). Sexual dimorphism in rats was interpreted as a consequence of the action of different sex hormones on brain development (Cerghet et al., <xref ref-type="bibr" rid="B45">2009</xref>).</p>
<p>We know relatively little concerning sexual dimorphism of OLs and central myelin. WM volume (Gur et al., <xref ref-type="bibr" rid="B113">1999</xref>), especially in the corpus callosum (Fitch et al., <xref ref-type="bibr" rid="B90">1990</xref>) is increased in males, with females having more unmyelinated fibers. Yang et al. (<xref ref-type="bibr" rid="B273">2008</xref>) later confirmed that WM volume, myelinated fiber volume and volume of myelin sheaths in young rats are significantly larger in males, although this ratio was reversed in middle-aged animals. Differences in steroid hormone levels in developing animals could account for sex differences in myelination of axons through hormone action on myelin protein expression (Jung-Testas and Baulieu, <xref ref-type="bibr" rid="B134">1998</xref>; Nuñez et al., <xref ref-type="bibr" rid="B191">2000</xref>). It is also possible that sex steroids could exert a protective effect on myelin in developing, as well as injured WM (De Nicola et al., <xref ref-type="bibr" rid="B66">2006</xref>; Gerstner et al., <xref ref-type="bibr" rid="B104">2007</xref>; Garay et al., <xref ref-type="bibr" rid="B98">2008</xref>).</p>
<p>Sexual differences in rodents are also manifested in terms of OL myelin protein expression (Cerghet et al., <xref ref-type="bibr" rid="B45">2009</xref>). Female rodent OLs showed increased proliferation and death rate, suggesting that their OLs have a shorter lifespan and more rapid turnover. In male mice, castration increased glial cell proliferation and decreased OL density (Cerghet et al., <xref ref-type="bibr" rid="B45">2009</xref>). Sex hormones, in particular testosterone, influence proliferation and are potent inducers of remyelination (Hussain et al., <xref ref-type="bibr" rid="B127">2013</xref>). In enriched mouse OLs primary cultures, progesterone (P2), estrogen (E2) and dihydrotestosterone (DHT) influenced total cell number, proliferation and cell death independent of sex. In particular, P2 significantly increased OL numbers (more so in cultures from female mice), while E2 had a minor effect and DHT reduced OL numbers in both sexes (Cerghet et al., <xref ref-type="bibr" rid="B45">2009</xref>).</p>
<p>Protein kinase B (Akt), MAPK and mammalian target of rapamycin (mTOR) pathways are highly expressed in OLs (Flores et al., <xref ref-type="bibr" rid="B91">2000</xref>; Horiuchi et al., <xref ref-type="bibr" rid="B124">2006</xref>) and represent, in relation to cell survival/proliferation, possible biochemical targets for these hormones (Hay, <xref ref-type="bibr" rid="B120">2005</xref>; Chong et al., <xref ref-type="bibr" rid="B52">2007</xref>). P2 caused a more robust Akt up-regulation in OLs cultured from female mice in comparison to male-derived cells, in line with effects of P2 on OL numbers. Akt influences cell survival and proliferation through downstream mTOR activation via transcriptional regulation (Hay, <xref ref-type="bibr" rid="B120">2005</xref>; Chong et al., <xref ref-type="bibr" rid="B52">2007</xref>). P2 markedly increased mTOR activity in an Akt-dependent manner, indicating a role for this pathway in OL survival. As expected from its effects on OL numbers, DHT reduced Akt activity in both sexes (Cerghet et al., <xref ref-type="bibr" rid="B45">2009</xref>). Interestingly, MAPK p42/p44 activation is involved in excitotoxic cell death, mediated by Glu and pro-inflammatory processes and leading to neurodegenerative diseases (Rosin et al., <xref ref-type="bibr" rid="B210">2004</xref>; Nikodemova et al., <xref ref-type="bibr" rid="B185">2006</xref>). It is tempting to speculate that by influencing proliferation and death of Ols, sex hormones may contribute to differences in disease phenotype between male and female MS patients.</p>
</sec>
<sec id="s2-12-3">
<title>Oxysterols and Liver X Receptors</title>
<p>The liver X receptor (LXR) is a member of the NR family of transcription factors (Janowski et al., <xref ref-type="bibr" rid="B133">1996</xref>) and is closely related to NRs such as the peroxisome proliferator-activated receptor (PPAR), farnesoid X receptor and retinoid X receptor (RXR). Both LXR isoforms (α and β) are activated by oxysterols originating from cholesterol oxidation (Freemantle et al., <xref ref-type="bibr" rid="B95">2013</xref>). OLs express LXR α and β which are crucial for cholesterol homeostasis, a major lipid constituent of myelin sheaths. LXRs are involved in myelination and remyelination processes. LXR<sub>α/β</sub> double knockout mice exhibit altered motor coordination and spatial learning, thinner myelin sheaths, and reduced myelin gene expression in cerebellum. Conversely, activation of LXRs by either 25-hydroxycholesterol or the agonist TO901317 stimulates myelin gene expression at the promoter, mRNA, and protein (PLP and MBP) levels. LXR activation also promotes OLs cell maturation and remyelination after lysolecithin-induced demyelination in organotypic cerebellar slice cultures. These data strongly support a new role for LXRs as positive modulators in central (re)myelination processes (Meffre et al., <xref ref-type="bibr" rid="B169">2015</xref>).</p>
</sec>
<sec id="s2-12-4">
<title>1,25-Dihydroxyvitamin D3</title>
<p>1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) was initially described to suppress experimental autoimmune encephalomyelitis (Lemire and Archer, <xref ref-type="bibr" rid="B150">1991</xref>; Spach et al., <xref ref-type="bibr" rid="B232">2006</xref>) through an anti-inflammatory mechanism. New data show that 1,25(OH)2D3 can directly promote neural stem cell (NSC) proliferation, survival and differentiation along the neuron and OL, but not astrocyte, lineages. NSCs constitutively express vitamin D receptor, which can be up-regulated by 1,25(OH)2D3. NSCs treated with 1,25(OH)2D3 showed increased expression of neurotrophic factors subserving neuronal cell survival and differentiation (Shirazi et al., <xref ref-type="bibr" rid="B224">2015</xref>).</p>
</sec>
<sec id="s2-12-5">
<title>Retinoic Acid and Retinoid X Receptor</title>
<p>The RXR (Prineas and Connell, <xref ref-type="bibr" rid="B200">1979</xref>) is activated by 9-cis retinoic acid (Patani et al., <xref ref-type="bibr" rid="B195">2007</xref>), as well as 9-cis-13,14-dihydro-retinoic acid (Raine and Wu, <xref ref-type="bibr" rid="B202">1993</xref>) and comprises three isoforms: RXR-α, -β and -γ. RXRs work through heterodimeric association with other NRs, such as retinoic acid receptors, TH receptors, vitamin D receptors, PPARs and LXRs to regulate cell proliferation, differentiation and apoptosis (Germain et al., <xref ref-type="bibr" rid="B102">2006a</xref>). RXR-γ is generally expressed at low levels in all glial cell populations (Moreno et al., <xref ref-type="bibr" rid="B178">2004</xref>) but is up-regulated in activated microglia and macrophages, reactive astrocytes and OLs after CNS injury (Schrage et al., <xref ref-type="bibr" rid="B221">2006</xref>). RXR signaling is associated with the CNS regenerative response and is involved in the remyelination transcriptome (Huang et al., <xref ref-type="bibr" rid="B126">2011</xref>). The remyelination environment is composed of demyelinated axons, activated adult OPCs, regenerated OLs, microglia and/or macrophages and reactive astrocytes (Franklin and ffrench-Constant, <xref ref-type="bibr" rid="B93">2008</xref>). Functional analyses in cultured OPCs using RNA interference to knock down RXR-γ gene expression, RXR-specific antagonists, as well as RXR-γ null mice showed inefficient OL differentiation, indicating that RXR-γ is an important regulator of remyelination (Huang et al., <xref ref-type="bibr" rid="B126">2011</xref>). The ability of RXR to form permissive or non-permissive heterodimers with other NRs suggests that RXR can modulate the expression of different genes, in a receptor- and context-specific fashion (Altucci et al., <xref ref-type="bibr" rid="B6">2007</xref>). Identification of which nuclear receptor(s) heterodimerize with RXR-γ in OL lineage cells after demyelination, and what genes are transcribed in response to RXR-γ activation to promote the differentiation of OPCs have remained open questions until now. However, a new study by de la Fuente et al. (<xref ref-type="bibr" rid="B65">2015</xref>) provides data indicating that RXR-γ binds to several NRs, including the vitamin D receptor, in OPCs and mature OLs. These authors showed that inhibition of vitamin D receptor signaling impaired OPC differentiation and reduced the cells’ ability to remyelinate axons <italic>ex vivo</italic>. Vitamin D, in contrast, boosted OPC differentiation (de la Fuente et al., <xref ref-type="bibr" rid="B65">2015</xref>).</p>
</sec>
<sec id="s2-12-6">
<title>Thyroid Hormone</title>
<p>TH actions are mediated mainly by T3 (Yen, <xref ref-type="bibr" rid="B275">2001</xref>) which derives by conversion of T4 to T3 via deiodinases. THs activate two nuclear hormone receptor genes. The THR-α gene encodes two isoforms (α1 and α2) while four additional isoforms are encoded by the β gene (β1–4; Williams, <xref ref-type="bibr" rid="B268">2000</xref>; Yen, <xref ref-type="bibr" rid="B275">2001</xref>; Tagami et al., <xref ref-type="bibr" rid="B236">2010</xref>). THs play a critical role in oligodendrogenesis and myelination. Acting through their cognate receptors, THs promote expression of OL-specific genes including MBP, myelin-associated glycoprotein (MAG), PLP, and 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) (Farsetti et al., <xref ref-type="bibr" rid="B850">1991</xref>; Tosic et al., <xref ref-type="bibr" rid="B248">1992</xref>; Rodriguez-Pena et al., <xref ref-type="bibr" rid="B208">1993</xref>). Studies using hypo- and hyperthyroid animals as well as genetically modified rodents clearly show that THs regulate OL differentiation and maturation (Bernal, <xref ref-type="bibr" rid="B30">2002</xref>; O’Shea and Williams, <xref ref-type="bibr" rid="B193">2002</xref>; Zoeller and Rovet, <xref ref-type="bibr" rid="B280">2004</xref>; Dugas et al., <xref ref-type="bibr" rid="B77">2012</xref>). <italic>In vitro</italic>, OPCs express both THR-α and THR-β1; expression of the latter increases with OL maturation (Barres et al., <xref ref-type="bibr" rid="B22">1994</xref>; Gao et al., <xref ref-type="bibr" rid="B97">1998</xref>). GC-1, a thyromimetic with selective THR-β action (Chiellini et al., <xref ref-type="bibr" rid="B50">1998</xref>), promotes differentiation of both rodent and human OPCs <italic>in vitro</italic> (Trost et al., <xref ref-type="bibr" rid="B250">2000</xref>; Manzano et al., <xref ref-type="bibr" rid="B159">2003</xref>). Furthermore, GC-1 induces OL maturation during development with increased production of MBP, CNPase and MAG (Baxi et al., <xref ref-type="bibr" rid="B25">2014</xref>).</p>
<p>OL differentiation can follow several distinct pathways, including mitogen withdrawal and exposure to T3 (Barres et al., <xref ref-type="bibr" rid="B23">1993</xref>; Dugas et al., <xref ref-type="bibr" rid="B76">2010</xref>), whereas OPC proliferation is induced by PDGF (Barres et al., <xref ref-type="bibr" rid="B21">1992</xref>). When exposed to T3 and PDGF, OPCs continue to proliferate, differentiating only after multiple rounds of cell division (Temple and Raff, <xref ref-type="bibr" rid="B244">1986</xref>; Barres et al., <xref ref-type="bibr" rid="B22">1994</xref>; Durand and Raff, <xref ref-type="bibr" rid="B79">2000</xref>). Like T3, GC-1 does not significantly affect PDGF-induced OPC proliferation. Inappropriate OL differentiation could thus deplete OPC numbers and hinder myelination (Baxi et al., <xref ref-type="bibr" rid="B25">2014</xref>).</p>
</sec>
<sec id="s2-12-7">
<title>PPAR-γ and 15-deoxy 12,14 Prostaglandin J2</title>
<p>The three known PPARs (PPAR-α, PPAR-β/δ and PPAR-γ) belong to the superfamily of NRs. While ubiquitously expressed, they also exhibit specific patterns of distribution. PPAR-γ agonists exert anti-inflammatory, insulin-sensitizing and neuroprotective effects, as well as promote the protection and differentiation of OLs (Bernardo et al., <xref ref-type="bibr" rid="B31">2009</xref>). In addition, PPAR-γ agonists increase OL mitochondrial respiratory chain activity and the cell’s ability to respond to environmental signals with oscillatory Ca<sup>2+</sup> waves. Both OL maturation and oscillatory Ca<sup>2+</sup> waves are prevented by the mitochondrial inhibitor rotenone and restored by PPAR-γ agonists, suggesting that PPAR-γ promotes myelination through mechanisms involving mitochondria (Bernardo et al., <xref ref-type="bibr" rid="B31">2009</xref>, <xref ref-type="bibr" rid="B32">2013</xref>). Calcium signaling plays an important role in OPC differentiation and myelination (Soliven, <xref ref-type="bibr" rid="B231">2001</xref>), process extension and migration (Simpson and Armstrong, <xref ref-type="bibr" rid="B227">1999</xref>; Yoo et al., <xref ref-type="bibr" rid="B277">1999</xref>), and in retraction of membrane sheets and cell death in mature mouse OLs (Benjamins and Nedelkoska, <xref ref-type="bibr" rid="B29">1996</xref>).</p>
</sec>
</sec>
</sec>
<sec id="s3">
<title>Conclusion and Perspectives</title>
<p>The main functions of OLs in CNS are to provide support and insulation to axons of some vertebrates, forming functional units that allow the propagation of electrical signals. On the other hand, neuronal activity regulates myelinating cell development through signals that activate Ca<sup>2+</sup>-dependent pathways (Butt, <xref ref-type="bibr" rid="B36">2006</xref>). As discussed in this review, activation is evoked by a wide range of membrane/intracellular receptors or ion channels (for the latter, see Cheli et al., <xref ref-type="bibr" rid="B47">2015</xref>) that can induce an influx or release from intracellular stores, increasing [Ca<sup>2+</sup>]<sub>i</sub>. To restore homeostasis, [Ca<sup>2+</sup>]<sub>i</sub> can be sequestered into endoplasmic reticulum or extruded (Butt, <xref ref-type="bibr" rid="B36">2006</xref>). The balance between Ca<sup>2+</sup> influx and efflux can determine the temporal and special properties of OLs. Moreover, Ca<sup>2+</sup> signaling in OPCs can influence not only differentiation and myelination (Soliven, <xref ref-type="bibr" rid="B231">2001</xref>), but also process extension and migration (Simpson and Armstrong, <xref ref-type="bibr" rid="B227">1999</xref>; Yoo et al., <xref ref-type="bibr" rid="B277">1999</xref>), and cell death in mature mouse OLs (Benjamins and Nedelkoska, <xref ref-type="bibr" rid="B29">1996</xref>). There is also evidence that oligodendroglia exhibit Ca<sup>2+</sup> transients in response to electrical activity of axons for activity-dependent myelination (Wake et al., <xref ref-type="bibr" rid="B260">2015</xref>).</p>
<p>Failure of myelin development and oligodendrocyte loss results in serious human disorders, including MS. Understanding how different neurotransmitters and hormones can regulate [Ca<sup>2+</sup>]<sub>i</sub>, driving important effects on different stages of OPCs development and specific molecular events could provide the framework to facilitate the development of effective new approaches in the therapeutic repair of myelin disorders that complement established immunosuppressive approaches. In this regard the landscape is beginning to show the fruits of these investigations (Mullard, <xref ref-type="bibr" rid="B180">2014</xref>; Ransohoff et al., <xref ref-type="bibr" rid="B204">2015</xref>). For example, several U.S. Food and Drug Administration-approved drugs have shown promise in this direction, although most are anticholinergics. Whether or not the other possible pharmacological pathways are ineffective or have not been tried in not known. The antidyskinetic drug benztropine, a selective M1 muscarinic acetylcholine receptor antagonist, induced MBP expression in primary rat optic-nerve-derived OPCs and decreased clinical severity in an experimental autoimmune encephalomyelitis model of relapsing-remitting MS when administered alone or in combination with the approved immunosuppressive MS drugs FTY720 or interferon-β (Deshmukh et al., <xref ref-type="bibr" rid="B71">2013</xref>). However, potential dose-dependent side-effects are associated with benztropine treatment in man (Modell et al., <xref ref-type="bibr" rid="B175">1989</xref>). Systemic treatment with the selective M3 antagonist solifenacin increased oligodendrocyte differentiation of transplanted human OPCs in hypomyelinated shiverer/rag2 brain and enhanced functional repair (Abiraman et al., <xref ref-type="bibr" rid="B1">2015</xref>). Donepezil, an acetylcholinesterase inhibitor developed for the treatment of Alzheimer’s disease, can stimulate oligodendrocyte differentiation and maturation of NSC-derived OPCs (Imamura et al., <xref ref-type="bibr" rid="B130">2015</xref>). Importantly, neural precursor cells have recently been demonstrated to make a major contribution to remyelination in the cuprizone model of CNS demyelination (Xing et al., <xref ref-type="bibr" rid="B269">2014</xref>). Although some of the reviewed pathways are involved in apoptosis (e.g., opioids, acetylcholine), the PPAR-α agonist palmitoylethanolamide (a fatty acid amide signaling molecule structurally related to the endocannabinoid anandamide), presented as a co-ultramicronized composite with the flavonoid luteolin is also reported to promote OPC maturation (Barbierato et al., <xref ref-type="bibr" rid="B19">2015</xref>). Neither palmitoylethanolamide (Skaper et al., <xref ref-type="bibr" rid="B228">2014</xref>) not luteolin (Theoharides et al., <xref ref-type="bibr" rid="B245">2012</xref>), at pharmacologically relevant doses, has been reported to show adverse effects in man. While we have focused on MS as an emblematic pathological condition that could eventually benefit from OL-based repair therapies for myelin loss, preventive treatment of premature infants with drugs that accelerate the proliferation and/or maturation of OPCs could reveal itself as the key to prevent an important cause of mental retardation. No doubt the initial results discussed in this review will encourage further progress in the years ahead.</p>
</sec>
<sec id="s4">
<title>Search Strategy</title>
<p>A search for original articles focusing on OLs and neurotransmitters and signaling was performed in PubMed and SCOPUS. The search terms used were “oligodendrocyte”, “myelin”, “myelination”, “oligodendrocyte precursor”, “nuclear receptor”, “opioid”, “glutamate”, “GABA”, “serotonin”, “cholinergic”, “muscarinic”, “cannabinoid”, “demyelination”, “autoimmune”, alone and in combination (other terms?). All articles identified were English language (with the exception of Virchow, R. 1854, originally written in German), full-text articles. We also searched the reference lists of identified articles for additional relevant articles.</p>
</sec>
<sec id="s5">
<title>Author Contributions</title>
<p>PG and CM conceived the study, and PG, CM, TB, MZ and SDS participated in drafting the manuscript. All authors critically revised and approved the final manuscript.</p>
</sec>
<sec id="s6">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abiraman</surname><given-names>K.</given-names></name><name><surname>Pol</surname><given-names>S. U.</given-names></name><name><surname>O’Bara</surname><given-names>M. A.</given-names></name><name><surname>Chen</surname><given-names>G. D.</given-names></name><name><surname>Khaku</surname><given-names>Z. M.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte repair</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>3676</fpage>–<lpage>3688</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3510-14.2015</pub-id><pub-id pub-id-type="pmid">25716865</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agresti</surname><given-names>C.</given-names></name><name><surname>Meomartini</surname><given-names>M. E.</given-names></name><name><surname>Amadio</surname><given-names>S.</given-names></name><name><surname>Ambrosini</surname><given-names>E.</given-names></name><name><surname>Volonté</surname><given-names>C.</given-names></name><name><surname>Aloisi</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development</article-title>. <source/>Glia
<volume>50</volume>, <fpage>132</fpage>–<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20160</pub-id><pub-id pub-id-type="pmid">15657938</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberdi</surname><given-names>E.</given-names></name><name><surname>Sánchez-Gómez</surname><given-names>M. V.</given-names></name><name><surname>Matute</surname><given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>Calcium and glial cell death</article-title>. <source/>Cell Calcium
<volume>38</volume>, <fpage>417</fpage>–<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2005.06.020</pub-id><pub-id pub-id-type="pmid">16095689</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alberdi</surname><given-names>E.</given-names></name><name><surname>Sánchez-Gómez</surname><given-names>M. V.</given-names></name><name><surname>Torre</surname><given-names>I.</given-names></name><name><surname>Domercq</surname><given-names>M.</given-names></name><name><surname>Pérez-Samartín</surname><given-names>A.</given-names></name><name><surname>Pérez-Cerdá</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Activation of kainate receptors sensitizes oligodendrocytes to complement attack</article-title>. <source/>J. Neurosci.
<volume>26</volume>, <fpage>3220</fpage>–<lpage>3228</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3780-05.2006</pub-id><pub-id pub-id-type="pmid">16554473</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almazan</surname><given-names>G.</given-names></name><name><surname>Honegger</surname><given-names>P.</given-names></name><name><surname>Du Pasquier</surname><given-names>P.</given-names></name><name><surname>Matthieu</surname><given-names>J. M.</given-names></name></person-group> (<year>1986</year>). <article-title>Dexamethasone stimulates the biochemical differentiation of fetal forebrain cells in reaggregating cultures</article-title>. <source/>Dev. Neurosci.
<volume>8</volume>, <fpage>14</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1159/000112237</pub-id><pub-id pub-id-type="pmid">2427305</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altucci</surname><given-names>L.</given-names></name><name><surname>Leibowitz</surname><given-names>M. D.</given-names></name><name><surname>Ogilvie</surname><given-names>K. M.</given-names></name><name><surname>de Lera</surname><given-names>A. R.</given-names></name><name><surname>Gronemeyer</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>RAR and RXR modulation in cancer and metabolic disease</article-title>. <source/>Nat. Rev. Drug Discov.
<volume>6</volume>, <fpage>793</fpage>–<lpage>810</lpage>. <pub-id pub-id-type="doi">10.1038/nrd2397</pub-id><pub-id pub-id-type="pmid">17906642</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreasson</surname><given-names>K. I.</given-names></name><name><surname>Savonenko</surname><given-names>A.</given-names></name><name><surname>Vidensky</surname><given-names>S.</given-names></name><name><surname>Goellner</surname><given-names>J. J.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Shaffer</surname><given-names>A.</given-names></name></person-group> (<year>2001</year>). <article-title>Age dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice</article-title>. <source/>J. Neurosci.
<volume>21</volume>, <fpage>8198</fpage>–<lpage>8209</lpage>. <pub-id pub-id-type="pmid">11588192</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Armstrong</surname><given-names>R. C.</given-names></name><name><surname>Harvath</surname><given-names>L.</given-names></name><name><surname>Dubois-Dalcq</surname><given-names>M. E.</given-names></name></person-group> (<year>1990</year>). <article-title>Type 1 astrocytes and oligodendrocyte-type2 astrocyte glial progenitors migrate toward distinct molecole</article-title>. <source/>J. Neurosci. Res.
<volume>27</volume>, <fpage>400</fpage>–<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.490270319</pub-id><pub-id pub-id-type="pmid">2097382</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnett</surname><given-names>H. A.</given-names></name><name><surname>Fancy</surname><given-names>S. P.</given-names></name><name><surname>Alberta</surname><given-names>J. A.</given-names></name><name><surname>Zhao</surname><given-names>C.</given-names></name><name><surname>Plant</surname><given-names>S. R.</given-names></name><name><surname>Kaing</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS</article-title>. <source/>Science
<volume>306</volume>, <fpage>2111</fpage>–<lpage>2115</lpage>. <pub-id pub-id-type="doi">10.1126/science.1103709</pub-id><pub-id pub-id-type="pmid">15604411</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asotra</surname><given-names>K.</given-names></name><name><surname>Macklin</surname><given-names>W. B.</given-names></name></person-group> (<year>1993</year>). <article-title>Protein kinase C activity modulates myelin gene expression in enriched oligodendrocytes</article-title>. <source/>J. Neurosci. Res.
<volume>34</volume>, <fpage>571</fpage>–<lpage>588</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.490340509</pub-id><pub-id pub-id-type="pmid">7683060</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aston</surname><given-names>C.</given-names></name><name><surname>Jiang</surname><given-names>L.</given-names></name><name><surname>Sokolov</surname><given-names>B. P.</given-names></name></person-group> (<year>2005</year>). <article-title>Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder</article-title>. <source/>Mol. Psychiatry
<volume>10</volume>, <fpage>309</fpage>–<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001565</pub-id><pub-id pub-id-type="pmid">15303102</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atkins</surname><given-names>C. M.</given-names></name><name><surname>Sweatt</surname><given-names>J. D.</given-names></name></person-group> (<year>1999</year>). <article-title>Reactive oxygen species mediate activity- dependent neuron-glia signaling in output fibers of the hippocampus</article-title>. <source/>J. Neurosci.
<volume>19</volume>, <fpage>7241</fpage>–<lpage>7248</lpage>. <pub-id pub-id-type="pmid">10460230</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avenell</surname><given-names>K. Y.</given-names></name><name><surname>Boyfield</surname><given-names>I.</given-names></name><name><surname>Coldwell</surname><given-names>M. C.</given-names></name><name><surname>Hadley</surname><given-names>M. S.</given-names></name><name><surname>Healy</surname><given-names>M. A.</given-names></name><name><surname>Jeffrey</surname><given-names>P. M.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Fused aminotetralins: novel antagonists with high selectivity for the dopamine D3 receptor</article-title>. <source/>Bioorg. Med. Chem. Lett.
<volume>8</volume>, <fpage>2859</fpage>–<lpage>2864</lpage>. <pub-id pub-id-type="doi">10.1016/s0960-894x(98)00512-5</pub-id><pub-id pub-id-type="pmid">9873637</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avenell</surname><given-names>K. Y.</given-names></name><name><surname>Boyfield</surname><given-names>I.</given-names></name><name><surname>Hadley</surname><given-names>M. S.</given-names></name><name><surname>Johnson</surname><given-names>C. N.</given-names></name><name><surname>Nash</surname><given-names>D. J.</given-names></name><name><surname>Riley</surname><given-names>G. J.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Heterocyclic analogues of 2-aminotetralins with high affinity and selectivity for the dopamine D3 receptor</article-title>. <source/>Bioorg. Med. Chem. Lett.
<volume>9</volume>, <fpage>2715</fpage>–<lpage>2720</lpage>. <pub-id pub-id-type="doi">10.1016/s0960-894x(99)00454-0</pub-id><pub-id pub-id-type="pmid">10509922</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Back</surname><given-names>S. A.</given-names></name><name><surname>Riddle</surname><given-names>A.</given-names></name><name><surname>McClure</surname><given-names>M. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Maturation-dependent vulnerability of perinatal white matter in premature birth</article-title>. <source/>Stroke
<volume>38</volume>, <fpage>724</fpage>–<lpage>730</lpage>. <pub-id pub-id-type="doi">10.1161/01.str.0000254729.27386.05</pub-id><pub-id pub-id-type="pmid">17261726</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bajic</surname><given-names>D.</given-names></name><name><surname>Commons</surname><given-names>K. G.</given-names></name><name><surname>Soriano</surname><given-names>S. G.</given-names></name></person-group> (<year>2013</year>). <article-title>Morphine-enhanced apoptosis in selective brain regions of neonatal rats</article-title>. <source/>Int. J. Dev. Neurosci.
<volume>31</volume>, <fpage>258</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijdevneu.2013.02.009</pub-id><pub-id pub-id-type="pmid">23499314</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakiri</surname><given-names>Y.</given-names></name><name><surname>Burzomato</surname><given-names>V.</given-names></name><name><surname>Frugier</surname><given-names>G.</given-names></name></person-group> (<year>2009</year>). <article-title>Glutamatergic signaling in the brain’s white matter</article-title>. <source/>Neuroscience
<volume>158</volume>, <fpage>266</fpage>–<lpage>274</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.01.015</pub-id><pub-id pub-id-type="pmid">18314276</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballerini</surname><given-names>P.</given-names></name><name><surname>Di Iorio</surname><given-names>P.</given-names></name><name><surname>Ciccarelli</surname><given-names>R.</given-names></name><name><surname>Nargi</surname><given-names>E.</given-names></name><name><surname>D’Alimonte</surname><given-names>I.</given-names></name><name><surname>Traversa</surname><given-names>U.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Glial cells express multiple ATP binding cassette proteins which are involved in ATP release</article-title>. <source/>Neuroreport
<volume>13</volume>, <fpage>1789</fpage>–<lpage>1792</lpage>. <pub-id pub-id-type="doi">10.1097/00001756-200210070-00019</pub-id><pub-id pub-id-type="pmid">12395124</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbierato</surname><given-names>M.</given-names></name><name><surname>Facci</surname><given-names>L.</given-names></name><name><surname>Marinelli</surname><given-names>C.</given-names></name><name><surname>Zusso</surname><given-names>M.</given-names></name><name><surname>Argentini</surname><given-names>C.</given-names></name><name><surname>Skaper</surname><given-names>S. D.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Co-ultramicronized palmitoylethanolamide/luteolin promotes the maturation of oligodendrocyte precursor cells</article-title>. <source/>Sci. Rep.
<volume>5</volume>:<fpage>16676</fpage>. <pub-id pub-id-type="doi">10.1038/srep16676</pub-id><pub-id pub-id-type="pmid">26578323</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron</surname><given-names>W.</given-names></name><name><surname>de Jonge</surname><given-names>J. C.</given-names></name><name><surname>de Vries</surname><given-names>H.</given-names></name><name><surname>Hoekstra</surname><given-names>D.</given-names></name></person-group> (<year>1998</year>). <article-title>Regulation of oligodendrocyte differentiation: protein kinase C activation prevents differentiation of O2A progenitor cells toward oligodendrocytes</article-title>. <source/>Glia
<volume>22</volume>, <fpage>121</fpage>–<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1098-1136(199802)22:2&lt;121::aid-glia3&gt;3.0.co;2-a</pub-id><pub-id pub-id-type="pmid">9537832</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barres</surname><given-names>B. A.</given-names></name><name><surname>Hart</surname><given-names>I. K.</given-names></name><name><surname>Coles</surname><given-names>H. S.</given-names></name><name><surname>Burne</surname><given-names>J. F.</given-names></name><name><surname>Voyvodic</surname><given-names>J. T.</given-names></name><name><surname>Richardson</surname><given-names>W. D.</given-names></name><etal></etal></person-group>. (<year>1992</year>). <article-title>Cell death and control of cell survival in the OL lineage</article-title>. <source/>Cell
<volume>70</volume>, <fpage>31</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(92)90531-g</pub-id><pub-id pub-id-type="pmid">1623522</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barres</surname><given-names>B. A.</given-names></name><name><surname>Lazar</surname><given-names>M. A.</given-names></name><name><surname>Raff</surname><given-names>M. C.</given-names></name></person-group> (<year>1994</year>). <article-title>A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development</article-title>. <source/>Development
<volume>120</volume>, <fpage>1097</fpage>–<lpage>1108</lpage>. <pub-id pub-id-type="pmid">8026323</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barres</surname><given-names>B. A.</given-names></name><name><surname>Schmid</surname><given-names>R.</given-names></name><name><surname>Sendnter</surname><given-names>M.</given-names></name><name><surname>Raff</surname><given-names>M. C.</given-names></name></person-group> (<year>1993</year>). <article-title>Multiple extracellular signals are required for long-term oligodendrocyte survival</article-title>. <source/>Development
<volume>118</volume>, <fpage>283</fpage>–<lpage>295</lpage>. <pub-id pub-id-type="pmid">8375338</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basavarajappa</surname><given-names>B. S.</given-names></name></person-group> (<year>2007</year>). <article-title>Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity</article-title>. <source/>Curr. Neuropharmacol.
<volume>5</volume>, <fpage>81</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.2174/157015907780866910</pub-id><pub-id pub-id-type="pmid">18084639</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baxi</surname><given-names>E. G.</given-names></name><name><surname>Schott</surname><given-names>J. T.</given-names></name><name><surname>Fairchild</surname><given-names>A. N.</given-names></name><name><surname>Kirby</surname><given-names>L. A.</given-names></name><name><surname>Karani</surname><given-names>R.</given-names></name><name><surname>Uapinyoying</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation</article-title>. <source/>Glia
<volume>62</volume>, <fpage>1513</fpage>–<lpage>1529</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22697</pub-id><pub-id pub-id-type="pmid">24863526</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazan</surname><given-names>J. F.</given-names></name></person-group> (<year>1990a</year>). <article-title>Haemopoietic receptors and helical cytokines</article-title>. <source/>Immunol. Today
<volume>11</volume>, <fpage>350</fpage>–<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1016/0167-5699(90)90139-z</pub-id><pub-id pub-id-type="pmid">2171545</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bazan</surname><given-names>J. F.</given-names></name></person-group> (<year>1990b</year>). <article-title>Structural design and molecular evolution of a cytokine receptor superfamily</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>87</volume>, <fpage>6934</fpage>–<lpage>6938</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.87.18.6934</pub-id><pub-id pub-id-type="pmid">2169613</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benito</surname><given-names>C.</given-names></name><name><surname>Romero</surname><given-names>J. P.</given-names></name><name><surname>Tolón</surname><given-names>R. M.</given-names></name><name><surname>Clemente</surname><given-names>D.</given-names></name><name><surname>Docagne</surname><given-names>F.</given-names></name><name><surname>Hillard</surname><given-names>C. J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>2396</fpage>–<lpage>2402</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4814-06.2007</pub-id><pub-id pub-id-type="pmid">17329437</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamins</surname><given-names>J. A.</given-names></name><name><surname>Nedelkoska</surname><given-names>L.</given-names></name></person-group> (<year>1996</year>). <article-title>Release of intracellular calcium stores leads to retraction of membrane sheets and cell death in mature mouse oligodendrocytes</article-title>. <source/>Neurochem. Res.
<volume>21</volume>, <fpage>471</fpage>–<lpage>479</lpage>. <pub-id pub-id-type="doi">10.1007/bf02527712</pub-id><pub-id pub-id-type="pmid">8734441</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernal</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Action of thyroid hormone in brain</article-title>. <source/>J. Endocrinol. Invest.
<volume>25</volume>, <fpage>268</fpage>–<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1007/BF03344003</pub-id><pub-id pub-id-type="pmid">11936472</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernardo</surname><given-names>A.</given-names></name><name><surname>Bianchi</surname><given-names>D.</given-names></name><name><surname>Magnaghi</surname><given-names>V.</given-names></name><name><surname>Minghetti</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>Peroxisome proliferator-activated receptor-gamma agonists promote differentiation and antioxidant defenses of oligodendrocyte progenitor cells</article-title>. <source/>J. Neuropathol. Exp. Neurol.
<volume>68</volume>, <fpage>797</fpage>–<lpage>808</lpage>. <pub-id pub-id-type="doi">10.1097/NEN.0b013e3181aba2c1</pub-id><pub-id pub-id-type="pmid">19535992</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernardo</surname><given-names>A.</given-names></name><name><surname>De Simone</surname><given-names>R.</given-names></name><name><surname>De Nuccio</surname><given-names>C.</given-names></name><name><surname>Visentin</surname><given-names>S.</given-names></name><name><surname>Minghetti</surname><given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>The nuclear receptor peroxisome proliferator-activated receptor-γ promotes OL differentiation through mechanisms involving mitochondria and oscillatory Ca<sup>2+</sup> waves</article-title>. <source/>Biol. Chem.
<volume>394</volume>, <fpage>1607</fpage>–<lpage>1614</lpage>. <pub-id pub-id-type="doi">10.1515/hsz-2013-0152</pub-id><pub-id pub-id-type="pmid">23770533</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bissay</surname><given-names>V.</given-names></name><name><surname>De Klippel</surname><given-names>N.</given-names></name><name><surname>Herroelen</surname><given-names>L.</given-names></name><name><surname>Schmedding</surname><given-names>E.</given-names></name><name><surname>Buisseret</surname><given-names>T.</given-names></name><name><surname>Ebinger</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>1994</year>). <article-title>Bromocriptine therapy in multiple sclerosis: an open label pilot study</article-title>. <source/>Clin. Neuropharmacol.
<volume>17</volume>, <fpage>473</fpage>–<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1097/00002826-199410000-00011</pub-id><pub-id pub-id-type="pmid">9316698</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bongarzone</surname><given-names>E. R.</given-names></name><name><surname>Howard</surname><given-names>S. G.</given-names></name><name><surname>Schonmann</surname><given-names>V.</given-names></name><name><surname>Campagnoni</surname><given-names>A. T.</given-names></name></person-group> (<year>1998</year>). <article-title>Identification of the dopamine D3 receptor in oligodendrocyte precursors: potential role in regulating differentiation and myelin formation</article-title>. <source/>J. Neurosci.
<volume>18</volume>, <fpage>5344</fpage>–<lpage>5353</lpage>. <pub-id pub-id-type="pmid">9651217</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brazel</surname><given-names>C. Y.</given-names></name><name><surname>Romanko</surname><given-names>M. J.</given-names></name><name><surname>Rothstein</surname><given-names>R. P.</given-names></name><name><surname>Levison</surname><given-names>S. W.</given-names></name></person-group> (<year>2003</year>). <article-title>Roles of the mammalian subventricular zone in brain development</article-title>. <source/>Prog. Neurobiol.
<volume>69</volume>, <fpage>49</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/s0301-0082(03)00002-9</pub-id><pub-id pub-id-type="pmid">12637172</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butt</surname><given-names>A. M.</given-names></name></person-group> (<year>2006</year>). <article-title>Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology</article-title>. <source/>Glia
<volume>54</volume>, <fpage>666</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20424</pub-id><pub-id pub-id-type="pmid">17006895</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calcaterra</surname><given-names>S.</given-names></name><name><surname>Glanz</surname><given-names>J.</given-names></name><name><surname>Binswanger</surname><given-names>I. A.</given-names></name></person-group> (<year>2013</year>). <article-title>National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999–2009</article-title>. <source/>Drug Alcohol Depend.
<volume>131</volume>, <fpage>263</fpage>–<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2012.11.018</pub-id><pub-id pub-id-type="pmid">23294765</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canonico</surname><given-names>P. L.</given-names></name><name><surname>Sortino</surname><given-names>M. A.</given-names></name><name><surname>Favit</surname><given-names>A.</given-names></name><name><surname>Aleppo</surname><given-names>G.</given-names></name><name><surname>Scapagnini</surname><given-names>U.</given-names></name></person-group> (<year>1993</year>). <article-title>Dihydroergocryptine protects from acute experimental allergic encephalomyelitis in the rat</article-title>. <source/>Funct. Neurol.
<volume>8</volume>, <fpage>183</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="pmid">8406136</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>N. G.</given-names></name></person-group> (<year>2003</year>). <article-title>Neuroprotection of cultured cortical neurons mediated by the cyclooxygenase-2 inhibitor APHS can be reversed by a prostanoid</article-title>. <source/>J. Neurosci. Res.
<volume>71</volume>, <fpage>79</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.10465</pub-id><pub-id pub-id-type="pmid">12478616</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>N. G.</given-names></name><name><surname>Bellamkonda</surname><given-names>S.</given-names></name><name><surname>Schmidt</surname><given-names>L.</given-names></name><name><surname>Redd</surname><given-names>J.</given-names></name><name><surname>Huecksteadt</surname><given-names>T.</given-names></name><name><surname>Weber</surname><given-names>L. M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>The role of the prostaglandin E2 receptors in vulnerability of OL precursor cells to death</article-title>. <source/>J. Neuroinflammation
<volume>12</volume>:<fpage>101</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-015-0323-7</pub-id><pub-id pub-id-type="pmid">25997851</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>N. G.</given-names></name><name><surname>Hill</surname><given-names>K. E.</given-names></name><name><surname>Tsunoda</surname><given-names>I.</given-names></name><name><surname>Fujinami</surname><given-names>R. S.</given-names></name><name><surname>Rose</surname><given-names>J. W.</given-names></name></person-group> (<year>2006</year>). <article-title>The pathologic role for COX-2 in apoptotic oligodendrocytes in virus induced demyelinating disease: implications for multiple sclerosis</article-title>. <source/>J. Neuroimmunol.
<volume>174</volume>, <fpage>21</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneuroim.2006.01.008</pub-id><pub-id pub-id-type="pmid">16516308</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlson</surname><given-names>N. G.</given-names></name><name><surname>Rojas</surname><given-names>M. A.</given-names></name><name><surname>Redd</surname><given-names>J. W.</given-names></name><name><surname>Tang</surname><given-names>P.</given-names></name><name><surname>Wood</surname><given-names>B.</given-names></name><name><surname>Hill</surname><given-names>K. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Cyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic death</article-title>. <source/>J. Neuroinflammation
<volume>7</volume>:<fpage>25</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-7-25</pub-id><pub-id pub-id-type="pmid">20388219</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cases</surname><given-names>O.</given-names></name><name><surname>Vitalis</surname><given-names>T.</given-names></name><name><surname>Seif</surname><given-names>I.</given-names></name><name><surname>De Maeyer</surname><given-names>E.</given-names></name><name><surname>Sotelo</surname><given-names>C.</given-names></name><name><surname>Gaspar</surname><given-names>P.</given-names></name></person-group> (<year>1996</year>). <article-title>Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period</article-title>. <source/>Neuron
<volume>16</volume>, <fpage>297</fpage>–<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(00)80048-3</pub-id><pub-id pub-id-type="pmid">8789945</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavaliere</surname><given-names>F.</given-names></name><name><surname>Urra</surname><given-names>O.</given-names></name><name><surname>Alberdi</surname><given-names>E.</given-names></name><name><surname>Matute</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Oligodendrocyte differentiation from adult multipotent stem cells is modulated by glutamate</article-title>. <source/>Cell Death Dis.
<volume>3</volume>:<fpage>e268</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2011.144</pub-id><pub-id pub-id-type="pmid">22297298</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerghet</surname><given-names>M.</given-names></name><name><surname>Skoff</surname><given-names>R. P.</given-names></name><name><surname>Swamydas</surname><given-names>M.</given-names></name><name><surname>Bessert</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Sexual dimorphism in the white matter of rodents</article-title>. <source/>J. Neurol. Sci.
<volume>286</volume>, <fpage>76</fpage>–<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2009.06.039</pub-id><pub-id pub-id-type="pmid">19625027</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chambon</surname><given-names>P.</given-names></name></person-group> (<year>2005</year>). <article-title>The nuclear receptor superfamily: a personal retrospect on the first two decades</article-title>. <source/>Mol. Endocrinol.
<volume>19</volume>, <fpage>1418</fpage>–<lpage>1428</lpage>. <pub-id pub-id-type="doi">10.1210/me.2005-0125</pub-id><pub-id pub-id-type="pmid">15914711</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheli</surname><given-names>V. T.</given-names></name><name><surname>Santiago González</surname><given-names>D. A.</given-names></name><name><surname>Spreuer</surname><given-names>V.</given-names></name><name><surname>Paez</surname><given-names>P. M.</given-names></name></person-group> (<year>2015</year>). <article-title>Voltage-gated Ca<sup>2+</sup> entry promotes oligodendrocyte progenitor cell maturation and myelination <italic>in vitro</italic></article-title>. <source/>Exp. Neurol.
<volume>265</volume>, <fpage>69</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2014.12.012</pub-id><pub-id pub-id-type="pmid">25542980</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C. Y.</given-names></name><name><surname>Lee</surname><given-names>K. W.</given-names></name><name><surname>Lee</surname><given-names>C. C.</given-names></name><name><surname>Chin</surname><given-names>S. C.</given-names></name><name><surname>Chung</surname><given-names>H. W.</given-names></name><name><surname>Zimmerman</surname><given-names>R. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Heroin-induced spongiform leukoencephalopathy: value of diffusion MR imaging</article-title>. <source/>J. Comput. Assist. Tomogr.
<volume>24</volume>, <fpage>735</fpage>–<lpage>737</lpage>. <pub-id pub-id-type="doi">10.1097/00004728-200009000-00013</pub-id><pub-id pub-id-type="pmid">11045695</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chevaleyre</surname><given-names>V.</given-names></name><name><surname>Takahashi</surname><given-names>K. A.</given-names></name><name><surname>Castillo</surname><given-names>P. E.</given-names></name></person-group> (<year>2006</year>). <article-title>Endocannabinoid-mediated synaptic plasticity in the CNS</article-title>. <source/>Annu. Rev. Neurosci.
<volume>29</volume>, <fpage>37</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.29.051605.112834</pub-id><pub-id pub-id-type="pmid">16776579</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiellini</surname><given-names>G.</given-names></name><name><surname>Apriletti</surname><given-names>J. W.</given-names></name><name><surname>Yoshihara</surname><given-names>H. A.</given-names></name><name><surname>Baxter</surname><given-names>J. D.</given-names></name><name><surname>Ribeiro</surname><given-names>R. C.</given-names></name><name><surname>Scanlan</surname><given-names>T. S.</given-names></name></person-group> (<year>1998</year>). <article-title>A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor</article-title>. <source/>Chem. Biol.
<volume>5</volume>, <fpage>299</fpage>–<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1016/s1074-5521(98)90168-5</pub-id><pub-id pub-id-type="pmid">9653548</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>D. W.</given-names></name></person-group> (<year>1988</year>). <article-title>Glutamate neurotoxicity and diseases of the nervous system</article-title>. <source/>Neuron
<volume>1</volume>, <fpage>623</fpage>–<lpage>634</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(88)90162-6</pub-id><pub-id pub-id-type="pmid">2908446</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chong</surname><given-names>Z. Z.</given-names></name><name><surname>Li</surname><given-names>F.</given-names></name><name><surname>Maiese</surname><given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>The pro-survival pathways of mTOR and protein kinase B target glucogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection</article-title>. <source/>Int. J. Mol. Med.
<volume>19</volume>, <fpage>263</fpage>–<lpage>272</lpage>. <pub-id pub-id-type="doi">10.3892/ijmm.19.2.263</pub-id><pub-id pub-id-type="pmid">17203200</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Civelli</surname><given-names>O.</given-names></name><name><surname>Bunzow</surname><given-names>J. R.</given-names></name><name><surname>Grandy</surname><given-names>D. K.</given-names></name></person-group> (<year>1993</year>). <article-title>Molecular diversity of the dopamine receptors</article-title>. <source/>Annu. Rev. Pharmacol. Toxicol.
<volume>33</volume>, <fpage>281</fpage>–<lpage>307</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.pharmtox.33.1.281</pub-id><pub-id pub-id-type="pmid">8494342</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coco</surname><given-names>S.</given-names></name><name><surname>Calegari</surname><given-names>F.</given-names></name><name><surname>Pravettoni</surname><given-names>E.</given-names></name><name><surname>Pozzi</surname><given-names>D.</given-names></name><name><surname>Taverna</surname><given-names>E.</given-names></name><name><surname>Rosa</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Storage and release of ATP from astrocytes in culture</article-title>. <source/>J. Biol. Chem.
<volume>278</volume>, <fpage>1354</fpage>–<lpage>1362</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m209454200</pub-id><pub-id pub-id-type="pmid">12414798</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>R. I.</given-names></name><name><surname>Almazan</surname><given-names>G.</given-names></name></person-group> (<year>1993</year>). <article-title>Norepinephrine-stimulated PI hydrolysis in oligodendrocytes is mediated by alpha 1A-adrenoceptors</article-title>. <source/>Neuroreport
<volume>4</volume>, <fpage>1115</fpage>–<lpage>1158</lpage>. <pub-id pub-id-type="pmid">8106008</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>R. I.</given-names></name><name><surname>Almazan</surname><given-names>G.</given-names></name></person-group> (<year>1994</year>). <article-title>Rat oligodendrocytes express muscarinic receptors coupled to phosphoinositide hydrolysis and adenylyl ciclase</article-title>. <source/>Eur. J. Neurosci.
<volume>6</volume>, <fpage>1213</fpage>–<lpage>1224</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.1994.tb00620.x</pub-id><pub-id pub-id-type="pmid">7952301</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>R. I.</given-names></name><name><surname>Molina-Holgado</surname><given-names>E.</given-names></name><name><surname>Almazan</surname><given-names>G.</given-names></name></person-group> (<year>1996</year>). <article-title>Carbachol stimulates c-fos expression and proliferation in oligodendrocyte progenitors</article-title>. <source/>Brain Res. Mol. Brain Res.
<volume>43</volume>, <fpage>193</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1016/s0169-328x(96)00176-3</pub-id><pub-id pub-id-type="pmid">9037533</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Compston</surname><given-names>A.</given-names></name></person-group> (<year>2002</year>). “<article-title>Myelination, demyelination and remyelination</article-title>,” in <source/>Diseases of the Nervous System: Clinical Neuroscience and Therapeutic Principles, 3rd Edn. eds <person-group person-group-type="editor"><name><surname>Asbury</surname><given-names>A. K.</given-names></name><name><surname>McKhann</surname><given-names>G. M.</given-names></name><name><surname>McDonald</surname><given-names>W. I.</given-names></name><name><surname>Goadsby</surname><given-names>P. J.</given-names></name><name><surname>McArthur</surname><given-names>J. C.</given-names></name></person-group> (<publisher-loc>Cambridge</publisher-loc>: <publisher-name>Cambridge University Press</publisher-name>), <fpage>1593</fpage>–<lpage>1605</lpage>.</mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Compton</surname><given-names>W. M.</given-names></name><name><surname>Volkow</surname><given-names>N. D.</given-names></name></person-group> (<year>2006</year>). <article-title>Major increases in opioid analgesic abuse in the United States: concerns and strategies</article-title>. <source/>Drug Alcohol Depend.
<volume>81</volume>, <fpage>103</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2005.05.009</pub-id><pub-id pub-id-type="pmid">16023304</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contestabile</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Role of nitric oxide in cerebellar development and function: focus on granule neurons</article-title>. <source/>Cerebellum
<volume>11</volume>, <fpage>50</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1007/s12311-010-0234-1</pub-id><pub-id pub-id-type="pmid">21104176</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corti</surname><given-names>C.</given-names></name><name><surname>Battaglia</surname><given-names>G.</given-names></name><name><surname>Molinaro</surname><given-names>G.</given-names></name><name><surname>Riozzi</surname><given-names>B.</given-names></name><name><surname>Pittaluga</surname><given-names>A.</given-names></name><name><surname>Corsi</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>8297</fpage>–<lpage>8308</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1889-07.2007</pub-id><pub-id pub-id-type="pmid">17670976</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costanza</surname><given-names>M.</given-names></name><name><surname>Musio</surname><given-names>S.</given-names></name><name><surname>Abou-Hamdan</surname><given-names>M.</given-names></name><name><surname>Binart</surname><given-names>N.</given-names></name><name><surname>Pedotti</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Prolactin is not required for the development of severe chronic experimental autoimmune encephalomyelitis</article-title>. <source/>J. Immunol.
<volume>191</volume>, <fpage>2082</fpage>–<lpage>2088</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1301128</pub-id><pub-id pub-id-type="pmid">23885109</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daubert</surname><given-names>E. A.</given-names></name><name><surname>Condron</surname><given-names>B. G.</given-names></name></person-group> (<year>2010</year>). <article-title>Serotonin: a regulator of neuronal morphology and circuitry</article-title>. <source/>Trends Neurosci.
<volume>33</volume>, <fpage>424</fpage>–<lpage>434</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2010.05.005</pub-id><pub-id pub-id-type="pmid">20561690</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Angelis</surname><given-names>F.</given-names></name><name><surname>Bernardo</surname><given-names>A.</given-names></name><name><surname>Magnaghi</surname><given-names>V.</given-names></name><name><surname>Minghetti</surname><given-names>L.</given-names></name><name><surname>Tata</surname><given-names>A. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Muscarinic receptor subtypes as potential targets to modulate oligodendrocyte progenitor survival, proliferation, and differentiation</article-title>. <source/>Dev. Neurobiol.
<volume>72</volume>, <fpage>713</fpage>–<lpage>728</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.20976</pub-id><pub-id pub-id-type="pmid">21913336</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname><given-names>L.</given-names></name><name><surname>Avellana-Adalid</surname><given-names>V.</given-names></name><name><surname>Nait-Oumesmar</surname><given-names>B.</given-names></name><name><surname>Durbec</surname><given-names>P.</given-names></name><name><surname>Baron-VanEvercooren</surname><given-names>A.</given-names></name></person-group> (<year>2000</year>). <article-title>Oligodendrocyte precursor migration and differentiation: combined effects of PSA residues, growth factors and substrates</article-title>. <source/>Mol. Cell. Neurosci.
<volume>16</volume>, <fpage>422</fpage>–<lpage>439</lpage>. <pub-id pub-id-type="doi">10.1006/mcne.2000.0885</pub-id><pub-id pub-id-type="pmid">11085879</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Fuente</surname><given-names>A. G.</given-names></name><name><surname>Errea</surname><given-names>O.</given-names></name><name><surname>van Wijngaarden</surname><given-names>P.</given-names></name><name><surname>Gonzalez</surname><given-names>G. A.</given-names></name><name><surname>Kerninon</surname><given-names>C.</given-names></name><name><surname>Jarjour</surname><given-names>A. A.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Vitamin D receptor-retinoid X receptor heterodimer signaling regulates oligodendrocyte progenitor cell differentiation</article-title>. <source/>J. Cell Biol.
<volume>211</volume>, <fpage>975</fpage>–<lpage>985</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201505119</pub-id><pub-id pub-id-type="pmid">26644513</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>W.</given-names></name><name><surname>Rosenberg</surname><given-names>P. A.</given-names></name><name><surname>Volpe</surname><given-names>J. J.</given-names></name><name><surname>Jensen</surname><given-names>F. E.</given-names></name></person-group> (<year>2003</year>). <article-title>Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>100</volume>, <fpage>6801</fpage>–<lpage>6806</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1136624100</pub-id><pub-id pub-id-type="pmid">12743362</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Rosenberg</surname><given-names>P. A.</given-names></name><name><surname>Volpe</surname><given-names>J. J.</given-names></name><name><surname>Jensen</surname><given-names>F. E.</given-names></name></person-group> (<year>2004</year>). <article-title>Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>101</volume>, <fpage>7751</fpage>–<lpage>7756</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0307850101</pub-id><pub-id pub-id-type="pmid">15136737</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Nicola</surname><given-names>A. F.</given-names></name><name><surname>Gonzalez</surname><given-names>S. L.</given-names></name><name><surname>Labombarda</surname><given-names>F.</given-names></name><name><surname>González Deniselle</surname><given-names>M. C.</given-names></name><name><surname>Garay</surname><given-names>L.</given-names></name><name><surname>Guennoun</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Progesterone treatment of spinal cord injury: effects on receptors, neurotrophins and myelination</article-title>. <source/>J. Mol. Neurosci.
<volume>28</volume>, <fpage>3</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1385/jmn:28:1:3</pub-id><pub-id pub-id-type="pmid">16632872</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deshmukh</surname><given-names>V. A.</given-names></name><name><surname>Tardif</surname><given-names>V.</given-names></name><name><surname>Lyssiotis</surname><given-names>C. A.</given-names></name><name><surname>Green</surname><given-names>C. C.</given-names></name><name><surname>Kerman</surname><given-names>B.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>A regenerative approach to the treatment of multiple sclerosis</article-title>. <source/>Nature
<volume>502</volume>, <fpage>327</fpage>–<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1038/nature12647</pub-id><pub-id pub-id-type="pmid">24107995</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Simone</surname><given-names>R.</given-names></name><name><surname>Ajmone-Cat</surname><given-names>M. A.</given-names></name><name><surname>Carnevale</surname><given-names>D.</given-names></name><name><surname>Minghetti</surname><given-names>L.</given-names></name></person-group> (<year>2005</year>). <article-title>Activation of alpha7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures</article-title>. <source/>J. Neuroinflammation
<volume>2</volume>:<fpage>4</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-2-4</pub-id><pub-id pub-id-type="pmid">15670336</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devito</surname><given-names>W. J.</given-names></name></person-group> (<year>1988</year>). <article-title>Distribution of immunoreactive prolactin in the male and female rat brain: effects of hypophysectomy and intraventricular administration of colchicine</article-title>. <source/>Neuroendocrinology
<volume>47</volume>, <fpage>284</fpage>–<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1159/000124926</pub-id><pub-id pub-id-type="pmid">3374755</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dingledine</surname><given-names>R.</given-names></name><name><surname>Borges</surname><given-names>K.</given-names></name><name><surname>Bowie</surname><given-names>D.</given-names></name><name><surname>Traynelis</surname><given-names>S. F.</given-names></name></person-group> (<year>1999</year>). <article-title>The glutamate receptor ion channels</article-title>. <source/>Pharmacol. Rev.
<volume>51</volume>, <fpage>7</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="pmid">10049997</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domercq</surname><given-names>M.</given-names></name><name><surname>Etxebarria</surname><given-names>E.</given-names></name><name><surname>Pérez-Samartín</surname><given-names>A.</given-names></name><name><surname>Matute</surname><given-names>C.</given-names></name></person-group> (<year>2005</year>). <article-title>Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition</article-title>. <source/>Glia
<volume>52</volume>, <fpage>36</fpage>–<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20221</pub-id><pub-id pub-id-type="pmid">15892126</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Domercq</surname><given-names>M.</given-names></name><name><surname>Sánchez-Gómez</surname><given-names>M. V.</given-names></name><name><surname>Areso</surname><given-names>P.</given-names></name><name><surname>Matute</surname><given-names>C.</given-names></name></person-group> (<year>1999</year>). <article-title>Expression of glutamate transporters in rat optic nerve oligodendrocytes</article-title>. <source/>Eur. J. Neurosci.
<volume>11</volume>, <fpage>2226</fpage>–<lpage>2236</lpage>. <pub-id pub-id-type="doi">10.1046/j.1460-9568.1999.00639.x</pub-id><pub-id pub-id-type="pmid">10383611</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dugas</surname><given-names>J. C.</given-names></name><name><surname>Cuellar</surname><given-names>T. L.</given-names></name><name><surname>Scholze</surname><given-names>A.</given-names></name><name><surname>Ason</surname><given-names>B.</given-names></name><name><surname>Ibrahim</surname><given-names>A.</given-names></name><name><surname>Emery</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination</article-title>. <source/>Neuron
<volume>65</volume>, <fpage>597</fpage>–<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.01.027</pub-id><pub-id pub-id-type="pmid">20223197</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dugas</surname><given-names>J. C.</given-names></name><name><surname>Ibrahim</surname><given-names>A.</given-names></name><name><surname>Barres</surname><given-names>B. A.</given-names></name></person-group> (<year>2012</year>). <article-title>The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration</article-title>. <source/>Mol. Cell. Neurosci.
<volume>50</volume>, <fpage>45</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2012.03.007</pub-id><pub-id pub-id-type="pmid">22472204</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dum</surname><given-names>J. E.</given-names></name><name><surname>Herz</surname><given-names>A.</given-names></name></person-group> (<year>1981</year>). <article-title><italic>In vivo</italic> receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions</article-title>. <source/>Br. J. Pharmacol.
<volume>74</volume>, <fpage>627</fpage>–<lpage>633</lpage>. <pub-id pub-id-type="doi">10.1111/j.1476-5381.1981.tb10473.x</pub-id><pub-id pub-id-type="pmid">6271322</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durand</surname><given-names>B.</given-names></name><name><surname>Raff</surname><given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>A cell-intrinsic timer that operates during oligodendrocyte development</article-title>. <source/>Bioessays
<volume>22</volume>, <fpage>64</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1521-1878(200001)22:1&lt;64::aid-bies11&gt;3.0.co;2-q</pub-id><pub-id pub-id-type="pmid">10649292</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dzhala</surname><given-names>V. I.</given-names></name><name><surname>Talos</surname><given-names>D. M.</given-names></name><name><surname>Sdrulla</surname><given-names>D. A.</given-names></name><name><surname>Brumback</surname><given-names>A. C.</given-names></name><name><surname>Mathews</surname><given-names>G. C.</given-names></name><name><surname>Benke</surname><given-names>T. A.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>NKCC1 transporter facilitates seizures in the developing brain</article-title>. <source/>Nat. Med.
<volume>11</volume>, <fpage>1205</fpage>–<lpage>1213</lpage>. <pub-id pub-id-type="doi">10.1038/nm1301</pub-id><pub-id pub-id-type="pmid">16227993</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eglen</surname><given-names>R. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function</article-title>. <source/>Autonom. Autocoid Pharmacol.
<volume>26</volume>, <fpage>219</fpage>–<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-8673.2006.00368.x</pub-id><pub-id pub-id-type="pmid">16879488</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esaki</surname><given-names>T.</given-names></name><name><surname>Cook</surname><given-names>M.</given-names></name><name><surname>Shimoji</surname><given-names>K.</given-names></name><name><surname>Murphy</surname><given-names>D. L.</given-names></name><name><surname>Sokoloff</surname><given-names>L.</given-names></name><name><surname>Holmes</surname><given-names>A.</given-names></name></person-group> (<year>2005</year>). <article-title>Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>102</volume>, <fpage>5582</fpage>–<lpage>5587</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0501509102</pub-id><pub-id pub-id-type="pmid">15809439</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eschenroeder</surname><given-names>A. C.</given-names></name><name><surname>Vestal-Laborde</surname><given-names>A. A.</given-names></name><name><surname>Sanchez</surname><given-names>E. S.</given-names></name><name><surname>Robinson</surname><given-names>S. E.</given-names></name><name><surname>Sato-Bigbee</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancy</article-title>. <source/>Glia
<volume>60</volume>, <fpage>125</fpage>–<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1002/glia.21253</pub-id><pub-id pub-id-type="pmid">22002899</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>R. M.</given-names></name></person-group> (<year>2005</year>). <article-title>The nuclear receptor superfamily: a Rosetta stone for physiology</article-title>. <source/>Mol. Endocrinol.
<volume>19</volume>, <fpage>1429</fpage>–<lpage>1438</lpage>. <pub-id pub-id-type="doi">10.1210/me.2005-0046</pub-id><pub-id pub-id-type="pmid">15914712</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>L. W.</given-names></name><name><surname>Bhatt</surname><given-names>A.</given-names></name><name><surname>Tien</surname><given-names>L. T.</given-names></name><name><surname>Zheng</surname><given-names>B.</given-names></name><name><surname>Simpson</surname><given-names>K. L.</given-names></name><name><surname>Lin</surname><given-names>R. C.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Exposure to serotonin adversely affects oligodendrocyte development and myelination <italic>in vitro</italic></article-title>. <source/>J. Neurochem.
<volume>133</volume>, <fpage>532</fpage>–<lpage>543</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.12988</pub-id><pub-id pub-id-type="pmid">25382136</pub-id></mixed-citation>
</ref>
<ref id="B850">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farsetti</surname><given-names>A.</given-names></name><name><surname>Mitsuhashi</surname><given-names>T.</given-names></name><name><surname>Desvergne</surname><given-names>B.</given-names></name><name><surname>Robbins</surname><given-names>J.</given-names></name><name><surname>Nikodem</surname><given-names>V. M.</given-names></name></person-group> (<year>1991</year>). <article-title>Molecular basis of thyroid hormone regulation of myelin basic protein gene expression in rodent brain</article-title>. <source/>J. Biol. Chem.
<volume>266</volume>, <fpage>23226</fpage>–<lpage>23232</lpage>.<pub-id pub-id-type="pmid">1720778</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felder</surname><given-names>C. C.</given-names></name><name><surname>Bymaster</surname><given-names>F. P.</given-names></name><name><surname>Ward</surname><given-names>J.</given-names></name><name><surname>DeLapp</surname><given-names>N.</given-names></name></person-group> (<year>2000</year>). <article-title>Therapeutic opportunities for muscarinic receptors in central nervous system</article-title>. <source/>J. Med. Chem.
<volume>43</volume>, <fpage>4333</fpage>–<lpage>4353</lpage>. <pub-id pub-id-type="doi">10.1021/jm990607u</pub-id><pub-id pub-id-type="pmid">11087557</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felts</surname><given-names>P. A.</given-names></name><name><surname>Baker</surname><given-names>T. A.</given-names></name><name><surname>Smith</surname><given-names>K. J.</given-names></name></person-group> (<year>1997</year>). <article-title>Conduction in segmentally demyelinated mammalian central axons</article-title>. <source/>J. Neurosci.
<volume>17</volume>, <fpage>7267</fpage>–<lpage>7277</lpage>. <pub-id pub-id-type="pmid">9295373</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>J. F.</given-names></name><name><surname>Gao</surname><given-names>X. F.</given-names></name><name><surname>Pu</surname><given-names>Y. Y.</given-names></name><name><surname>Burnstock</surname><given-names>G.</given-names></name><name><surname>Xiang</surname><given-names>Z.</given-names></name><name><surname>He</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>P2X7 receptors and Fyn kinase mediate ATP-induced oligodendrocyte progenitor cell migration</article-title>. <source/>Purinergic Signal.
<volume>11</volume>, <fpage>361</fpage>–<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1007/s11302-015-9458-3</pub-id><pub-id pub-id-type="pmid">26099359</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fields</surname><given-names>R. D.</given-names></name><name><surname>Stevens</surname><given-names>B.</given-names></name></person-group> (<year>2000</year>). <article-title>ATP: an extracellular signaling molecule between neurons and glia</article-title>. <source/>Trends Neurosci.
<volume>23</volume>, <fpage>625</fpage>–<lpage>633</lpage>. <pub-id pub-id-type="doi">10.1016/s0166-2236(00)01674-x</pub-id><pub-id pub-id-type="pmid">11137153</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fitch</surname><given-names>R. H.</given-names></name><name><surname>Berrebi</surname><given-names>A. S.</given-names></name><name><surname>Cowell</surname><given-names>P. E.</given-names></name><name><surname>Schrott</surname><given-names>L. M.</given-names></name><name><surname>Denenberg</surname><given-names>V. H.</given-names></name></person-group> (<year>1990</year>). <article-title>Corpus callosum: effects of neonatal hormones on sexual dimorphism in the rat</article-title>. <source/>Brain Res.
<volume>51</volume>, <fpage>111</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(90)90584-x</pub-id><pub-id pub-id-type="pmid">2357549</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores</surname><given-names>A. I.</given-names></name><name><surname>Mallon</surname><given-names>B. S.</given-names></name><name><surname>Matsui</surname><given-names>T.</given-names></name><name><surname>Ogawa</surname><given-names>W.</given-names></name><name><surname>Rosenzweig</surname><given-names>A.</given-names></name><name><surname>Okamoto</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Akt-mediated survival of oligodendrocytes induced by neuregulins</article-title>. <source/>J. Neurosci.
<volume>20</volume>, <fpage>7622</fpage>–<lpage>7630</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m910419199</pub-id><pub-id pub-id-type="pmid">11027222</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franklin</surname><given-names>R. J. M.</given-names></name><name><surname>ffrench-Constant</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Remyelination in the CNS: from biology to therapy</article-title>. <source/>Nat. Rev. Neurosci.
<volume>9</volume>, <fpage>839</fpage>–<lpage>855</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2480</pub-id><pub-id pub-id-type="pmid">18931697</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Franklin</surname><given-names>R. J.</given-names></name><name><surname>Kotter</surname><given-names>M. R.</given-names></name></person-group> (<year>2008</year>). <article-title>The biology of CNS remyelination: the key to therapeutic advances</article-title>. <source/>J. Neurol.
<volume>255</volume>, <fpage>19</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-008-1004-6</pub-id><pub-id pub-id-type="pmid">18317673</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>M. E.</given-names></name><name><surname>Kanyicska</surname><given-names>B.</given-names></name><name><surname>Lerant</surname><given-names>A.</given-names></name><name><surname>Nagy</surname><given-names>G.</given-names></name></person-group> (<year>2000</year>). <article-title>Prolactin: structure, function and regulation of secretion</article-title>. <source/>Physiol. Rev.
<volume>80</volume>, <fpage>1523</fpage>–<lpage>1631</lpage>. <pub-id pub-id-type="pmid">11015620</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freemantle</surname><given-names>E.</given-names></name><name><surname>Chen</surname><given-names>G. G.</given-names></name><name><surname>Cruceanu</surname><given-names>C.</given-names></name><name><surname>Mechawar</surname><given-names>N.</given-names></name><name><surname>Turecki</surname><given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>Analysis of oxysterols and cholesterol in prefrontal cortex of suicides</article-title>. <source/>Int. J. Neuropsychopharmacol.
<volume>16</volume>, <fpage>1241</fpage>–<lpage>1249</lpage>. <pub-id pub-id-type="doi">10.1017/s1461145712001587</pub-id><pub-id pub-id-type="pmid">23369504</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuxe</surname><given-names>K.</given-names></name><name><surname>Hökfelt</surname><given-names>T.</given-names></name><name><surname>Eneroth</surname><given-names>P.</given-names></name><name><surname>Gustafsson</surname><given-names>J. A.</given-names></name><name><surname>Skett</surname><given-names>P.</given-names></name></person-group> (<year>1977</year>). <article-title>Prolactin-like immunoreactivity: localization in nerve terminals of rat hypothalamus</article-title>. <source/>Science
<volume>196</volume>, <fpage>899</fpage>–<lpage>900</lpage>. <pub-id pub-id-type="doi">10.1126/science.323973</pub-id><pub-id pub-id-type="pmid">323973</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>F. B.</given-names></name><name><surname>Apperly</surname><given-names>J.</given-names></name><name><surname>Raff</surname><given-names>M.</given-names></name></person-group> (<year>1998</year>). <article-title>Cell-intrinsic timers and thyroid hormone regulate the probability of cell-cycle withdrawal and differentiation of oligodendrocyte precursor cells</article-title>. <source/>Dev. Biol.
<volume>197</volume>, <fpage>54</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1006/dbio.1998.8877</pub-id><pub-id pub-id-type="pmid">9578618</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garay</surname><given-names>L.</given-names></name><name><surname>Gonzalez Deniselle</surname><given-names>M. C.</given-names></name><name><surname>Gierman</surname><given-names>L.</given-names></name><name><surname>Meyer</surname><given-names>M.</given-names></name><name><surname>Lima</surname><given-names>A.</given-names></name><name><surname>Roig</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis</article-title>. <source/>Neuroimmunomodulation
<volume>15</volume>, <fpage>76</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1159/000135627</pub-id><pub-id pub-id-type="pmid">18667803</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garthwaite</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Concepts of neural nitric oxide-mediated transmission</article-title>. <source/>Eur. J. Neurosci.
<volume>27</volume>, <fpage>2783</fpage>–<lpage>2802</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06285.x</pub-id><pub-id pub-id-type="pmid">18588525</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garthwaite</surname><given-names>G.</given-names></name><name><surname>Hampden-Smith</surname><given-names>K.</given-names></name><name><surname>Wilson</surname><given-names>G. W.</given-names></name><name><surname>Goodwin</surname><given-names>D. A.</given-names></name><name><surname>Garthwaite</surname><given-names>J.</given-names></name></person-group> (<year>2015</year>). <article-title>Nitric oxide targets oligodendrocytes and promotes their morphological differentiation</article-title>. <source/>Glia
<volume>63</volume>, <fpage>383</fpage>–<lpage>399</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22759</pub-id><pub-id pub-id-type="pmid">25327839</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautier</surname><given-names>H. O.</given-names></name><name><surname>Evans</surname><given-names>K. A.</given-names></name><name><surname>Volbracht</surname><given-names>K.</given-names></name><name><surname>James</surname><given-names>R.</given-names></name><name><surname>Sitnikov</surname><given-names>S.</given-names></name><name><surname>Lundgaard</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Neuronal activity regulates remyelination via glutamate signalling to oligodendrocyte progenitors</article-title>. <source/>Nat. Commun.
<volume>6</volume>:<fpage>8518</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms9518</pub-id><pub-id pub-id-type="pmid">26439639</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Germain</surname><given-names>P.</given-names></name><name><surname>Chambon</surname><given-names>P.</given-names></name><name><surname>Eichele</surname><given-names>G.</given-names></name><name><surname>Evans</surname><given-names>R. M.</given-names></name><name><surname>Lazar</surname><given-names>M. A.</given-names></name><name><surname>Leid</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2006a</year>). <article-title>International union of pharmacology. LXIII. Retinoid X receptors</article-title>. <source/>Pharmacol. Rev.
<volume>58</volume>, <fpage>760</fpage>–<lpage>772</lpage>. <pub-id pub-id-type="doi">10.1124/pr.58.4.7</pub-id><pub-id pub-id-type="pmid">17132853</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Germain</surname><given-names>P.</given-names></name><name><surname>Staels</surname><given-names>B.</given-names></name><name><surname>Dacquet</surname><given-names>C.</given-names></name><name><surname>Spedding</surname><given-names>M.</given-names></name><name><surname>Laudet</surname><given-names>V.</given-names></name></person-group> (<year>2006b</year>). <article-title>Overview of nomenclature of nuclear receptors</article-title>. <source/>Pharmacol. Rev.
<volume>58</volume>, <fpage>685</fpage>–<lpage>704</lpage>. <pub-id pub-id-type="doi">10.1124/pr.58.4.2</pub-id><pub-id pub-id-type="pmid">17132848</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerstner</surname><given-names>B.</given-names></name><name><surname>Sifringe</surname><given-names>M.</given-names></name><name><surname>Dzietko</surname><given-names>M.</given-names></name><name><surname>Schüller</surname><given-names>A.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><name><surname>Simons</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Estradiol attenuates-induced cell death in the developing white matter</article-title>. <source/>Ann. Neurol.
<volume>61</volume>, <fpage>562</fpage>–<lpage>573</lpage>. <pub-id pub-id-type="doi">10.1002/ana.21118</pub-id><pub-id pub-id-type="pmid">17427919</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghiani</surname><given-names>C. A.</given-names></name><name><surname>Eisen</surname><given-names>A. M.</given-names></name><name><surname>Yuan</surname><given-names>X.</given-names></name><name><surname>DePinho</surname><given-names>R. A.</given-names></name><name><surname>McBain</surname><given-names>C. J.</given-names></name><name><surname>Gallo</surname><given-names>V.</given-names></name></person-group> (<year>1999</year>). <article-title>Neurotransmitter receptor activation triggers p27(Kip1 )and p21(CIP1) accumulation and G1 cell cycle arrest in oligodendrocyte progenitors</article-title>. <source/>Development
<volume>12</volume>, <fpage>1077</fpage>–<lpage>1090</lpage>. <pub-id pub-id-type="pmid">9927607</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gianola</surname><given-names>S.</given-names></name><name><surname>Savio</surname><given-names>T.</given-names></name><name><surname>Schwab</surname><given-names>M. E.</given-names></name><name><surname>Rossi</surname><given-names>F.</given-names></name></person-group> (<year>2003</year>). <article-title>Cell-autonomous mechanisms and myelin-associated factors contribute to the development of Purkinje axon intracortical plexus in the rat cerebellum</article-title>. <source/>J. Neurosci.
<volume>23</volume>, <fpage>4613</fpage>–<lpage>4624</lpage>. <pub-id pub-id-type="pmid">12805301</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldman</surname><given-names>S. A.</given-names></name><name><surname>Nedergaard</surname><given-names>M.</given-names></name><name><surname>Windrem</surname><given-names>M. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Glial progenitor cell-based treatment and modeling of neurological disease</article-title>. <source/>Science
<volume>338</volume>, <fpage>491</fpage>–<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1126/science.1218071</pub-id><pub-id pub-id-type="pmid">23112326</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>J. M.</given-names></name><name><surname>Seidman</surname><given-names>L. J.</given-names></name><name><surname>Horton</surname><given-names>N. J.</given-names></name><name><surname>Makris</surname><given-names>N.</given-names></name><name><surname>Kennedy</surname><given-names>D. N.</given-names></name><name><surname>Caviness Jr</surname><given-names>V. S.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Normal sexual dimorphism of the adult brain assessed by <italic>in vivo</italic> magnetic resonance imaging</article-title>. <source/>Cereb. Cortex
<volume>11</volume>, <fpage>490</fpage>–<lpage>497</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/11.6.490</pub-id><pub-id pub-id-type="pmid">11375910</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gregg</surname><given-names>C.</given-names></name><name><surname>Shikar</surname><given-names>V.</given-names></name><name><surname>Larsen</surname><given-names>P.</given-names></name><name><surname>Mak</surname><given-names>G.</given-names></name><name><surname>Chojnacki</surname><given-names>A.</given-names></name><name><surname>Yong</surname><given-names>V. W.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>White matter plasticity and enhanced remyelination in the maternal CNS</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>1812</fpage>–<lpage>1823</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4441-06.2007</pub-id><pub-id pub-id-type="pmid">17314279</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grinspan</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Cells and signaling in oligodendrocyte development</article-title>. <source/>J. Neuropathol. Exp. Neurol.
<volume>61</volume>, <fpage>297</fpage>–<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1093/jnen/61.4.297</pub-id><pub-id pub-id-type="pmid">11939585</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gronemeyer</surname><given-names>H.</given-names></name><name><surname>Gustafsson</surname><given-names>J. A.</given-names></name><name><surname>Laudet</surname><given-names>V.</given-names></name></person-group> (<year>2004</year>). <article-title>Principles for modulation of the nuclear receptor superfamily</article-title>. <source/>Nat. Rev. Drug Discov.
<volume>3</volume>, <fpage>950</fpage>–<lpage>964</lpage>. <pub-id pub-id-type="doi">10.1038/nrd1551</pub-id><pub-id pub-id-type="pmid">15520817</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guizzetti</surname><given-names>M.</given-names></name><name><surname>Costa</surname><given-names>P.</given-names></name><name><surname>Peters</surname><given-names>J.</given-names></name><name><surname>Costa</surname><given-names>L. G.</given-names></name></person-group> (<year>1996</year>). <article-title>Acetylcholine as a mitogen: muscarinic receptor-mediated proliferation of rat astrocytes and human astrocytoma cells</article-title>. <source/>Eur. J. Pharmacol.
<volume>297</volume>, <fpage>265</fpage>–<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1016/0014-2999(95)00746-6</pub-id><pub-id pub-id-type="pmid">8666059</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gur</surname><given-names>R. C.</given-names></name><name><surname>Turetsky</surname><given-names>B. I.</given-names></name><name><surname>Matsui</surname><given-names>M.</given-names></name><name><surname>Yan</surname><given-names>M.</given-names></name><name><surname>Bilker</surname><given-names>W.</given-names></name><name><surname>Hughett</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Sex differences in brain gray and white matter in healthy young adults: correlations with cognitive performance</article-title>. <source/>J. Neurosci.
<volume>19</volume>, <fpage>4065</fpage>–<lpage>4072</lpage>. <pub-id pub-id-type="pmid">10234034</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haas</surname><given-names>J.</given-names></name><name><surname>Erdö</surname><given-names>S. L.</given-names></name></person-group> (<year>1991</year>). <article-title>Quisqualate-induced excitotoxic death of glial cells: transient vulnerability of cultured astrocytes</article-title>. <source/>Glia
<volume>4</volume>, <fpage>111</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1002/glia.440040113</pub-id><pub-id pub-id-type="pmid">1828782</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>C. N.</given-names></name><name><surname>Garthwaite</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>What is the real physiological NO concentration <italic>in vivo</italic>?</article-title>
<source/>Nitric Oxide
<volume>21</volume>, <fpage>92</fpage>–<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1016/j.niox.2009.07.002</pub-id><pub-id pub-id-type="pmid">19602444</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harasty</surname><given-names>J.</given-names></name><name><surname>Double</surname><given-names>K. L.</given-names></name><name><surname>Halliday</surname><given-names>G. M.</given-names></name><name><surname>Kril</surname><given-names>J. J.</given-names></name><name><surname>McRitchie</surname><given-names>D. A.</given-names></name></person-group> (<year>1997</year>). <article-title>Language-associated cortical regions are proportionally larger in the female brain</article-title>. <source/>Arch. Neurol.
<volume>54</volume>, <fpage>171</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.1997.00550140045011</pub-id><pub-id pub-id-type="pmid">9041858</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardingham</surname><given-names>N.</given-names></name><name><surname>Dachtler</surname><given-names>J.</given-names></name><name><surname>Fox</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>The role of nitric oxide in pre-synaptic plasticity and homeostasis</article-title>. <source/>Front. Cell. Neurosci.
<volume>7</volume>:<fpage>190</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2013.00190</pub-id><pub-id pub-id-type="pmid">24198758</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harlan</surname><given-names>R. E.</given-names></name><name><surname>Shivers</surname><given-names>B. D.</given-names></name><name><surname>Fox</surname><given-names>S. R.</given-names></name><name><surname>Kaplove</surname><given-names>K. A.</given-names></name><name><surname>Schachter</surname><given-names>B. S.</given-names></name><name><surname>Pfaff</surname><given-names>S. W.</given-names></name></person-group> (<year>1989</year>). <article-title>Distribution and partial characterization of immunoreactive prolactin in the rat brain</article-title>. <source/>Neuroendocrinology
<volume>49</volume>, <fpage>7</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1159/000125085</pub-id><pub-id pub-id-type="pmid">2716951</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartline</surname><given-names>D. K.</given-names></name><name><surname>Colman</surname><given-names>D. R.</given-names></name></person-group> (<year>2007</year>). <article-title>Rapid conduction and the evolution of giant axons and myelinated fibers</article-title>. <source/>Curr. Biol.
<volume>17</volume>, <fpage>R29</fpage>–<lpage>R35</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2006.11.042</pub-id><pub-id pub-id-type="pmid">17208176</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hay</surname><given-names>N.</given-names></name></person-group> (<year>2005</year>). <article-title>The Akt-mTOR tango and its relevance to cancer</article-title>. <source/>Cancer Cell
<volume>8</volume>, <fpage>179</fpage>–<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2005.08.008</pub-id><pub-id pub-id-type="pmid">16169463</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hebert-Chatelain</surname><given-names>E.</given-names></name><name><surname>Reguero</surname><given-names>L.</given-names></name><name><surname>Puente</surname><given-names>N.</given-names></name><name><surname>Lutz</surname><given-names>B.</given-names></name><name><surname>Chaouloff</surname><given-names>F.</given-names></name><name><surname>Rossignol</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Cannabinoid control of brain bioenergetics: exploring the subcellular localization of the CB1 receptor</article-title>. <source/>Mol. Metab.
<volume>3</volume>, <fpage>495</fpage>–<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmet.2014.03.007</pub-id><pub-id pub-id-type="pmid">24944910</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewett</surname><given-names>S. J.</given-names></name><name><surname>Uliasz</surname><given-names>T. F.</given-names></name><name><surname>Vidwans</surname><given-names>A. S.</given-names></name><name><surname>Hewett</surname><given-names>J. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture</article-title>. <source/>J. Pharmacol. Exp. Ther.
<volume>293</volume>, <fpage>417</fpage>–<lpage>425</lpage>. <pub-id pub-id-type="pmid">10773011</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honer</surname><given-names>W. G.</given-names></name><name><surname>Falkal</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Arango</surname><given-names>V.</given-names></name><name><surname>Mann</surname><given-names>J. J.</given-names></name><name><surname>Dwork</surname><given-names>A. J.</given-names></name></person-group> (<year>1999</year>). <article-title>Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness</article-title>. <source/>Neuroscience
<volume>91</volume>, <fpage>1247</fpage>–<lpage>1255</lpage>. <pub-id pub-id-type="doi">10.1016/s0306-4522(98)00679-4</pub-id><pub-id pub-id-type="pmid">10391432</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horiuchi</surname><given-names>M.</given-names></name><name><surname>Itoh</surname><given-names>A.</given-names></name><name><surname>Pleasure</surname><given-names>D.</given-names></name><name><surname>Itoh</surname><given-names>T.</given-names></name></person-group> (<year>2006</year>). <article-title>MEK-ERK signaling is involved in interferon-gamma-induced death of oligodendroglial progenitor cells</article-title>. <source/>J. Biol. Chem.
<volume>281</volume>, <fpage>20095</fpage>–<lpage>20106</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m603179200</pub-id><pub-id pub-id-type="pmid">16728393</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howlett</surname><given-names>A. C.</given-names></name><name><surname>Barth</surname><given-names>F.</given-names></name><name><surname>Bonner</surname><given-names>T. I.</given-names></name><name><surname>Cabral</surname><given-names>G.</given-names></name><name><surname>Casellas</surname><given-names>P.</given-names></name><name><surname>Devane</surname><given-names>W. A.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>International union of pharmacology. XXVII. Classification of cannabinoid receptors</article-title>. <source/>Pharmacol. Rev.
<volume>54</volume>, <fpage>161</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1124/pr.54.2.161</pub-id><pub-id pub-id-type="pmid">12037135</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J. K.</given-names></name><name><surname>Jarjour</surname><given-names>A. A.</given-names></name><name><surname>Nait Oumesmar</surname><given-names>B.</given-names></name><name><surname>Kerninon</surname><given-names>C.</given-names></name><name><surname>Williams</surname><given-names>A.</given-names></name><name><surname>Krezel</surname><given-names>W.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Retinoid X receptor gamma signaling accelerates CNS remyelination</article-title>. <source/>Nat. Neurosci.
<volume>14</volume>, <fpage>45</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2702</pub-id><pub-id pub-id-type="pmid">21131950</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussain</surname><given-names>R.</given-names></name><name><surname>Ghoumari</surname><given-names>A. M.</given-names></name><name><surname>Bielecki</surname><given-names>B.</given-names></name><name><surname>Steibel</surname><given-names>J.</given-names></name><name><surname>Boehm</surname><given-names>N.</given-names></name><name><surname>Liere</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination</article-title>. <source/>Brain
<volume>1</volume>, <fpage>132</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aws284</pub-id><pub-id pub-id-type="pmid">23365095</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iadecola</surname><given-names>C.</given-names></name><name><surname>Niwa</surname><given-names>K.</given-names></name><name><surname>Nogawa</surname><given-names>S.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Nagayama</surname><given-names>M.</given-names></name><name><surname>Araki</surname><given-names>E.</given-names></name></person-group> (<year>2001</year>). <article-title>Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate-mediated neurotoxicity in cyclooxygenase-2-deficient mice</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>98</volume>, <fpage>1294</fpage>–<lpage>1299</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.98.3.1294</pub-id><pub-id pub-id-type="pmid">11158633</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iglesias-Rozas</surname><given-names>J. R.</given-names></name><name><surname>Garrosa</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>The discovery of oligodendroglia cells by Rio-Hortega: his original articles. 1921</article-title>. <source/>Clin. Neuropathol.
<volume>31</volume>, <fpage>437</fpage>–<lpage>439</lpage>. <pub-id pub-id-type="doi">10.5414/np301001</pub-id><pub-id pub-id-type="pmid">23083462</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imamura</surname><given-names>O.</given-names></name><name><surname>Arai</surname><given-names>M.</given-names></name><name><surname>Dateki</surname><given-names>M.</given-names></name><name><surname>Ogata</surname><given-names>T.</given-names></name><name><surname>Uchida</surname><given-names>R.</given-names></name><name><surname>Tomoda</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Nicotinic acetylcholine receptors mediate donepezil-induced oligodendrocyte differentiation</article-title>. <source/>J. Neurochem.
<volume>135</volume>, <fpage>1086</fpage>–<lpage>1098</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13294</pub-id><pub-id pub-id-type="pmid">26315944</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izzo</surname><given-names>A. A.</given-names></name><name><surname>Borrelli</surname><given-names>F.</given-names></name><name><surname>Capasso</surname><given-names>R.</given-names></name><name><surname>Di Marzo</surname><given-names>V.</given-names></name><name><surname>Mechoulam</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb</article-title>. <source/>Trends Pharmacol. Sci.
<volume>30</volume>, <fpage>515</fpage>–<lpage>527</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2009.07.006</pub-id><pub-id pub-id-type="pmid">19729208</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jabs</surname><given-names>R.</given-names></name><name><surname>Pivneva</surname><given-names>T.</given-names></name><name><surname>Hüttmann</surname><given-names>K.</given-names></name><name><surname>Wyczynski</surname><given-names>A.</given-names></name><name><surname>Nolte</surname><given-names>C.</given-names></name><name><surname>Kettenmann</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Synaptic transmission onto hippocampal glial cells with hGFAP promoter activity</article-title>. <source/>J. Cell Sci.
<volume>118</volume>, <fpage>3791</fpage>–<lpage>3803</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.02515</pub-id><pub-id pub-id-type="pmid">16076898</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janowski</surname><given-names>B. A.</given-names></name><name><surname>Willy</surname><given-names>P. J.</given-names></name><name><surname>Devi</surname><given-names>T. R.</given-names></name><name><surname>Falck</surname><given-names>J. R.</given-names></name><name><surname>Mangelsdorf</surname><given-names>D. J.</given-names></name></person-group> (<year>1996</year>). <article-title>An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha</article-title>. <source/>Nature
<volume>383</volume>, <fpage>728</fpage>–<lpage>731</lpage>. <pub-id pub-id-type="doi">10.1038/383728a0</pub-id><pub-id pub-id-type="pmid">8878485</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung-Testas</surname><given-names>I.</given-names></name><name><surname>Baulieu</surname><given-names>E. E.</given-names></name></person-group> (<year>1998</year>). <article-title>Steroid hormone receptors and steroid action in rat glial cells of the central and peripheral nervous system</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>65</volume>, <fpage>243</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1016/s0960-0760(97)00191-x</pub-id><pub-id pub-id-type="pmid">9699879</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Káradóttir</surname><given-names>R.</given-names></name><name><surname>Cavelier</surname><given-names>P.</given-names></name><name><surname>Bergersen</surname><given-names>L. H.</given-names></name><name><surname>Attwell</surname><given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>NMDA receptors are expressed in oligodendrocytes and activated in ischaemia</article-title>. <source/>Nature
<volume>438</volume>, <fpage>1162</fpage>–<lpage>1166</lpage>. <pub-id pub-id-type="doi">10.1038/nature04302</pub-id><pub-id pub-id-type="pmid">16372011</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kastritsis</surname><given-names>C. H.</given-names></name><name><surname>McCarthy</surname><given-names>K. D.</given-names></name></person-group> (<year>1993</year>). <article-title>Oligodendroglial lineage cells express neuroligand receptors</article-title>. <source/>Glia
<volume>8</volume>, <fpage>106</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1002/glia.440080206</pub-id><pub-id pub-id-type="pmid">8104891</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawashima</surname><given-names>K.</given-names></name><name><surname>Fuji</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Basic and clinical aspects of non-neuronal acetylcholine: overview of non-neuronal cholinergic systems and their biological significance</article-title>. <source/>J. Pharmacol. Sci.
<volume>106</volume>, <fpage>167</fpage>–<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1254/jphs.fm0070073</pub-id><pub-id pub-id-type="pmid">18285657</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelley</surname><given-names>K. A.</given-names></name><name><surname>Ho</surname><given-names>L.</given-names></name><name><surname>Winger</surname><given-names>D.</given-names></name><name><surname>Freire-Moar</surname><given-names>J.</given-names></name><name><surname>Borelli</surname><given-names>C. B.</given-names></name><name><surname>Aisen</surname><given-names>P. S.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2</article-title>. <source/>Am. J. Pathol.
<volume>155</volume>, <fpage>995</fpage>–<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1016/s0002-9440(10)65199-1</pub-id><pub-id pub-id-type="pmid">10487857</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>P. A.</given-names></name><name><surname>Djiane</surname><given-names>J.</given-names></name><name><surname>Postel-Vinay</surname><given-names>M. C.</given-names></name><name><surname>Edery</surname><given-names>M.</given-names></name></person-group> (<year>1991</year>). <article-title>The prolactin/growth hormone receptor family</article-title>. <source/>Endocr. Rev.
<volume>12</volume>, <fpage>235</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1210/edrv-12-3-235</pub-id><pub-id pub-id-type="pmid">1935820</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khakh</surname><given-names>B. S.</given-names></name><name><surname>Bao</surname><given-names>X. R.</given-names></name><name><surname>Labarca</surname><given-names>C.</given-names></name><name><surname>Lester</surname><given-names>H. A.</given-names></name></person-group> (<year>1999</year>). <article-title>Neuronal P2X transmitter-gated cation channels change their ion selectivity in seconds</article-title>. <source/>Nat. Neurosci.
<volume>2</volume>, <fpage>322</fpage>–<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1038/7233</pub-id><pub-id pub-id-type="pmid">10204538</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knapp</surname><given-names>P. E.</given-names></name><name><surname>Itkis</surname><given-names>O. S.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Spruce</surname><given-names>B. A.</given-names></name><name><surname>Bakalkin</surname><given-names>G.</given-names></name><name><surname>Hauser</surname><given-names>K. F.</given-names></name></person-group> (<year>2001</year>). <article-title>Endogenous opioids and oligodendroglial function: possible autocrine/paracrine effects on cell survival and development</article-title>. <source/>Glia
<volume>35</volume>, <fpage>156</fpage>–<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1002/glia.1080</pub-id><pub-id pub-id-type="pmid">11460271</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knapp</surname><given-names>P. E.</given-names></name><name><surname>Maderspach</surname><given-names>K.</given-names></name><name><surname>Hauser</surname><given-names>K. F.</given-names></name></person-group> (<year>1998</year>). <article-title>Endogenous opioid system in developing normal and jimpy oligodendrocytes: mu and kappa opioid receptors mediate differential mitogenic and growth responses</article-title>. <source/>Glia
<volume>22</volume>, <fpage>189</fpage>–<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1098-1136(199802)22:2&lt;189::aid-glia10&gt;3.0.co;2-u</pub-id><pub-id pub-id-type="pmid">9537839</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koós</surname><given-names>T.</given-names></name><name><surname>Tepper</surname><given-names>J. M.</given-names></name></person-group> (<year>1999</year>). <article-title>Inhibitory control of neostriatal projection neurons by GABAergic interneurons</article-title>. <source/>Nat. Neurosci.
<volume>2</volume>, <fpage>467</fpage>–<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1038/8138</pub-id><pub-id pub-id-type="pmid">10321252</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname><given-names>C. J.</given-names></name><name><surname>Watson</surname><given-names>J.</given-names></name><name><surname>Reavill</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Muscarinic acetylcholine receptors as CNS drug targets</article-title>. <source/>Pharmacol. Ther.
<volume>117</volume>, <fpage>232</fpage>–<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2007.09.009</pub-id><pub-id pub-id-type="pmid">18082893</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larocca</surname><given-names>J. N.</given-names></name><name><surname>Almazan</surname><given-names>G.</given-names></name></person-group> (<year>1997</year>). <article-title>Acetylcholine agonists stimulate mitogen-activated protein-kinase in oligodendrocyte progenitors by muscarinic receptors</article-title>. <source/>J. Neurosci. Res.
<volume>50</volume>, <fpage>743</fpage>–<lpage>754</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1097-4547(19971201)50:5&lt;743::aid-jnr11&gt;3.3.co;2-y</pub-id><pub-id pub-id-type="pmid">9418962</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lassmann</surname><given-names>H.</given-names></name></person-group> (<year>2011</year>). <article-title>Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer’s disease</article-title>. <source/>J. Neural Transm. (Vienna)
<volume>118</volume>, <fpage>747</fpage>–<lpage>752</lpage>. <pub-id pub-id-type="doi">10.1007/s00702-011-0607-8</pub-id><pub-id pub-id-type="pmid">21373761</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauder</surname><given-names>J. M.</given-names></name></person-group> (<year>1993</year>). <article-title>Neurotransmitters as growth regulatory signal: role of receptors and second messangers</article-title>. <source/>Trends Neurosci.
<volume>16</volume>, <fpage>233</fpage>–<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1016/0166-2236(93)90162-f</pub-id><pub-id pub-id-type="pmid">7688165</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Laudet</surname><given-names>V.</given-names></name><name><surname>Gronemeyer</surname><given-names>H.</given-names></name></person-group> (<year>2002</year>). <source/>The Nuclear Receptor Facts Book.
<publisher-loc>San Diego, CA</publisher-loc>: <publisher-name>Academic Press</publisher-name>.</mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J. Y.</given-names></name><name><surname>Kang So</surname><given-names>R.</given-names></name><name><surname>Yune</surname><given-names>T. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury</article-title>. <source/>J. Neurotrauma
<volume>32</volume>, <fpage>633</fpage>–<lpage>644</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2014.3527</pub-id><pub-id pub-id-type="pmid">25366938</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemire</surname><given-names>J. M.</given-names></name><name><surname>Archer</surname><given-names>D. C.</given-names></name></person-group> (<year>1991</year>). <article-title>1,25-Dihydroxyvitamin D3 prevents the <italic>in vivo</italic> induction of murine experimental autoimmune encephalomyelitis</article-title>. <source/>J. Clin. Invest.
<volume>87</volume>, <fpage>1103</fpage>–<lpage>1107</lpage>. <pub-id pub-id-type="doi">10.1172/jci115072</pub-id><pub-id pub-id-type="pmid">1705564</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Stys</surname><given-names>P. K.</given-names></name></person-group> (<year>2000</year>). <article-title>Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter</article-title>. <source/>J. Neurosci.
<volume>20</volume>, <fpage>1190</fpage>–<lpage>1198</lpage>. <pub-id pub-id-type="pmid">10648723</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipton</surname><given-names>S. A.</given-names></name><name><surname>Rosenberg</surname><given-names>P. A.</given-names></name></person-group> (<year>1994</year>). <article-title>Excitatory amino acids as a final common pathway for neurologic disorders</article-title>. <source/>N. Engl. J. Med.
<volume>330</volume>, <fpage>613</fpage>–<lpage>622</lpage>. <pub-id pub-id-type="doi">10.1056/nejm199403033300907</pub-id><pub-id pub-id-type="pmid">7905600</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lizasoain</surname><given-names>I.</given-names></name><name><surname>Leza</surname><given-names>J. C.</given-names></name><name><surname>Lorenzo</surname><given-names>P.</given-names></name></person-group> (<year>1991</year>). <article-title>Buprenorphine: bell-shaped dose-response curve for its antagonist effects</article-title>. <source/>Gen. Pharmacol.
<volume>22</volume>, <fpage>297</fpage>–<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1016/0306-3623(91)90452-c</pub-id><pub-id pub-id-type="pmid">2055424</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loreti</surname><given-names>S.</given-names></name><name><surname>Ricordy</surname><given-names>R.</given-names></name><name><surname>De Stefano</surname><given-names>M. E.</given-names></name><name><surname>Augusti-Tocco</surname><given-names>G.</given-names></name><name><surname>Tata</surname><given-names>A. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Acetylcholine inhibits cell cycle progression in rat Schwann cells by activation of the M2 receptor subtype</article-title>. <source/>Neuron Glia Biol.
<volume>4</volume>, <fpage>269</fpage>–<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1017/s1740925x08000045</pub-id><pub-id pub-id-type="pmid">18634559</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loughhead</surname><given-names>A. M.</given-names></name><name><surname>Stowe</surname><given-names>Z. N.</given-names></name><name><surname>Newport</surname><given-names>D. J.</given-names></name><name><surname>Ritchie</surname><given-names>J. C.</given-names></name><name><surname>DeVane</surname><given-names>C. L.</given-names></name><name><surname>Owens</surname><given-names>M. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Placental passage of tricyclic antidepressants</article-title>. <source/>Biol. Psychiatry
<volume>59</volume>, <fpage>287</fpage>–<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2005.06.040</pub-id><pub-id pub-id-type="pmid">16271264</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Q. R.</given-names></name><name><surname>Cai</surname><given-names>L.</given-names></name><name><surname>Rowitch</surname><given-names>D.</given-names></name><name><surname>Cepko</surname><given-names>C. L.</given-names></name><name><surname>Stiles</surname><given-names>C. D.</given-names></name></person-group> (<year>2001</year>). <article-title>Ectopic expression of Olig1 promotes oligodendrocyte formation and reduces neuronal survival in developing mouse cortex</article-title>. <source/>Nat. Neurosci.
<volume>4</volume>, <fpage>973</fpage>–<lpage>974</lpage>. <pub-id pub-id-type="doi">10.1038/nn718</pub-id><pub-id pub-id-type="pmid">11574831</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lutfy</surname><given-names>K.</given-names></name><name><surname>Eitan</surname><given-names>S.</given-names></name><name><surname>Bryant</surname><given-names>C. D.</given-names></name><name><surname>Yang</surname><given-names>Y. C.</given-names></name><name><surname>Saliminejad</surname><given-names>N.</given-names></name><name><surname>Walwyn</surname><given-names>W.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors</article-title>. <source/>J. Neurosci.
<volume>23</volume>, <fpage>10331</fpage>–<lpage>10337</lpage>. <pub-id pub-id-type="pmid">14614092</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luyt</surname><given-names>K.</given-names></name><name><surname>Slade</surname><given-names>T. P.</given-names></name><name><surname>Dorward</surname><given-names>J. J.</given-names></name><name><surname>Durant</surname><given-names>C. F.</given-names></name><name><surname>Yue</surname><given-names>W.</given-names></name><name><surname>Shigemoto</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Developing oligodendrocytes express functional GABAB receptors that stimulate cell proliferation and migration</article-title>. <source/>J. Neurochem.
<volume>100</volume>, <fpage>822</fpage>–<lpage>840</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.04255.x</pub-id><pub-id pub-id-type="pmid">17144904</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manzano</surname><given-names>J.</given-names></name><name><surname>Morte</surname><given-names>B.</given-names></name><name><surname>Scanlan</surname><given-names>T. S.</given-names></name><name><surname>Bernal</surname><given-names>J.</given-names></name></person-group> (<year>2003</year>). <article-title>Differential effects of triiodothyronine and the thyroid hormone receptor beta-specific agonist GC-1 on thyroid hormone target genes in the brain</article-title>. <source/>Endocrinology
<volume>144</volume>, <fpage>5480</fpage>–<lpage>5487</lpage>. <pub-id pub-id-type="doi">10.1210/en.2003-0633</pub-id><pub-id pub-id-type="pmid">12959999</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markram</surname><given-names>H.</given-names></name><name><surname>Toledo-Rodriguez</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Gupta</surname><given-names>A.</given-names></name><name><surname>Silberberg</surname><given-names>G.</given-names></name><name><surname>Wu</surname><given-names>C.</given-names></name></person-group> (<year>2004</year>). <article-title>Interneurons of the neocortical inhibitory system</article-title>. <source/>Nat. Rev. Neurosci.
<volume>5</volume>, <fpage>793</fpage>–<lpage>807</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1519</pub-id><pub-id pub-id-type="pmid">15378039</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruyama</surname><given-names>S.</given-names></name><name><surname>Tsukada</surname><given-names>H.</given-names></name><name><surname>Nishiyama</surname><given-names>S.</given-names></name><name><surname>Kakiuchi</surname><given-names>T.</given-names></name><name><surname>Fukumoto</surname><given-names>D.</given-names></name><name><surname>Oku</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title><italic>In vivo</italic> quantitative autoradiographic analysis of brain muscarinic receptor occupancy by antimuscarinic agents for overactive bladder treatment</article-title>. <source/>J. Pharmacol. Exp. Ther.
<volume>325</volume>, <fpage>774</fpage>–<lpage>781</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.108.136390</pub-id><pub-id pub-id-type="pmid">18326811</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mato</surname><given-names>S.</given-names></name><name><surname>Alberdi</surname><given-names>E.</given-names></name><name><surname>Ledent</surname><given-names>C.</given-names></name><name><surname>Watanabe</surname><given-names>M.</given-names></name><name><surname>Matute</surname><given-names>C.</given-names></name></person-group> (<year>2009</year>). <article-title>CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes</article-title>. <source/>Glia
<volume>57</volume>, <fpage>295</fpage>–<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20757</pub-id><pub-id pub-id-type="pmid">18814177</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mato</surname><given-names>S.</given-names></name><name><surname>Victoria Sánchez-Gómez</surname><given-names>M.</given-names></name><name><surname>Matute</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Cannabidiol induces intracellular calcium elevation and cytotoxicity in oligodendrocytes</article-title>. <source/>Glia
<volume>58</volume>, <fpage>1739</fpage>–<lpage>1747</lpage>. <pub-id pub-id-type="doi">10.1002/glia.21044</pub-id><pub-id pub-id-type="pmid">20645411</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matute</surname><given-names>C.</given-names></name></person-group> (<year>2006</year>). <article-title>Oligodendrocyte NMDA receptors: a novel therapeutic target</article-title>. <source/>Trends Mol. Med.
<volume>12</volume>, <fpage>289</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2006.05.004</pub-id><pub-id pub-id-type="pmid">16750425</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matute</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Calcium dyshomeostasis in white matter pathology</article-title>. <source/>Cell Calcium
<volume>47</volume>, <fpage>150</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2009.12.004</pub-id><pub-id pub-id-type="pmid">20036774</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matute</surname><given-names>C.</given-names></name><name><surname>Sánchez-Gómez</surname><given-names>M. V.</given-names></name><name><surname>Martínez-Millán</surname><given-names>L.</given-names></name><name><surname>Miledi</surname><given-names>R.</given-names></name></person-group> (<year>1997</year>). <article-title>Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>94</volume>, <fpage>8830</fpage>–<lpage>8835</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.16.8830</pub-id><pub-id pub-id-type="pmid">9238063</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McArthur</surname><given-names>R. A.</given-names></name><name><surname>Gray</surname><given-names>J.</given-names></name><name><surname>Schreiber</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>Cognitive effects of muscarinic M1 functional agonists in non-human primates and clinical trials</article-title>. <source/>Curr. Opin. Investig. Drugs
<volume>11</volume>, <fpage>740</fpage>–<lpage>760</lpage>. <pub-id pub-id-type="pmid">20571970</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>J. W.</given-names></name><name><surname>Althomsons</surname><given-names>S. P.</given-names></name><name><surname>Hyrc</surname><given-names>K. L.</given-names></name><name><surname>Choi</surname><given-names>D. W.</given-names></name><name><surname>Goldberg</surname><given-names>M. P.</given-names></name></person-group> (<year>1998</year>). <article-title>Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity</article-title>. <source/>Nat. Med.
<volume>4</volume>, <fpage>291</fpage>–<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1038/nm0398-291</pub-id><pub-id pub-id-type="pmid">9500601</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meffre</surname><given-names>D.</given-names></name><name><surname>Shackleford</surname><given-names>G.</given-names></name><name><surname>Hichor</surname><given-names>M.</given-names></name><name><surname>Gorgievski</surname><given-names>V.</given-names></name><name><surname>Tzavara</surname><given-names>E. T.</given-names></name><name><surname>Trousson</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>112</volume>, <fpage>7587</fpage>–<lpage>7592</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1424951112</pub-id><pub-id pub-id-type="pmid">26023184</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mensch</surname><given-names>S.</given-names></name><name><surname>Baraban</surname><given-names>M.</given-names></name><name><surname>Almeida</surname><given-names>R.</given-names></name><name><surname>Czopka</surname><given-names>T.</given-names></name><name><surname>Ausborn</surname><given-names>J.</given-names></name><name><surname>El Manira</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Synaptic vesicle release regulates myelin sheath number of individual oligodendrocytes <italic>in vivo</italic></article-title>. <source/>Nat. Neurosci.
<volume>18</volume>, <fpage>628</fpage>–<lpage>630</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3991</pub-id><pub-id pub-id-type="pmid">25849985</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merrill</surname><given-names>J. E.</given-names></name><name><surname>Benveniste</surname><given-names>E. N.</given-names></name></person-group> (<year>1996</year>). <article-title>Cytokines in inflammatory brain lesions: helpful and harmful</article-title>. <source/>Trends Neurosci.
<volume>19</volume>, <fpage>331</fpage>–<lpage>338</lpage>. <pub-id pub-id-type="doi">10.1016/0166-2236(96)10047-3</pub-id><pub-id pub-id-type="pmid">8843602</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Micu</surname><given-names>I.</given-names></name><name><surname>Jiang</surname><given-names>Q.</given-names></name><name><surname>Coderre</surname><given-names>E.</given-names></name><name><surname>Ridsdale</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Woulfe</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia</article-title>. <source/>Nature
<volume>439</volume>, <fpage>988</fpage>–<lpage>992</lpage>. <pub-id pub-id-type="doi">10.1038/nature04474</pub-id><pub-id pub-id-type="pmid">16372019</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milner</surname><given-names>R.</given-names></name><name><surname>Anderson</surname><given-names>H. J.</given-names></name><name><surname>Rippon</surname><given-names>R. F.</given-names></name><name><surname>McKay</surname><given-names>J. S.</given-names></name><name><surname>Franklin</surname><given-names>R. J.</given-names></name><name><surname>Marchionni</surname><given-names>M. A.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Contrasting effects of mitogenic growth factors on oligodendrocyte precursor cell migration</article-title>. <source/>Glia
<volume>19</volume>, <fpage>85</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1098-1136(199701)19:1&lt;85::aid-glia9&gt;3.0.co;2-9</pub-id><pub-id pub-id-type="pmid">8989571</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Missale</surname><given-names>C.</given-names></name><name><surname>Nash</surname><given-names>S. R.</given-names></name><name><surname>Robinson</surname><given-names>S. W.</given-names></name><name><surname>Jaber</surname><given-names>M.</given-names></name><name><surname>Caron</surname><given-names>M. G.</given-names></name></person-group> (<year>1998</year>). <article-title>Dopamine receptors: from structure to function</article-title>. <source/>Physiol. Rev.
<volume>78</volume>, <fpage>189</fpage>–<lpage>225</lpage>. <pub-id pub-id-type="pmid">9457173</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modell</surname><given-names>J. G.</given-names></name><name><surname>Tandon</surname><given-names>R.</given-names></name><name><surname>Beresford</surname><given-names>T. P.</given-names></name></person-group> (<year>1989</year>). <article-title>Dopaminergic activity of the antimuscarinic antiparkinsonian agents</article-title>. <source/>J. Clin. Psychopharmacol.
<volume>9</volume>, <fpage>347</fpage>–<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1097/00004714-198910000-00006</pub-id><pub-id pub-id-type="pmid">2551932</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moher</surname><given-names>D.</given-names></name><name><surname>Liberati</surname><given-names>A.</given-names></name><name><surname>Tetzlaff</surname><given-names>J.</given-names></name><name><surname>Altman</surname><given-names>D. G.</given-names></name><collab>PRISMA Group</collab></person-group>. (<year>2010</year>). <article-title>Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement</article-title>. <source/>Int. J. Surg.
<volume>8</volume>, <fpage>336</fpage>–<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijsu.2010.02.007</pub-id><pub-id pub-id-type="pmid">20171303</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina-Holgado</surname><given-names>E.</given-names></name><name><surname>Khorchid</surname><given-names>A.</given-names></name><name><surname>Liu</surname><given-names>H. N.</given-names></name><name><surname>Almazan</surname><given-names>G.</given-names></name></person-group> (<year>2003</year>). <article-title>Regulation of muscarinic receptor function in developing oligodendrocytes by agonistic exposure</article-title>. <source/>Br. J. Pharmacol.
<volume>138</volume>, <fpage>47</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0705002</pub-id><pub-id pub-id-type="pmid">12522072</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno</surname><given-names>S.</given-names></name><name><surname>Farioli-Vecchioli</surname><given-names>S.</given-names></name><name><surname>Cerù</surname><given-names>M. P.</given-names></name></person-group> (<year>2004</year>). <article-title>Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS</article-title>. <source/>Neuroscience
<volume>123</volume>, <fpage>131</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2003.08.064</pub-id><pub-id pub-id-type="pmid">14667448</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriya</surname><given-names>H.</given-names></name><name><surname>Takagi</surname><given-names>Y.</given-names></name><name><surname>Nakanishi</surname><given-names>T.</given-names></name><name><surname>Hayashi</surname><given-names>M.</given-names></name><name><surname>Tani</surname><given-names>T.</given-names></name><name><surname>Hirotsu</surname><given-names>I.</given-names></name></person-group> (<year>1999</year>). <article-title>Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (mAChR) subtypes and mAChRs in rat heart and submandibular gland</article-title>. <source/>Life Sci.
<volume>64</volume>, <fpage>2351</fpage>–<lpage>2358</lpage>. <pub-id pub-id-type="doi">10.1016/s0024-3205(99)00188-5</pub-id><pub-id pub-id-type="pmid">10374898</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullard</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>News and analysis</article-title>. <source/>Nat. Rev. Drug Dis.
<volume>13</volume>, <fpage>880</fpage>–<lpage>881</lpage>. <pub-id pub-id-type="doi">10.1038/nrd4496</pub-id>
</mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>S.</given-names></name><name><surname>Pearce</surname><given-names>B.</given-names></name><name><surname>Morrow</surname><given-names>C.</given-names></name></person-group> (<year>1986</year>). <article-title>Astrocytes have both M1 and M2 muscarinic receptor subtypes</article-title>. <source/>Brain Res.
<volume>29</volume>, <fpage>177</fpage>–<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(86)91000-0</pub-id><pub-id pub-id-type="pmid">3004648</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>T. H.</given-names></name><name><surname>Schnaar</surname><given-names>R. L.</given-names></name><name><surname>Coyle</surname><given-names>J. T.</given-names></name></person-group> (<year>1990</year>). <article-title>Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake</article-title>. <source/>FASEB J.
<volume>4</volume>, <fpage>1624</fpage>–<lpage>1633</lpage>. <pub-id pub-id-type="pmid">2180770</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nanan</surname><given-names>R.</given-names></name><name><surname>von Stockhausen</surname><given-names>H. B.</given-names></name><name><surname>Petersen</surname><given-names>B.</given-names></name><name><surname>Solymosi</surname><given-names>L.</given-names></name><name><surname>Warmuth-Metz</surname><given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>Unusual pattern of leukoencephalopathy after morphine sulphate intoxication</article-title>. <source/>Neuroradiology
<volume>42</volume>, <fpage>845</fpage>–<lpage>848</lpage>. <pub-id pub-id-type="doi">10.1007/s002340000442</pub-id><pub-id pub-id-type="pmid">11151694</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nataf</surname><given-names>S.</given-names></name><name><surname>Levison</surname><given-names>S. W.</given-names></name><name><surname>Barnum</surname><given-names>S. R.</given-names></name></person-group> (<year>2001</year>). <article-title>Expression of the anaphylatoxin C5a receptor in the oligodendrocyte lineage</article-title>. <source/>Brain Res.
<volume>894</volume>, <fpage>321</fpage>–<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1016/s0006-8993(01)02003-0</pub-id><pub-id pub-id-type="pmid">11251209</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikodemova</surname><given-names>M.</given-names></name><name><surname>Duncan</surname><given-names>I. D.</given-names></name><name><surname>Watters</surname><given-names>J. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinase and IκBα degradation in a stimulus-specific manner in microglia</article-title>. <source/>J. Neurochem.
<volume>96</volume>, <fpage>314</fpage>–<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03520.x</pub-id><pub-id pub-id-type="pmid">16336636</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>J.</given-names></name><name><surname>Mei</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Tian</surname><given-names>Y.</given-names></name><name><surname>Mo</surname><given-names>W.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Phosphorylated olig1 localizes to the cytosol of oligodendrocytes and promotes membrane expansion and maturation</article-title>. <source/>Glia
<volume>60</volume>, <fpage>1427</fpage>–<lpage>1436</lpage>. <pub-id pub-id-type="doi">10.1002/glia.22364</pub-id><pub-id pub-id-type="pmid">22639060</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nogawa</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Ross</surname><given-names>M. E.</given-names></name><name><surname>Iadecola</surname><given-names>C.</given-names></name></person-group> (<year>1997</year>). <article-title>Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage</article-title>. <source/>J. Neurosci.
<volume>17</volume>, <fpage>2746</fpage>–<lpage>2755</lpage>. <pub-id pub-id-type="pmid">9092596</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nopoulos</surname><given-names>P.</given-names></name><name><surname>Flaum</surname><given-names>M.</given-names></name><name><surname>O’Leary</surname><given-names>D.</given-names></name><name><surname>Anderson</surname><given-names>N. C.</given-names></name></person-group> (<year>2000</year>). <article-title>Sexual dimorphism in the human brain: evaluation of tissue volume, tissue composition and surface anatomy using magnetic resonance imaging</article-title>. <source/>Psychiatry Res.
<volume>98</volume>, <fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/s0925-4927(99)00044-x</pub-id><pub-id pub-id-type="pmid">10708922</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>North</surname><given-names>R. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Molecular physiology of P2X receptors</article-title>. <source/>Physiol. Rev.
<volume>82</volume>, <fpage>1013</fpage>–<lpage>1067</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00015.2002</pub-id><pub-id pub-id-type="pmid">12270951</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nottebohm</surname><given-names>F.</given-names></name><name><surname>Arnold</surname><given-names>A. P.</given-names></name></person-group> (<year>1976</year>). <article-title>Sexual dimorphism in vocal control areas of the songbird brain</article-title>. <source/>Science
<volume>194</volume>, <fpage>211</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1126/science.959852</pub-id><pub-id pub-id-type="pmid">959852</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nuñez</surname><given-names>J. L.</given-names></name><name><surname>Nelson</surname><given-names>J.</given-names></name><name><surname>Pych</surname><given-names>J. C.</given-names></name><name><surname>Kim</surname><given-names>J. H. Y.</given-names></name><name><surname>Juraska</surname><given-names>J. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Myelination in the splenium of the corpus callosum in adult male and female rats</article-title>. <source/>Brain Res. Dev. Brain Res.
<volume>120</volume>, <fpage>87</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/s0165-3806(99)00193-5</pub-id><pub-id pub-id-type="pmid">10727734</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oka</surname><given-names>A.</given-names></name><name><surname>Belliveau</surname><given-names>M. J.</given-names></name><name><surname>Rosenberg</surname><given-names>P. A.</given-names></name><name><surname>Volpe</surname><given-names>J. J.</given-names></name></person-group> (<year>1993</year>). <article-title>Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms and prevention</article-title>. <source/>J. Neurosci.
<volume>13</volume>, <fpage>1441</fpage>–<lpage>1453</lpage>. <pub-id pub-id-type="pmid">8096541</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Shea</surname><given-names>P. J.</given-names></name><name><surname>Williams</surname><given-names>G. R.</given-names></name></person-group> (<year>2002</year>). <article-title>Insight into the physiological actions of thyroid hormone receptors from genetically modified mice</article-title>. <source/>J. Endocrinol.
<volume>175</volume>, <fpage>553</fpage>–<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1677/joe.0.1750553</pub-id><pub-id pub-id-type="pmid">12475367</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palumbo</surname><given-names>S.</given-names></name><name><surname>Toscano</surname><given-names>C. D.</given-names></name><name><surname>Parente</surname><given-names>L.</given-names></name><name><surname>Weigert</surname><given-names>R.</given-names></name><name><surname>Bosetti</surname><given-names>F.</given-names></name></person-group> (<year>2012</year>). <article-title>The cyclooxygenase-2 pathway via the PGE2 EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone-induced demyelination</article-title>. <source/>J. Neurochem.
<volume>121</volume>, <fpage>418</fpage>–<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07363.x</pub-id><pub-id pub-id-type="pmid">21699540</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patani</surname><given-names>R.</given-names></name><name><surname>Balaratnam</surname><given-names>M.</given-names></name><name><surname>Vora</surname><given-names>A.</given-names></name><name><surname>Reynolds</surname><given-names>R.</given-names></name></person-group> (<year>2007</year>). <article-title>Remyelination can be extensive in multiple sclerosis despite a long disease course</article-title>. <source/>Neuropathol. Appl. Neurobiol.
<volume>33</volume>, <fpage>277</fpage>–<lpage>287</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2990.2007.00805.x</pub-id><pub-id pub-id-type="pmid">17442065</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peralta</surname><given-names>E. G.</given-names></name><name><surname>Ashkenazi</surname><given-names>A.</given-names></name><name><surname>Winslow</surname><given-names>J. W.</given-names></name><name><surname>Smith</surname><given-names>D. H.</given-names></name><name><surname>Ramachandran</surname><given-names>J.</given-names></name><name><surname>Capon</surname><given-names>D. J.</given-names></name></person-group> (<year>1987</year>). <article-title>Distinct primary structures, ligand-binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors</article-title>. <source/>EMBO J.
<volume>6</volume>, <fpage>3923</fpage>–<lpage>3929</lpage>. <pub-id pub-id-type="pmid">3443095</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persico</surname><given-names>A. M.</given-names></name><name><surname>Altamura</surname><given-names>C.</given-names></name><name><surname>Calia</surname><given-names>E.</given-names></name><name><surname>Puglisi-Allegra</surname><given-names>S.</given-names></name><name><surname>Ventura</surname><given-names>R.</given-names></name><name><surname>Lucchese</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Serotonin depletion and barrel cortex development: impact of growth impairment vs. serotonin effects on thalamocortical endings</article-title>. <source/>Cereb. Cortex
<volume>10</volume>, <fpage>181</fpage>–<lpage>191</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/10.2.181</pub-id><pub-id pub-id-type="pmid">10667986</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Persson</surname><given-names>A. I.</given-names></name><name><surname>Bull</surname><given-names>C.</given-names></name><name><surname>Eriksson</surname><given-names>P. S.</given-names></name></person-group> (<year>2006</year>). <article-title>Requirement for Id1 in opioid-induced oligodendrogenesis in cultured adult rat hippocampal progenitors</article-title>. <source/>Eur. J. Neurosci.
<volume>23</volume>, <fpage>2277</fpage>–<lpage>2288</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.04764.x</pub-id><pub-id pub-id-type="pmid">16706836</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitt</surname><given-names>D.</given-names></name><name><surname>Werner</surname><given-names>P.</given-names></name><name><surname>Raine</surname><given-names>C. S.</given-names></name></person-group> (<year>2000</year>). <article-title>Glutamate excitotoxicity in a model of multiple sclerosis</article-title>. <source/>Nat. Med.
<volume>6</volume>, <fpage>67</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1038/71555</pub-id><pub-id pub-id-type="pmid">10613826</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prineas</surname><given-names>J. W.</given-names></name><name><surname>Connell</surname><given-names>F.</given-names></name></person-group> (<year>1979</year>). <article-title>Remyelination in multiple sclerosis</article-title>. <source/>Ann. Neurol.
<volume>5</volume>, <fpage>22</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410050105</pub-id><pub-id pub-id-type="pmid">426466</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proskocil</surname><given-names>B. J.</given-names></name><name><surname>Sekhon</surname><given-names>H. S.</given-names></name><name><surname>Jia</surname><given-names>Y.</given-names></name><name><surname>Savchenk</surname><given-names>V.</given-names></name><name><surname>Blakely</surname><given-names>R. D.</given-names></name><name><surname>Lindstrom</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Acetylcholine is an autocrine or paracrine hormone synthesized and secreted by airway bronchial epithelial cells</article-title>. <source/>Endocrinology
<volume>145</volume>, <fpage>2498</fpage>–<lpage>2506</lpage>. <pub-id pub-id-type="doi">10.1210/en.2003-1728</pub-id><pub-id pub-id-type="pmid">14764638</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raine</surname><given-names>C. S.</given-names></name><name><surname>Wu</surname><given-names>E.</given-names></name></person-group> (<year>1993</year>). <article-title>Multiple sclerosis: remyelination in acute lesions</article-title>. <source/>J. Neuropathol. Exp. Neurol.
<volume>52</volume>, <fpage>199</fpage>–<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1097/00005072-199305000-00003</pub-id><pub-id pub-id-type="pmid">7684075</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ralevic</surname><given-names>V.</given-names></name><name><surname>Burnstock</surname><given-names>G.</given-names></name></person-group> (<year>1998</year>). <article-title>Receptors for purines and pyrimidines</article-title>. <source/>Pharmacol. Rev.
<volume>50</volume>, <fpage>413</fpage>–<lpage>492</lpage>. <pub-id pub-id-type="pmid">9755289</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ransohoff</surname><given-names>R. M.</given-names></name><name><surname>Hafler</surname><given-names>D. A.</given-names></name><name><surname>Lucchinetti</surname><given-names>C. F.</given-names></name></person-group> (<year>2015</year>). <article-title>Multiple sclerosis - a quiet revolution</article-title>. <source/>Nat. Rev. Neurol.
<volume>11</volume>, <fpage>134</fpage>–<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1038/nrneurol.2015.14</pub-id><pub-id pub-id-type="pmid">25686758</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regenold</surname><given-names>W. T.</given-names></name><name><surname>Phatak</surname><given-names>P.</given-names></name><name><surname>Marano</surname><given-names>C. M.</given-names></name><name><surname>Gearhart</surname><given-names>L.</given-names></name><name><surname>Viens</surname><given-names>C. H.</given-names></name><name><surname>Hisley</surname><given-names>K. C.</given-names></name></person-group> (<year>2007</year>). <article-title>Myelin staining of deep white matter in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder and unipolar major depression</article-title>. <source/>Psychiatry Res.
<volume>151</volume>, <fpage>179</fpage>–<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2006.12.019</pub-id><pub-id pub-id-type="pmid">17433451</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riskind</surname><given-names>P. N.</given-names></name><name><surname>Massacesi</surname><given-names>L.</given-names></name><name><surname>Doolittle</surname><given-names>T. H.</given-names></name><name><surname>Hauser</surname><given-names>S. L.</given-names></name></person-group> (<year>1991</year>). <article-title>The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine</article-title>. <source/>Ann. Neurol.
<volume>29</volume>, <fpage>542</fpage>–<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410290514</pub-id><pub-id pub-id-type="pmid">1859183</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>T.</given-names></name><name><surname>Cole</surname><given-names>R.</given-names></name><name><surname>Kim</surname><given-names>H. S.</given-names></name><name><surname>de Vellis</surname><given-names>J.</given-names></name><name><surname>Noble</surname><given-names>E. P.</given-names></name></person-group> (<year>1987</year>). <article-title>Inositol phospholipids hydrolysis in cultured astrocytes and oligodendrocytes</article-title>. <source/>Life Sci.
<volume>41</volume>, <fpage>31</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/0024-3205(87)90553-4</pub-id><pub-id pub-id-type="pmid">3037217</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Pena</surname><given-names>A.</given-names></name><name><surname>Ibarrola</surname><given-names>N.</given-names></name><name><surname>Iñiguez</surname><given-names>M. A.</given-names></name><name><surname>Muñoz</surname><given-names>A.</given-names></name><name><surname>Bernal</surname><given-names>J.</given-names></name></person-group> (<year>1993</year>). <article-title>Neonatal hypothyroidism affects the timely expression of myelin-associated glycoprotein in the rat brain</article-title>. <source/>J. Clin. Invest.
<volume>91</volume>, <fpage>812</fpage>–<lpage>818</lpage>. <pub-id pub-id-type="doi">10.1172/jci116301</pub-id><pub-id pub-id-type="pmid">7680668</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>S. W.</given-names></name><name><surname>Gregori</surname><given-names>N. Z.</given-names></name><name><surname>Carlson</surname><given-names>N.</given-names></name><name><surname>Gahring</surname><given-names>L. C.</given-names></name><name><surname>Noble</surname><given-names>M.</given-names></name></person-group> (<year>2001</year>). <article-title>Neuronal nicotinic acetylcholine receptor expression by O2A/oligodendrocytes progenitor cells</article-title>. <source/>Glia
<volume>33</volume>, <fpage>306</fpage>–<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1002/1098-1136(20010315)33:4&lt;306::aid-glia1029&gt;3.3.co;2-n</pub-id><pub-id pub-id-type="pmid">11246229</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosin</surname><given-names>C.</given-names></name><name><surname>Bates</surname><given-names>T. E.</given-names></name><name><surname>Skaper</surname><given-names>S. D.</given-names></name></person-group> (<year>2004</year>). <article-title>Excitatory amino-acid induced oligodendrocyte cell death <italic>in vitro</italic>: receptor-dependent and independent mechanisms</article-title>. <source/>J. Neurochem.
<volume>90</volume>, <fpage>1173</fpage>–<lpage>1185</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02584.x</pub-id><pub-id pub-id-type="pmid">15312172</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosin</surname><given-names>C.</given-names></name><name><surname>Colombo</surname><given-names>S.</given-names></name><name><surname>Calver</surname><given-names>A.</given-names></name><name><surname>Bates</surname><given-names>T. E.</given-names></name><name><surname>Skaper</surname><given-names>S. D.</given-names></name></person-group> (<year>2005</year>). <article-title>Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation</article-title>. <source/>Glia
<volume>52</volume>, <fpage>336</fpage>–<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20250</pub-id><pub-id pub-id-type="pmid">16078234</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>D.</given-names></name><name><surname>Drysdale</surname><given-names>A. J.</given-names></name><name><surname>Lafourcade</surname><given-names>C.</given-names></name><name><surname>Pertwee</surname><given-names>R. G.</given-names></name><name><surname>Platt</surname><given-names>B.</given-names></name></person-group> (<year>2009</year>). <article-title>Cannabidiol targets mitochondria to regulate intracellular Ca<sup>2+</sup> levels</article-title>. <source/>J. Neurosci.
<volume>29</volume>, <fpage>2053</fpage>–<lpage>2063</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4212-08.2009</pub-id><pub-id pub-id-type="pmid">19228959</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saab</surname><given-names>A. S.</given-names></name><name><surname>Tzvetanova</surname><given-names>I. D.</given-names></name><name><surname>Nave</surname><given-names>K. A.</given-names></name></person-group> (<year>2013</year>). <article-title>The role of myelin and oligodendrocytes in axonal energy metabolism</article-title>. <source/>Curr. Opin. Neurobiol.
<volume>23</volume>, <fpage>1065</fpage>–<lpage>1072</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2013.09.008</pub-id><pub-id pub-id-type="pmid">24094633</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salani</surname><given-names>M.</given-names></name><name><surname>Anelli</surname><given-names>T.</given-names></name><name><surname>Tocco</surname><given-names>G. A.</given-names></name><name><surname>Lucarini</surname><given-names>E.</given-names></name><name><surname>Mozzetta</surname><given-names>C.</given-names></name><name><surname>Poiana</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Acetylcholine induced neuronal differentiation: muscarinic receptor activations regulates EGR-1 and REST expression in neuroblastoma cells</article-title>. <source/>J. Neurochem.
<volume>108</volume>, <fpage>821</fpage>–<lpage>834</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05829.x</pub-id><pub-id pub-id-type="pmid">19187099</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salter</surname><given-names>M. G.</given-names></name><name><surname>Fern</surname><given-names>R.</given-names></name></person-group> (<year>2005</year>). <article-title>NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury</article-title>. <source/>Nature
<volume>438</volume>, <fpage>1167</fpage>–<lpage>1171</lpage>. <pub-id pub-id-type="doi">10.1038/nature04301</pub-id><pub-id pub-id-type="pmid">16372012</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>E. S.</given-names></name><name><surname>Bigbee</surname><given-names>J. W.</given-names></name><name><surname>Fobbs</surname><given-names>W.</given-names></name><name><surname>Robinson</surname><given-names>S. E.</given-names></name><name><surname>Sato-Bigbee</surname><given-names>C.</given-names></name></person-group> (<year>2008</year>). <article-title>Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain</article-title>. <source/>Glia
<volume>56</volume>, <fpage>1017</fpage>–<lpage>1027</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20675</pub-id><pub-id pub-id-type="pmid">18381654</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sastre-Garriga</surname><given-names>J.</given-names></name><name><surname>Vila</surname><given-names>C.</given-names></name><name><surname>Clissold</surname><given-names>S.</given-names></name><name><surname>Montalban</surname><given-names>X.</given-names></name></person-group> (<year>2011</year>). <article-title>THC and CBD oromucosal spray (Sativex<sup>®</sup>) in the management of spasticity associated with multiple sclerosis</article-title>. <source/>Expert Rev. Neurother.
<volume>11</volume>, <fpage>627</fpage>–<lpage>637</lpage>. <pub-id pub-id-type="doi">10.1586/ern.11.47</pub-id><pub-id pub-id-type="pmid">21456949</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawada</surname><given-names>H.</given-names></name><name><surname>Ibi</surname><given-names>M.</given-names></name><name><surname>Kihara</surname><given-names>T.</given-names></name><name><surname>Urushitani</surname><given-names>M.</given-names></name><name><surname>Akaike</surname><given-names>A.</given-names></name><name><surname>Kimura</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: mechanisms of neuroprotective treatment against oxidative stress</article-title>. <source/>Ann. Neurol.
<volume>44</volume>, <fpage>110</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410440117</pub-id><pub-id pub-id-type="pmid">9667598</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawada</surname><given-names>H.</given-names></name><name><surname>Shimohama</surname><given-names>S.</given-names></name><name><surname>Tamura</surname><given-names>Y.</given-names></name><name><surname>Kawamura</surname><given-names>T.</given-names></name><name><surname>Akaike</surname><given-names>A.</given-names></name><name><surname>Kimura</surname><given-names>J.</given-names></name></person-group> (<year>1996</year>). <article-title>Methylphenylpyridium ion (MPP<sup>+</sup>) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon</article-title>. <source/>J. Neurosci. Res.
<volume>43</volume>, <fpage>55</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.490430107</pub-id><pub-id pub-id-type="pmid">8838574</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlaepfer</surname><given-names>T. E.</given-names></name><name><surname>Harris</surname><given-names>G. J.</given-names></name><name><surname>Tien</surname><given-names>A. Y.</given-names></name><name><surname>Peng</surname><given-names>L.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Pearlson</surname><given-names>G. D.</given-names></name></person-group> (<year>1995</year>). <article-title>Structural differences in the cerebral cortex of healthy female and male subjects: a magnetic resonance imaging study</article-title>. <source/>Psychiatry Res.
<volume>61</volume>, <fpage>129</fpage>–<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1016/0925-4927(95)02634-a</pub-id><pub-id pub-id-type="pmid">8545497</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schrage</surname><given-names>K.</given-names></name><name><surname>Koopmans</surname><given-names>G.</given-names></name><name><surname>Joosten</surname><given-names>E. A. J.</given-names></name><name><surname>Mey</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Macrophages and neurons are targets of retinoic acid signaling after spinal cord contusion injury</article-title>. <source/>Eur. J. Neurosci.
<volume>23</volume>, <fpage>285</fpage>–<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.04534.x</pub-id><pub-id pub-id-type="pmid">16420438</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarz</surname><given-names>J. M.</given-names></name><name><surname>Bilbo</surname><given-names>S. D.</given-names></name></person-group> (<year>2013</year>). <article-title>Adolescent morphine exposure affects long-term microglial function and later-life relapse liability in a model of addiction</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>961</fpage>–<lpage>971</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2516-12.2013</pub-id><pub-id pub-id-type="pmid">23325235</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seroogy</surname><given-names>K.</given-names></name><name><surname>Tsuruo</surname><given-names>Y.</given-names></name><name><surname>Hökfelt</surname><given-names>T.</given-names></name><name><surname>Walsh</surname><given-names>J.</given-names></name><name><surname>Fahrenkrug</surname><given-names>J.</given-names></name><name><surname>Emson</surname><given-names>P. C.</given-names></name><etal></etal></person-group>. (<year>1988</year>). <article-title>Further analysis of presence of peptides in dopamine neurons: cholecystokinin, peptide histidine-isoleucine/vasoactive intestinal polypeptide and substance P in rat supramammillary region and mesencephalon</article-title>. <source/>Exp. Brain Res.
<volume>72</volume>, <fpage>523</fpage>–<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1007/bf00250598</pub-id><pub-id pub-id-type="pmid">2466680</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirazi</surname><given-names>H. A.</given-names></name><name><surname>Rasouli</surname><given-names>J.</given-names></name><name><surname>Ciric</surname><given-names>B.</given-names></name><name><surname>Rostami</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>G. X.</given-names></name></person-group> (<year>2015</year>). <article-title>1,25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation</article-title>. <source/>Exp. Mol. Pathol.
<volume>98</volume>, <fpage>240</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1016/j.yexmp.2015.02.004</pub-id><pub-id pub-id-type="pmid">25681066</pub-id></mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siaud</surname><given-names>P.</given-names></name><name><surname>Manzoni</surname><given-names>O.</given-names></name><name><surname>Balmefrezol</surname><given-names>M.</given-names></name><name><surname>Barbanel</surname><given-names>G.</given-names></name><name><surname>Assenmacher</surname><given-names>I.</given-names></name><name><surname>Alonso</surname><given-names>G.</given-names></name></person-group> (<year>1989</year>). <article-title>The organization of prolactin-like-immunoreactive neurons in the rat central nervous system. Light- and electron-microscopic immunocytochemical studies</article-title>. <source/>Cell Tissue Res.
<volume>255</volume>, <fpage>107</fpage>–<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1007/BF00229071</pub-id><pub-id pub-id-type="pmid">2544274</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>P. B.</given-names></name><name><surname>Armstrong</surname><given-names>R. C.</given-names></name></person-group> (<year>1999</year>). <article-title>Intracellular signals and cytoskeletal elements involved in oligodendrocyte progenitor migration</article-title>. <source/>Glia
<volume>26</volume>, <fpage>22</fpage>–<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1098-1136(199903)26:1&lt;22::aid-glia3&gt;3.3.co;2-d</pub-id><pub-id pub-id-type="pmid">10088669</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>K. L.</given-names></name><name><surname>Weaver</surname><given-names>K. J.</given-names></name><name><surname>de Villers-Sidani</surname><given-names>E.</given-names></name><name><surname>Lu</surname><given-names>J. Y.</given-names></name><name><surname>Cai</surname><given-names>Z.</given-names></name><name><surname>Pang</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Perinatal antidepressant exposure alters cortical network function in rodents</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>108</volume>, <fpage>18465</fpage>–<lpage>18470</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1109353108</pub-id><pub-id pub-id-type="pmid">22025710</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skaper</surname><given-names>S. D.</given-names></name><name><surname>Facci</surname><given-names>L.</given-names></name><name><surname>Fusco</surname><given-names>M.</given-names></name><name><surname>Della Valle</surname><given-names>M. F.</given-names></name><name><surname>Zusso</surname><given-names>M.</given-names></name><name><surname>Costa</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain</article-title>. <source/>Inflammopharmacology
<volume>22</volume>, <fpage>79</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1007/s10787-013-0191-7</pub-id><pub-id pub-id-type="pmid">24178954</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>W. L.</given-names></name><name><surname>Garavito</surname><given-names>R. M.</given-names></name><name><surname>DeWitt</surname><given-names>D. L.</given-names></name></person-group> (<year>1996</year>). <article-title>Prostaglandin endoperoxide H synthases (cyclooxygenases)−1 and −2</article-title>. <source/>J. Biol. Chem.
<volume>271</volume>, <fpage>33157</fpage>–<lpage>33160</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.271.52.33157</pub-id><pub-id pub-id-type="pmid">8969167</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sokoloff</surname><given-names>P.</given-names></name><name><surname>Giros</surname><given-names>B.</given-names></name><name><surname>Martres</surname><given-names>M. P.</given-names></name><name><surname>Bouthenet</surname><given-names>M. L.</given-names></name><name><surname>Schwartz</surname><given-names>J. C.</given-names></name></person-group> (<year>1990</year>). <article-title>Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics</article-title>. <source/>Nature
<volume>347</volume>, <fpage>146</fpage>–<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1038/347146a0</pub-id><pub-id pub-id-type="pmid">1975644</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soliven</surname><given-names>B.</given-names></name></person-group> (<year>2001</year>). <article-title>Calcium signalling in cells of oligodendroglial lineage</article-title>. <source/>Microsc. Res. Tech.
<volume>52</volume>, <fpage>672</fpage>–<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1002/jemt.1051</pub-id><pub-id pub-id-type="pmid">11276119</pub-id></mixed-citation>
</ref>
<ref id="B232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spach</surname><given-names>K. M.</given-names></name><name><surname>Nashold</surname><given-names>F. E.</given-names></name><name><surname>Dittel</surname><given-names>B. N.</given-names></name><name><surname>Hayes</surname><given-names>C. E.</given-names></name></person-group> (<year>2006</year>). <article-title>IL-10 signaling is essential for 1,25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis</article-title>. <source/>J. Immunol.
<volume>177</volume>, <fpage>6030</fpage>–<lpage>6037</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.177.9.6030</pub-id><pub-id pub-id-type="pmid">17056528</pub-id></mixed-citation>
</ref>
<ref id="B233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spampinato</surname><given-names>S. F.</given-names></name><name><surname>Merlo</surname><given-names>S.</given-names></name><name><surname>Chisari</surname><given-names>M.</given-names></name><name><surname>Nicoletti</surname><given-names>F.</given-names></name><name><surname>Sortino</surname><given-names>M. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Glial metabotropic glutamate receptor-4 increases maturation and survival of oligodendrocytes</article-title>. <source/>Front. Cell. Neurosci.
<volume>8</volume>:<fpage>462</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00462</pub-id><pub-id pub-id-type="pmid">25642169</pub-id></mixed-citation>
</ref>
<ref id="B234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunahara</surname><given-names>R. K.</given-names></name><name><surname>Guan</surname><given-names>H. C.</given-names></name><name><surname>O’Dowd</surname><given-names>B. F.</given-names></name><name><surname>Seeman</surname><given-names>P.</given-names></name><name><surname>Laurier</surname><given-names>L. G.</given-names></name><name><surname>Ng</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>1991</year>). <article-title>Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1</article-title>. <source/>Nature
<volume>350</volume>, <fpage>614</fpage>–<lpage>619</lpage>. <pub-id pub-id-type="doi">10.1038/350614a0</pub-id><pub-id pub-id-type="pmid">1826762</pub-id></mixed-citation>
</ref>
<ref id="B235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>C. J.</given-names></name><name><surname>Bures</surname><given-names>M.</given-names></name><name><surname>Johnson</surname><given-names>M. P.</given-names></name><name><surname>Linden</surname><given-names>A. M.</given-names></name><name><surname>Monn</surname><given-names>J. A.</given-names></name><name><surname>Schoepp</surname><given-names>D. D.</given-names></name></person-group> (<year>2005</year>). <article-title>Metabotropic glutamate receptors as novel targets for anxiety and stress disorders</article-title>. <source/>Nat. Rev. Drug Discov.
<volume>4</volume>, <fpage>131</fpage>–<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1038/nrd1630</pub-id><pub-id pub-id-type="pmid">15665858</pub-id></mixed-citation>
</ref>
<ref id="B236">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tagami</surname><given-names>T.</given-names></name><name><surname>Yamamoto</surname><given-names>H.</given-names></name><name><surname>Moriyama</surname><given-names>K.</given-names></name><name><surname>Sawai</surname><given-names>K.</given-names></name><name><surname>Usui</surname><given-names>T.</given-names></name><name><surname>Shimatsu</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Identification of a novel human thyroid hormone receptor beta isoform as a transcriptional modulator</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>396</volume>, <fpage>983</fpage>–<lpage>988</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2010.05.038</pub-id><pub-id pub-id-type="pmid">20470753</pub-id></mixed-citation>
</ref>
<ref id="B238">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>J. L.</given-names></name><name><surname>Giuliani</surname><given-names>F.</given-names></name><name><surname>Power</surname><given-names>C.</given-names></name><name><surname>Imai</surname><given-names>Y.</given-names></name><name><surname>Yong</surname><given-names>V. W.</given-names></name></person-group> (<year>2003</year>). <article-title>Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity</article-title>. <source/>Ann. Neurol.
<volume>53</volume>, <fpage>588</fpage>–<lpage>595</lpage>. <pub-id pub-id-type="doi">10.1002/ana.10519</pub-id><pub-id pub-id-type="pmid">12730992</pub-id></mixed-citation>
</ref>
<ref id="B237">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>C.</given-names></name><name><surname>Muramatsu</surname><given-names>R.</given-names></name><name><surname>Fujimura</surname><given-names>H.</given-names></name><name><surname>Mochizuki</surname><given-names>H.</given-names></name><name><surname>Yamashita</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>Prostacyclin promotes oligodendrocyte precursor recruitment and remyelination after spinal cord demyelination</article-title>. <source/>Cell Death Dis.
<volume>4</volume>:<fpage>e795</fpage>. <pub-id pub-id-type="doi">10.1038/cddis.2013.335</pub-id><pub-id pub-id-type="pmid">24030147</pub-id></mixed-citation>
</ref>
<ref id="B239">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takesian</surname><given-names>A. E.</given-names></name><name><surname>Hensch</surname><given-names>T. K.</given-names></name></person-group> (<year>2013</year>). <article-title>Balancing plasticity/stability across brain development</article-title>. <source/>Prog. Brain Res.
<volume>207</volume>, <fpage>3</fpage>–<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/b978-0-444-63327-9.00001-1</pub-id><pub-id pub-id-type="pmid">24309249</pub-id></mixed-citation>
</ref>
<ref id="B240">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>R.</given-names></name><name><surname>Ma</surname><given-names>Z.</given-names></name><name><surname>Auerbach</surname><given-names>S. B.</given-names></name></person-group> (<year>2000</year>). <article-title>Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin</article-title>. <source/>J. Pharmacol. Exp. Ther.
<volume>294</volume>, <fpage>571</fpage>–<lpage>579</lpage>. <pub-id pub-id-type="pmid">10900234</pub-id></mixed-citation>
</ref>
<ref id="B241">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tata</surname><given-names>A. M.</given-names></name><name><surname>Calogero</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Muscarinic receptors and cancer: possible implications in tumors of the nervous system</article-title>. <source/>Curr. Trends Neurol.
<volume>4</volume>, <fpage>23</fpage>–<lpage>31</lpage>.</mixed-citation>
</ref>
<ref id="B242">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tata</surname><given-names>A. M.</given-names></name><name><surname>Cursi</surname><given-names>S.</given-names></name><name><surname>Biagioni</surname><given-names>S.</given-names></name><name><surname>Augusti-Tocco</surname><given-names>G.</given-names></name></person-group> (<year>2003</year>). <article-title>Cholinergic modulation of neurofilament expression and neurite outgrowth in chick sensory neurons</article-title>. <source/>J. Neurosci. Res.
<volume>73</volume>, <fpage>227</fpage>–<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.10650</pub-id><pub-id pub-id-type="pmid">12836165</pub-id></mixed-citation>
</ref>
<ref id="B243">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>W. D.</given-names></name><name><surname>MacFall</surname><given-names>J. R.</given-names></name><name><surname>Payne</surname><given-names>M. E.</given-names></name><name><surname>McQuoid</surname><given-names>D. R.</given-names></name><name><surname>Provenzale</surname><given-names>J. M.</given-names></name><name><surname>Steffens</surname><given-names>D. C.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Late-life depression and microstructural abnormalities in dorsolateral prefrontal cortex white matter</article-title>. <source/>Am. J. Psychiatry
<volume>161</volume>, <fpage>1293</fpage>–<lpage>1296</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.161.7.1293</pub-id><pub-id pub-id-type="pmid">15229065</pub-id></mixed-citation>
</ref>
<ref id="B244">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temple</surname><given-names>S.</given-names></name><name><surname>Raff</surname><given-names>M. C.</given-names></name></person-group> (<year>1986</year>). <article-title>Clonal analysis of oligodendrocyte development in culture: evidence for a developmental clock that counts cell divisions</article-title>. <source/>Cell
<volume>44</volume>, <fpage>773</fpage>–<lpage>779</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(86)90843-3</pub-id><pub-id pub-id-type="pmid">3948247</pub-id></mixed-citation>
</ref>
<ref id="B245">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theoharides</surname><given-names>T. C.</given-names></name><name><surname>Asadi</surname><given-names>S.</given-names></name><name><surname>Panagiotidou</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>A case series of a luteolin formulation (NeuroProtek<sup>®</sup>) in children with autism spectrum disorders</article-title>. <source/>Int. J. Immunopathol. Pharmacol.
<volume>25</volume>, <fpage>317</fpage>–<lpage>323</lpage>. <pub-id pub-id-type="pmid">22697063</pub-id></mixed-citation>
</ref>
<ref id="B246">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>S. A.</given-names></name></person-group> (<year>1982</year>). <article-title>Localization of immunoreactive prolactin in ependyma and circumventricular organs of rat brain</article-title>. <source/>Cell Tissue Res.
<volume>225</volume>, <fpage>79</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1007/bf00216220</pub-id><pub-id pub-id-type="pmid">7116429</pub-id></mixed-citation>
</ref>
<ref id="B247">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiberi</surname><given-names>M.</given-names></name><name><surname>Jarvie</surname><given-names>K. R.</given-names></name><name><surname>Silvia</surname><given-names>C.</given-names></name><name><surname>Falardeau</surname><given-names>P.</given-names></name><name><surname>Gingrich</surname><given-names>J. A.</given-names></name><name><surname>Godinot</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>1991</year>). <article-title>Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>88</volume>, <fpage>7491</fpage>–<lpage>7495</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.88.17.7491</pub-id><pub-id pub-id-type="pmid">1831904</pub-id></mixed-citation>
</ref>
<ref id="B248">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tosic</surname><given-names>M.</given-names></name><name><surname>Torch</surname><given-names>S.</given-names></name><name><surname>Comte</surname><given-names>V.</given-names></name><name><surname>Dolivo</surname><given-names>M.</given-names></name><name><surname>Honegger</surname><given-names>P.</given-names></name><name><surname>Matthieu</surname><given-names>J. M.</given-names></name></person-group> (<year>1992</year>). <article-title>Triiodothyronine has diverse and multiple stimulating effects on expression of the major myelin protein genes</article-title>. <source/>J. Neurochem.
<volume>59</volume>, <fpage>1770</fpage>–<lpage>1777</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.1992.tb11009.x</pub-id><pub-id pub-id-type="pmid">1383426</pub-id></mixed-citation>
</ref>
<ref id="B249">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tracey</surname><given-names>K. J.</given-names></name></person-group> (<year>2002</year>). <article-title>The inflammatory reflex</article-title>. <source/>Nature
<volume>420</volume>, <fpage>853</fpage>–<lpage>859</lpage>. <pub-id pub-id-type="doi">10.1038/nature01321</pub-id><pub-id pub-id-type="pmid">12490958</pub-id></mixed-citation>
</ref>
<ref id="B250">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trost</surname><given-names>S. U.</given-names></name><name><surname>Swanson</surname><given-names>E.</given-names></name><name><surname>Gloss</surname><given-names>B.</given-names></name><name><surname>Wang-Iverson</surname><given-names>D. B.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Volodarsky</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>The thyroid hormone receptor-beta-selective agonist GC-1 differentially affects plasma lipids and cardiac activity</article-title>. <source/>Endocrinology
<volume>141</volume>, <fpage>3057</fpage>–<lpage>3064</lpage>. <pub-id pub-id-type="doi">10.1210/en.141.9.3057</pub-id><pub-id pub-id-type="pmid">10965874</pub-id></mixed-citation>
</ref>
<ref id="B251">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trousson</surname><given-names>A.</given-names></name><name><surname>Makoukji</surname><given-names>J.</given-names></name><name><surname>Petit</surname><given-names>P. X.</given-names></name><name><surname>Bernard</surname><given-names>S.</given-names></name><name><surname>Slomianny</surname><given-names>C.</given-names></name><name><surname>Schumacher</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Cross-talk between oxysterols and glucocorticoids: differential regulation of secreted phopholipase A2 and impact on oligodendrocyte death</article-title>. <source/>PLoS One
<volume>4</volume>:<fpage>e8080</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0008080</pub-id><pub-id pub-id-type="pmid">19956653</pub-id></mixed-citation>
</ref>
<ref id="B252">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>H. H.</given-names></name><name><surname>Miller</surname><given-names>R. H.</given-names></name></person-group> (<year>2002</year>). <article-title>Glial cell migration directed by axon guidance cues</article-title>. <source/>Trends Neurosci.
<volume>25</volume>, <fpage>173</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1016/s0166-2236(00)02096-8</pub-id><pub-id pub-id-type="pmid">11998681</pub-id></mixed-citation>
</ref>
<ref id="B253">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuneishi</surname><given-names>S.</given-names></name><name><surname>Takada</surname><given-names>S.</given-names></name><name><surname>Motoike</surname><given-names>T.</given-names></name><name><surname>Ohashi</surname><given-names>T.</given-names></name><name><surname>Sano</surname><given-names>K.</given-names></name><name><surname>Nakamura</surname><given-names>H.</given-names></name></person-group> (<year>1991</year>). <article-title>Effects of dexamethasone on the expression of myelin basic protein, proteolipid protein, and glial fibrillary acidic protein genes in developing rat brain</article-title>. <source/>Brain Res. Dev. Brain Res.
<volume>61</volume>, <fpage>117</fpage>–<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1016/0165-3806(91)90121-x</pub-id><pub-id pub-id-type="pmid">1717183</pub-id></mixed-citation>
</ref>
<ref id="B254">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Der Zee</surname><given-names>E. A.</given-names></name><name><surname>De Jong</surname><given-names>G. I.</given-names></name><name><surname>Strosberg</surname><given-names>A. D.</given-names></name><name><surname>Luiten</surname><given-names>P. G. M.</given-names></name></person-group> (<year>1993</year>). <article-title>Muscarinic acetylcholine receptor-expression in astrocytes in the cortex of young and aged rats</article-title>. <source/>Glia
<volume>8</volume>, <fpage>42</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1002/glia.440080106</pub-id><pub-id pub-id-type="pmid">8509163</pub-id></mixed-citation>
</ref>
<ref id="B255">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Tol</surname><given-names>H. H.</given-names></name><name><surname>Bunzow</surname><given-names>J. R.</given-names></name><name><surname>Guan</surname><given-names>H. C.</given-names></name><name><surname>Sunahara</surname><given-names>R. K.</given-names></name><name><surname>Seeman</surname><given-names>P.</given-names></name><name><surname>Niznik</surname><given-names>H. B.</given-names></name><etal></etal></person-group>. (<year>1991</year>). <article-title>Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine</article-title>. <source/>Nature
<volume>350</volume>, <fpage>610</fpage>–<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1038/350610a0</pub-id><pub-id pub-id-type="pmid">1840645</pub-id></mixed-citation>
</ref>
<ref id="B256">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vartanian</surname><given-names>T.</given-names></name><name><surname>Szuchet</surname><given-names>S.</given-names></name><name><surname>Dawson</surname><given-names>G.</given-names></name><name><surname>Campagnoni</surname><given-names>A. T.</given-names></name></person-group> (<year>1986</year>). <article-title>Oligodendrocyte adhesion activates protein kinase C-mediated phosphorylation of myelin basic protein</article-title>. <source/>Science
<volume>234</volume>, <fpage>1395</fpage>–<lpage>1398</lpage>. <pub-id pub-id-type="doi">10.1126/science.2431483</pub-id><pub-id pub-id-type="pmid">2431483</pub-id></mixed-citation>
</ref>
<ref id="B257">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vestal-Laborde</surname><given-names>A. A.</given-names></name><name><surname>Eschenroeder</surname><given-names>A. C.</given-names></name><name><surname>Bigbee</surname><given-names>J. W.</given-names></name><name><surname>Robinson</surname><given-names>S. E.</given-names></name><name><surname>Sato-Bigbee</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>The opioid system and brain development: effects of methadone on the OL lineage and the early stages of myelination</article-title>. <source/>Dev. Neurosci.
<volume>36</volume>, <fpage>409</fpage>–<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1159/000365074</pub-id><pub-id pub-id-type="pmid">25138998</pub-id></mixed-citation>
</ref>
<ref id="B258">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vielkind</surname><given-names>U.</given-names></name><name><surname>Walencewicz</surname><given-names>A.</given-names></name><name><surname>Levine</surname><given-names>J. M.</given-names></name><name><surname>Bohn</surname><given-names>M. C.</given-names></name></person-group> (<year>1990</year>). <article-title>Type II glucocorticoid receptors are expressed in oligodendrocytes and astrocytes</article-title>. <source/>J. Neurosci. Res.
<volume>27</volume>, <fpage>360</fpage>–<lpage>373</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.490270315</pub-id><pub-id pub-id-type="pmid">2097380</pub-id></mixed-citation>
</ref>
<ref id="B259">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virchow</surname><given-names>R.</given-names></name></person-group> (<year>1854</year>). <article-title>“Über das ausgebreitete vorkommen einer dem nervenmark analogen substanz in den tierischen Geweben”</article-title>. <source/>Archiv für pathologische Anatomie und Physiologie und für klinische Medizin (in German)
<volume>6</volume>, <fpage>562</fpage>–<lpage>572</lpage>.</mixed-citation>
</ref>
<ref id="B260">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wake</surname><given-names>H.</given-names></name><name><surname>Ortiz</surname><given-names>F. C.</given-names></name><name><surname>Woo</surname><given-names>D. H.</given-names></name><name><surname>Lee</surname><given-names>P. R.</given-names></name><name><surname>Angulo</surname><given-names>M. C.</given-names></name><name><surname>Fields</surname><given-names>R. D.</given-names></name></person-group> (<year>2015</year>). <article-title>Nonsynaptic junctions on myelinating glia promote preferential myelination of electrically active axons</article-title>. <source/>Nat. Commun.
<volume>6</volume>:<fpage>7844</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms8844</pub-id><pub-id pub-id-type="pmid">26238238</pub-id></mixed-citation>
</ref>
<ref id="B261">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>L.</given-names></name><name><surname>Stella</surname><given-names>N.</given-names></name></person-group> (<year>2004</year>). <article-title>Cannabinoids and neuroinflammation</article-title>. <source/>Br. J. Pharmacol.
<volume>141</volume>, <fpage>775</fpage>–<lpage>785</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0705667</pub-id><pub-id pub-id-type="pmid">14757702</pub-id></mixed-citation>
</ref>
<ref id="B262">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walz</surname><given-names>W.</given-names></name><name><surname>Ilschner</surname><given-names>S.</given-names></name><name><surname>Ohlemeyer</surname><given-names>C.</given-names></name><name><surname>Banati</surname><given-names>R.</given-names></name><name><surname>Kettenmann</surname><given-names>H.</given-names></name></person-group> (<year>1993</year>). <article-title>Extracellular ATP activates a cation conductance and a K<sup>+</sup> conductance in cultured microglial cells from mouse brain</article-title>. <source/>J. Neurosci.
<volume>13</volume>, <fpage>4403</fpage>–<lpage>4411</lpage>. <pub-id pub-id-type="pmid">7692013</pub-id></mixed-citation>
</ref>
<ref id="B264">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Qiao</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Zhu</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Desvenlafaxine prevents white matter injury and improves the decreased phosphorylation of the rate-limiting enzyme of cholesterol synthesis in a chronic mouse model of depression</article-title>. <source/>J. Neurochem.
<volume>131</volume>, <fpage>229</fpage>–<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.12792</pub-id><pub-id pub-id-type="pmid">24934403</pub-id></mixed-citation>
</ref>
<ref id="B263">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Yan</surname><given-names>Y.</given-names></name><name><surname>Kintner</surname><given-names>D. B.</given-names></name><name><surname>Lytle</surname><given-names>C.</given-names></name><name><surname>Sun</surname><given-names>D.</given-names></name></person-group> (<year>2003</year>). <article-title>GABA-mediated trophic effect on oligodendrocytes requires Na-K-2Cl cotransport activity</article-title>. <source/>J. Neurophysiol.
<volume>90</volume>, <fpage>1257</fpage>–<lpage>1265</lpage>. <pub-id pub-id-type="doi">10.1152/jn.01174.2002</pub-id><pub-id pub-id-type="pmid">12904508</pub-id></mixed-citation>
</ref>
<ref id="B2630">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>P. A.</given-names></name><name><surname>Newman</surname><given-names>L. J.</given-names></name></person-group> (<year>1969</year>). <article-title>A neutrophil chemotactic factor from human C’5</article-title>. <source/>J. Immunol.
<volume>102</volume>, <fpage>93</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="pmid">5765461</pub-id></mixed-citation>
</ref>
<ref id="B265">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname><given-names>P.</given-names></name><name><surname>Pitt</surname><given-names>D.</given-names></name><name><surname>Raine</surname><given-names>C. S.</given-names></name></person-group> (<year>2001</year>). <article-title>Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage</article-title>. <source/>Ann. Neurol.
<volume>50</volume>, <fpage>169</fpage>–<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1002/ana.1077</pub-id><pub-id pub-id-type="pmid">11506399</pub-id></mixed-citation>
</ref>
<ref id="B266">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wess</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications</article-title>. <source/>Annu. Rev. Pharmacol. Toxicol.
<volume>44</volume>, <fpage>423</fpage>–<lpage>450</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.pharmtox.44.101802.121622</pub-id><pub-id pub-id-type="pmid">14744253</pub-id></mixed-citation>
</ref>
<ref id="B267">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wessler</surname><given-names>I.</given-names></name><name><surname>Kilbinger</surname><given-names>H.</given-names></name><name><surname>Bittinger</surname><given-names>F.</given-names></name><name><surname>Unger</surname><given-names>R.</given-names></name><name><surname>Kirkpatrick</surname><given-names>C. J.</given-names></name></person-group> (<year>2001</year>). <article-title>The biological role of non-neuronal acetylcholine in plants and humans</article-title>. <source/>Jpn. J. Pharmacol.
<volume>85</volume>, <fpage>2</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1254/jjp.85.2</pub-id><pub-id pub-id-type="pmid">11243568</pub-id></mixed-citation>
</ref>
<ref id="B268">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>G. R.</given-names></name></person-group> (<year>2000</year>). <article-title>Cloning and characterization of two novel thyroid hormone receptor beta isoforms</article-title>. <source/>Mol. Cell. Biol.
<volume>20</volume>, <fpage>8329</fpage>–<lpage>8342</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.20.22.8329-8342.2000</pub-id><pub-id pub-id-type="pmid">11046130</pub-id></mixed-citation>
</ref>
<ref id="B269">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>Y. L.</given-names></name><name><surname>Röth</surname><given-names>P. T.</given-names></name><name><surname>Stratton</surname><given-names>J. A.</given-names></name><name><surname>Chuang</surname><given-names>B. H.</given-names></name><name><surname>Danne</surname><given-names>J.</given-names></name><name><surname>Ellis</surname><given-names>S. L.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination</article-title>. <source/>J. Neurosci.
<volume>34</volume>, <fpage>14128</fpage>–<lpage>14146</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3491-13.2014</pub-id><pub-id pub-id-type="pmid">25319708</pub-id></mixed-citation>
</ref>
<ref id="B270">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Sari</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>F. C.</given-names></name></person-group> (<year>2004</year>). <article-title>Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development</article-title>. <source/>Brain Res. Dev. Brain Res.
<volume>150</volume>, <fpage>151</fpage>–<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1016/j.devbrainres.2003.02.001</pub-id><pub-id pub-id-type="pmid">15158078</pub-id></mixed-citation>
</ref>
<ref id="B271">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamazaki</surname><given-names>Y.</given-names></name><name><surname>Hozumi</surname><given-names>Y.</given-names></name><name><surname>Kaneko</surname><given-names>K.</given-names></name><name><surname>Sugihara</surname><given-names>T.</given-names></name><name><surname>Fujii</surname><given-names>S.</given-names></name><name><surname>Goto</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Modulatory effects of oligodendrocytes on the conduction velocity of velocity of action potentials along axons in the alveus of rat CA1 hippocampal region</article-title>. <source/>Neuron Glia Biol.
<volume>3</volume>, <fpage>325</fpage>–<lpage>334</lpage>. <pub-id pub-id-type="doi">10.1017/S1740925x08000070</pub-id><pub-id pub-id-type="pmid">18634564</pub-id></mixed-citation>
</ref>
<ref id="B273">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name></person-group> (<year>2008</year>). <article-title>Sex differences in the white matter and myelinated nerve fibers of Long-Evans rats</article-title>. <source/>Brain Res.
<volume>1216</volume>, <fpage>16</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2008.03.052</pub-id><pub-id pub-id-type="pmid">18486116</pub-id></mixed-citation>
</ref>
<ref id="B272">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Ross</surname><given-names>M. E.</given-names></name><name><surname>Iadecola</surname><given-names>C.</given-names></name></person-group> (<year>2003</year>). <article-title>Attenuation of activity-induced increases in cerebellar blood flow in mice lacking neuronal nitric oxide synthase</article-title>. <source/>Am. J. Physiol. Heart Circ. Physiol.
<volume>285</volume>, <fpage>H298</fpage>–<lpage>H304</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00043.2003</pub-id><pub-id pub-id-type="pmid">12623792</pub-id></mixed-citation>
</ref>
<ref id="B274">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>H. H.</given-names></name><name><surname>Ding</surname><given-names>J. H.</given-names></name><name><surname>Zhou</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Hu</surname><given-names>L. F.</given-names></name><name><surname>Sun</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Enhancement of glutamate uptake mediates the neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes</article-title>. <source/>J. Neurochem.
<volume>92</volume>, <fpage>948</fpage>–<lpage>961</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02937.x</pub-id><pub-id pub-id-type="pmid">15686497</pub-id></mixed-citation>
</ref>
<ref id="B275">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>P. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Physiological and molecular basis of thyroid hormone action</article-title>. <source/>Physiol. Rev.
<volume>81</volume>, <fpage>1097</fpage>–<lpage>1142</lpage>. <pub-id pub-id-type="pmid">11427693</pub-id></mixed-citation>
</ref>
<ref id="B276">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yong</surname><given-names>V. W.</given-names></name><name><surname>Dooley</surname><given-names>N. P.</given-names></name><name><surname>Noble</surname><given-names>P. G.</given-names></name></person-group> (<year>1994</year>). <article-title>Protein kinase C in cultured adult human oligodendrocytes: a potential role for isoform alpha as a mediator of process outgrowth</article-title>. <source/>J. Neurosci. Res.
<volume>39</volume>, <fpage>83</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.490390111</pub-id><pub-id pub-id-type="pmid">7807594</pub-id></mixed-citation>
</ref>
<ref id="B277">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>A. S.</given-names></name><name><surname>Krieger</surname><given-names>C.</given-names></name><name><surname>Kim</surname><given-names>S. U.</given-names></name></person-group> (<year>1999</year>). <article-title>Process extension and intracellular Ca<sup>2+</sup> in cultured murine oligodendrocytes</article-title>. <source/>Brain Res.
<volume>827</volume>, <fpage>19</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/s0006-8993(99)01282-2</pub-id><pub-id pub-id-type="pmid">10320689</pub-id></mixed-citation>
</ref>
<ref id="B278">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhornitsky</surname><given-names>S.</given-names></name><name><surname>Johnson</surname><given-names>T. A.</given-names></name><name><surname>Metz</surname><given-names>L. M.</given-names></name><name><surname>Weiss</surname><given-names>S.</given-names></name><name><surname>Yong</surname><given-names>V. W.</given-names></name></person-group> (<year>2015</year>). <article-title>Prolactin in combination with interferon-β reduces disease severity in an animal model of multiple sclerosis</article-title>. <source/>J. Neuroinflammation
<volume>12</volume>:<fpage>55</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-015-0278-8</pub-id><pub-id pub-id-type="pmid">25889599</pub-id></mixed-citation>
</ref>
<ref id="B279">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Anderson</surname><given-names>D. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors</article-title>. <source/>Neuron
<volume>25</volume>, <fpage>331</fpage>–<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(00)80898-3</pub-id><pub-id pub-id-type="pmid">10719889</pub-id></mixed-citation>
</ref>
<ref id="B280">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoeller</surname><given-names>R. T.</given-names></name><name><surname>Rovet</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings</article-title>. <source/>J. Neuroendocrinol.
<volume>16</volume>, <fpage>809</fpage>–<lpage>818</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2826.2004.01243.x</pub-id><pub-id pub-id-type="pmid">15500540</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>